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Abstract 
This Thesis investigates immobilised metal- and biocatalysts for continuous 
reactions in scC02• Chemical transformations with high atom economy and 
low E-factor (amount of waste per kg of product) are highly desired in the 
green chemical viewpoint. One of the approaches to decrease the production of 
waste is the use of catalysis (possibly highly selective). Another approach is 
the use of a 'green' reaction medium as a substitute for traditional solvents that 
can reduce the production of harmful solvent waste. How this Thesis 
encompasses by these topics is discussed in Chapter 1. 
The details of the apparatus, experimental and analytical equipments and 
procedures are reported in Chapter 2. 
The field of asymmetric catalytic hydrogenation is a currently important and 
expanding field of research. In Chapters 3 and 4, the continuous asymmetric 
hydrogenation of dimethyl itaconate is covered. High enantioselectivity (ees up 
to 83 %) was obtained in the continuous asymmetric hydrogenation of 
dimethyl itaconate catalysed by supported homogeneous chiral Rh catalysts on 
alumina in SCC02 (Chapter 3). This is one of the first examples of the use of 
chiral catalyst in a continuous flow system without the need for the addition of 
the chiral modifier. The continuous asymmetric hydrogenation of dimethyl 
itaconate was also examined with chiral Rh catalysts immobilised in ionic 
liquids in a biphasic system ionic liquid/scC02 (Chapter 4). High 
enantioselectivity was achieved in the continuous flow system: ees up to 76 %. 
Chapter 5 describes the kinetic resolution of secondary alcohols catalysed by 
immobilised Candida antarctica lipase B (Cal B) in a continuous flow SCC02 
system. The continuous kinetic resolution of a-tetralol with Cal B immobilised 
in the form of Cross-Linked Enzyme Aggregate (CLEA) gave excellent 
enantioselectivity (eeR to 99 %). Different acyl donors (vinyl acetate, phenyl 
acetate and p-nitrophenyl acetate) were investigated, and were shown to 
influence the enantioselectivity of the reaction. 
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In Chapter 6, a two step catalytic cascade reaction is described in a continuous 
flow scC02 system: hydrogenation of acetophenone with a Pd catalyst (Pd 
Type 31) followed by the kinetic resolution of the product with Cal B CLEA. 
The series reaction gave good results even when un-optimised: 
• Step 1 (hydrogenation of acetophenone): conversion up to 91 % 
• Step 2 (kinetic resolution of (R/S)-l-phenylethanol): conversion of 
(R)-l-phenylethanol up to 22 %, enantioselectivity (R) > 99 %. 
Chapter 7 details the preparation of cholesterol oxidase CLEA and 
combi-CLEA of cholesterol oxidase and catalase, and their application for the 
continuous oxidation of cholesterol in scC02 with 'in-flow' cholesterol 
extraction. CLEA were successfully prepared with high retained activity: 
• Individual cholesterol oxidase CLEA: cholesterol oxidase activity up to 
99 % (relative to native), 
• Combi-CLEA: cholesterol oxidase activity up to 99 % (relative to 
native), catalase activity up to 53 % (relative to native). 
Unfortunately, the activity of the CLEA in the continuous oxidation was low, 
however, the findings of this work will aid in improving the performance of 
the continuous catalytic oxidation of cholesterol in the future. 
The possible future directions of this research are presented in Chapter 8. 
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List of Abbreviations 
Methods and materials: 
a-tetralol - 1 ,2,3,4-tetrahydro naphtol 
AGG - Aggregate 
Amms - Ammonium sulfate solution (aqueous, saturated) 
Ani - Aspergillus niger lipase 
BINAP - 2,2'-bis(diphenylphosphino)-1,1 '-binaphthyl 
[BMIM] - I-butyl-3-methylimidazolium 
[BMIM][BF4] - I-butyl-3-methylimidazolium tetrafluoroborate 
[BMIM] [BTA] - I-butyl-3-methylimidazolium bis(trifluoromethylsulfonyl) 
amide 
[BMIM][N(CNh] - I-butyl-3-methylimidazolium dicyanamide 
[BMIM][NTf2] - I-butyl-3-methylimidazolium bis(trifluoromethylsulfonyl) 
imide 
BPR - Back Pressure Regulator 
Cal A - Candida antarctica lipase A 
Cal B - Candida antarctica lipase B 
CAT AXAI Alumina - Rh[(COD)2t[BF 4FPT N Alumina 
CATAXAICarbon - Rh[(COD)2t[BF4rtPTNCarbon 
CD - Cyclodextrin 
CLE - Cross-Linked Enzyme 
CLEA - Cross-Linked Enzyme Aggregate 
CLEC - Cross-Linked Enzyme Crystal 
COD - 1,5-cyc1o-octadiene 
CRY - Crystal 
CSDE - Cross-Linked Spray Dried Enzyme 
dH20 - Distilled water 
DKR - Dynamic Kinetic resolution 
DLS - Dynamic Light Scattering 
DME - Dimethoxyethane (ethyleneglycol dimethyl ether) 
DMIT - Dimethyl itaconate 
DPA - Dextran polyaldehyde (solution in water) 
VI 
DPA 200 - Dextran polyaldehyde (200 J.lL DPA solution/mL enzyme solution) 
DPA 400 - Dextran polyaldehyde (400 J.lL DP A solution/mL enzyme solution) 
[EM 1M] - l-ethyl-3-methylimidazolium 
FAD - Flavin Adenine Dinucleotide 
FlD - Flame Ionisation Detector 
GA - Glutaraldehyde 
GA 10 - Glutaraldehyde (10 mM solution in water) 
GA 50 - Glutaraldehyde (50 mM solution in water) 
GLC - Gas-Liquid Chromatography 
HPLC - High Performance Liquid Chromatography 
HRP - Horseradish peroxidise 
ICP-MS - Inductively Coupled Plasma Mass Spectrometry 
IL - Ionic Liquid 
IP A - Iso-propanol or 2-propanol 
KR - Kinetic resolution 
NADPH - Nicotinamide Adenosine Diphosphate 
nbd - 2,5-norbomadiene 
PTA - Phosphotungstic acid H3040PW12 
Rml- Rhizomucor miehei lipase 
R2P*-P*R2 - Bisphosphine ligand 
RTIL - Room Temperature Ionic Liquid 
sc - Supercritical 
SCF - Supercritical fluid 
SDE - Spray dried enzyme 
SDS-P AGE - Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
SEM - Scanning Electron Microscopy 
SILP - Silica supported Ionic Liquid Phase 
SPB-20 - Poly(20% phenyV80% dimethylsiloxane) 
SPB-35 - Poly(35% diphenyl/ 65% dimethylsiloxane) 
TBDMS - Tert-butyldimethylsilyl 
TfO - Trifluoromethanesulfonate 
TMOS - Si(OMe)4 
UV -Vis - Ultraviolet-Visible Spectroscopy 
Vll 
VOC - Volatile organic compound 
VVVC - Variable volume view cell 
Physical-chemical parameters: 
dinner - Inner diameter of a tube 
ee- Enantiomeric excess, enantioselectivity 
ee(%) = [enentiomer A - enantiomerB] x 100 
[enantiomerA + enantiomerB] 
E-value - A measure of enantioselectivity (value > 100 indicate highly 
enantioselective reaction). It is calculated using the equation below. 
E = In[l- c(1 + eeR-acelale )] 
In[l- c(l- eeR-acetale)] 
E-factor - defined as amount of waste per kg of product. A parameter to report 
waste emission rate of chemical processes. 
EQ - Environmental quotient 
ppm - Part per million 
Q - Unfriendliness quotient 
TON - Turnover Number 
U - Enzyme Unit: that amount of the enzyme that catalyses the conversion of I 
micro mol of substrate per minute 
General: 
JM - Johnson Matthey PIc. (UK) 
NIST - National Institute of Standards and Technology 
SOP - Standard Operating Procedure 
Important notes 
C02 flow rate: The flow rate is given as volumetric flow rate (mLlmin). The 
corresponding temperature and pressure were -10 ·C and 40-50 bar. 
Experimental error: The experimental error (as standard deviation of 
enantioselectivity and conversion values) was not determined in each case 
throughout this study (Chapters 3 and 4), however, it is shown in most cases 
(Chapters 5, 6, and 7). Where no error bars are found in Chapters 5, 6, and 7 
the experimental error was very low. 
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Chapter 1 
Introduction 
This Thesis describes the use of supercritical flow reactors with heterogeneous 
catalysts (metal catalysts and enzymes). Supported homogeneous chiral Rh 
catalysts were used to investigate the enantioselective hydrogenation of 
dimethyl itaconate in a continuous flow SCC02 system (Chapter 3 and 
Chapter 4). Immobilised lipase in the form of Cross-Linked Enzyme 
Aggregate (CLEA) was examined for the continuous kinetic resolution of 
a-tetralol in scC02 (Chapter 5), and for the continuous kinetic resolution of 
I-phenylethanol in SCC02 as a step of a catalytic cascade reaction (Chapter 6). 
Furthermore, CLEA of cholesterol oxidase and combi-CLEAs of cholesterol 
oxidase and catalase were investigated for the continuous oxidation of 
cholesterol in scC02 with 'in-flow' extraction of cholesterol (Chapter 7). The 
possible future directions are detailed in Chapter 8. The aim of this Chapter is 
to introduce the importance of Green Chemistry and Catalysis, followed by an 
outline of catalyst immobilisation techniques and the potentials of supercritical 
CO2 (scC02) and other alternative 'green' solvents. 
1.1. Green Chemistry 
Chemistry has greatly improved the quality of our life in the 20th century. 
Some of the first symptoms of the damage caused by the global development 
to be recognised are the climate change and depletion of the ozone layer. I-8 
New environmentally friendly, sustainable and also cost-effective products and 
processes are therefore required. Sustainable development will improve the 
quality of life, not just the rate of development. 
Green chemistry is a comprehensive approach to the application of chemicals 
and their reactions, which aims to eliminate hazardous wastes and reduce 
pollution.9 In 1998, the 12 principles of Green Chemistry were created which 
can serve as a rough guide for green chemical process design.9 The 12 
principles of Green Chemistry are the following. 
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1. Prevention: It is better to prevent waste than to treat or clean up waste after 
it has been created. 
2. Atom Efficiency: Synthetic methods should be designed to maximise the 
incorporation of all materials used in the chemical process. 
3. Less Hazardous Chemical Syntheses: Wherever practicable, synthetic 
methodologies should be developed to use and generate substances that 
possess little or no toxicity to human health and the environment. 
4. Designing Safer Chemicals: Chemical products should be designed to 
preserve their efficacy of function while reducing toxicity. 
5. Safer Solvents and Auxiliaries: The use of auxiliary substances (e.g. 
solvents, separation agents, etc) should be made unnecessary wherever 
possible and, innocuous when used. 
6. Design for Energy Efficiency: Energy requirements should be recognised 
for their environmental and economic impacts and should be minimised. If 
possible, synthetic methods should be conducted at ambient temperature and 
pressure. 
7. Use of Renewable Feedstocks: A raw material or feedstock should be 
renewable rather than depleting wherever technically and economically 
practicable. 
8. Minimise Derivatisation: Unnecessary derivatisation (blocking group, 
protection! deprotection, temporary modification of physical! chemical 
processes) should be avoided whenever possible. 
9. Catalysis: Catalytic reagents (as selective as possible) are superior to 
stoichiometric reagents. 
10. Design for Degradation: Chemical products should be designed so that at 
the end of their function they do not persist in the environment and break down 
into innocuous degradation products. 
11. Real-time Analysis: Analytical methods should be developed to allow 
real-time in situ monitoring and control prior to the formation of hazardous 
substances. 
12. Safer Chemical Processes for Accident Prevention: Substances and the 
form of a substance used in a chemical process should be chosen so as to 
minimise the potential for chemical accidents, including releases, explosions 
and fires. 
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In this study, alternative solvents (Principle 5) and catalysis (Principle 9) were 
applied to design sustainable chemical processes. The environmental impact of 
chemical processes can be significantly reduced by the replacement of harmful 
solvents with more environmentally friendly/' alternative' solvents. 10. 14 A 
discussion of alternative solvents can be found below in this Chapter. The 
other approach was the application of catalysis in the production of chemicals, 
which can decrease the production of waste because catalytic reactions have 
high atom economy and catalysts can also be recycled.9• 10 
It is important to quantify the sustainability and efficiency of chemical 
processes. As Lord Kelvin said "when you can measure what you are speaking 
about, and express it in numbers, you know something about it" (1883). One of 
the qualifying measures is the E-factor (amount of waste per kg of product) 
created by Roger Sheldon where waste is defined as everything produced in 
the process except the desired product.9•12 The E-factors of various sectors of 
the chemical industry are available and shown in Table 1-1. 
Table 1-1. The E-factor for few segments of the chemical industry.ll 
Industr sector 
Oil refining 
Bulk chemicals 
Fine chemicals 
Pharmaceuticals 
roduct 
5 ~ > 5 0 0
25 -> 100 
The E-factor is a widely used parameter to report the waste emission rate of 
chemical processes. The E-factor is significantly larger for fine chemicals and 
pharmaceuticals probably due to the application of multi-step processes where 
many of these steps may use stoichiometric reagents rather than catalytic 
methods, and complex purification procedures, which can further increase the 
E-factor. Another measure, the environmental quotient (EQ) of individual 
chemical routes gives refined information about the environmental impact. The 
EQ is E-factor multiplied by an unfriendliness quotient (Q).13 For example, 
NaCI could be assigned by a Q value of 1 and heavy metal salts by 100-1000, 
depending on their toxicity, ease of recycling, etc. 
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Waste production depends on the selectivity of each step of a synthetic 
process. By studying the overall stoichiometry of the reaction, the atom 
selectivity or atom utilisation can be measured. Using the atom utilisation of a 
reaction, the amount of waste generated can be quickly evaluated. 14 
1.2. Catalyst Immobilisation 
Catalysis is widely used in organic synthesis1S, 16 and can be performed under 
homogeneous or heterogeneous conditions. The heterogeneous system has 
several benefits over the homogeneous method. Heterogeneous catalysis 
facilitates the catalyst recovery and product separation which is complicated in 
a homogeneous system. The immobilisation of homogeneous catalysts may 
also improve the catalyst stability and performance. 17-21 
Immobilised catalysts can be discussed as carrier-bond and carrier-free. 18 
Although the support material carries bulk matter into the system of 
carrier-bound enzymes, it can enhance the catalytic performance and 
stability. 17-21 Carrier-free immobilised catalysts can overcome the problem of 
the bulk matter by linking the catalyst particles to each other which is 
eliminating the need for support material. 18 In this case, the only inactive mass 
is that of the cross-linker that usually is negligible compared to the catalyst. 
Cross-Linked Enzymes (CLE), Cross-Linked Enzyme Crystals (CLEC), 
Cross-Linked Spray Dried Enzymes (CSDE) and Cross-Linked Enzyme 
Aggregates (CLEA) belong to the family of carrier-free immobilised 
enzymes.18 They are discriminated from each other by the precursor that is 
cross-linked (Scheme 1-1). The advantages and disadvantages of carrier-free 
immobilised enzymes are summarised in Table 1-2. 
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Table 1-2. The advantages and disadvantages of carrier-free immobilised enzymes. 
Precursor Advantages Disadvantages 
CLE - Cross-Linked Enzyme Dissolved enzyme Enhanced thermostability (that requires Low activity retain (usually below 50 % 
a delicate balance between the amount of the native enzyme) 
of cross linker, temperature, pH, ionic Poor reproducibility 
strength) Low mechanical stability 
Difficulties in handling of gelatinous 
CLE and controlling geometric 
parameters 
CLEC - Cross-Linked Enzyme Crystalline enzyme Relatively high retained activity (30 - Need for high purity enzyme 
Crystal 70 % of the native enzyme i 3 Need to crystallise the enzyme 
Enhanced thermostability and Crystal size is crucial for high activilf6, 
mechanical stability relative to CLE24 therefore need for the optimisation of 
Broad pH and temperature stabililf5,26 the crystal form 
High stability against organic solvents26, 
27 
CSDE - Cross-Linked Spray Spray dried enzyme Powder - easy to handle Spray drying reversibly deactivates the 
Dried Enzyme CDSE is till to be exploited enzyme 
Relatively low activity compared to 
CLE, CLEC, and CLEA 28 
CLEA - Cross-Linked Enzyme Physically Simple preparation procedure The catalytic behaviour depends on the 
Aggregates aggregated enzyme Precursor is prepared by physical precipitant29 
aggregation of the enzyme 
Precipitation also purifies the enzyme 
High thermostability, mechanical 
stability, and against organic solvents 
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Dissolved enzyn e 
o ~ ~:s 0'0 
Cross-linker 
~ R Y Y ~ ~ E E
CLEC CLEA CSDE CLE 
Scheme 1-1. Carrier-free immobilised enzymes. IS 
The Cross-Linked Enzyme Aggregate (CLEA) method is the most recently 
developed carrier-free immobilisation technique. 29• 3o A number of enzymes 
have already been immobilised successfully as CLEA 10• 29. 3 1-4 1 and there are 
few examples for combi-CLEA. 10• 42-44 The carrier-free nature, the high 
vo lumetric activity (U/g), the simple preparation, the high stability of the 
enzyme in the CLEA form, and the ease of recyclability make it widely 
attractive. 21 • 45 A 'spin-out ' company, CLEA Technologies46 has been 
established by the developer, Professor Roger Sheldon where specific research 
on CLEA of various enzymes is being performed. 
The CLEA is prepared by changing the proximity of the soluble enzyme 
particles to form aggregates: the addition of an appropriate aggregation agent 
changes the electrostatic properties of the solution and the enzyme particles 
associate and become insoluble. The aggregates of the native enzyme can be 
cross-linked using a bifunctional cross-linker (generaIly glutaraldehyde). The 
CLEAtion process consists of two steps, physical aggregation and 
cross-linking.3o The most commonly used precipitants are iso-propanol, 
acetone, ethanol, tert-butanol, dimethoxyethane (ethyleneglycol dimethyl 
ether), acetonitrile (90 % v/v) and ammonium sulfate.3o The second step of the 
process is the cross-linking of the solid particles which is performed with 
bifunctional linker molecules, usually dialdehydes. The most commonly used 
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linker is glutaraldehyde, however, other materials have also been used for 
example dextran polyaldehyde and polymeric dialdehydes ?9, 47, 48 The 
cross-linking requires amine groups of the lysine on the protein to be available 
to be linked to the aldehyde group of the cross-linker (Scheme 1-2). The 
success of the cross-linking depends on the number (and position) of available 
amine groups. The most reactive amine groups can be found on the lysine 
amino acid residue. If the cross-linker enters the active site of the enzyme and 
links to an amine group of a key amino acid, this particular enzyme unit will 
become inactive. 
e n Z Z ~ N H H(LV 2 OHC f::oss l i ~ ~ C H O O~ ~ e h Y V V
~ - - 2 0 0 cross-linking (di aldehyde) 
H ? N ~ y m e e
- ~ y s ) )
~ ~ -H20 
e n z z ~ _ _ NH-CH?!crOSS link:'\H C-H 
(LYV - ~ a l d e e Y d ~ ~ 2 
(.:zyme 
~ Y S ) )
Scheme 1-2. The cross-linking: reaction between an amino group of the 
lysine residue of the enzyme and an aldehyde group of the cross-linker. 
The work in this Thesis investigated the preparation of cholesterol oxidase 
CLEA and combi-CLEA of cholesterol oxidase and catalase. Cholesterol 
oxidase from Nocardia sp. and catalase from bovine liver were used for the 
studies. Both cholesterol oxidase from Nocardia sp. and catalase from bovine 
liver are cofactor dependent, FAD and NADPH, respectively, which are 
essential for their catalytic activity. The sequence and crystal structure of 
cholesterol oxidase from Nocardia sp. has not yet been published in the 
literature but cholesterol oxidase from Streptomyces sp. has been studied more 
extensively than cholesterol oxidase from Nocardia sp., and more than 
20 lysine residues were found in its structure.49 (Detailed description of 
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cholesterol oxidases can be found in Chapter 7.) Cholesterol oxidase from 
Nocardia sp. is therefore assumed to contain a sufficient number of amine 
groups of lysine residue required for cross-linking. The second enzyme of the 
combi-CLEA was catalase from bovine liver that contains 108 lysines in its 
structure. 50 Due to the large number of lysine residues in the structure of both 
cholesterol oxidase from Nocardia sp. and catalase from bovine liver, they are 
both potentially good candidates for being immobilised by cross-linking. 
Besides heterogenising homogeneous catalysts, the use of multiphase systems 
for catalytic reactions such as aqueous biphasic systems, fluorous biphasic 
systems, and a biphasic system ionic liquid/scC02 (where the homogeneous 
catalyst is immobilised in one of the phases) also offers promising 
opportunities. In principle, the catalyst is soluble only in one of the phases and 
the substrate/product in the other phase, which offers an easy separation of the 
catalyst and the prodUCt.l0, 51-53 A number of research groups has investigated 
this field as summarised in the reviews of Keim54 and Tundo.55 
1.3. Alternative Solvents 
One of the main concerns in Green Chemistry is the replacement of 
'traditional' solvents, chlorinated solvents and VOCs with environmentally 
benign (alternative) solvents.9, 10 The application of alternative solvents in the 
manufacture of chemicals can reduce the environmental impact and can also 
provide benefits by their unique physical and chemical properties.56 The ease 
of product and catalyst separation, and reduced waste disposal cost also create 
motivating aspects for their application?O, 51,57-60 Alternative solvents can be 
grouped as follows. 
i. Fluorinated solvents 
11. Ionic liquids (detailed description in Chapter 4) 
Ill. Supercritical fluids 
Conducting reactions in a solventless environment52 would be ideal in order to 
meet the conditions discussed previously but is not widely applicable because 
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of the need to remove heat from the reaction , mIx reagents , and transport 
reagents and products. 
1.3.1. Water 
Although water is not classed as an alternative solvent, it is discussed here 
because of its high environmentally benign nature. It is widely accepted that 
"the best solvent is no solvent" but when a solvent is required the second best 
is often water. Some of the advantages of water are the environmentally benign 
nature, non-toxicity and non-flammability. The disadvantages are the 
following 
• Difficulty of recovering materials (product, catalyst) from water 
• Purifying water before releasing it back to the ecosystem. 
Reactions can be conducted in water or in aqueous biphasic system. There are 
several methods to make materials soluble/dispersible in water61 for example 
use of surfactants, cosolvents, hydrophilic agents. In a liquid-liquid biphasic 
system where one of the immiscible phases is water, one of the phases 
dissolves the catalyst and the other one contains the substrate(s) and 
product(s), which therefore allows simple product separation and catalyst 
recovery. An example of large scale application of an aqueous biphasic system 
is the Ruhrchemie/Rhone-Poulenc process for the hydroformylation of 
propylene to n-butanal (Scheme 1_3).62, 63 
H 3 C ~ ~
organic phase 
cata lyst 
aqueous phase 
Scheme 1-3. The hydroformylation of propylene to n-butanal performed 
in aqueous biphasic system, the Ruhrchemie/Rhone-Poulenc process.62• 63 
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1.3.2. Fluorinated Solvents 
Fluorinated solvents are materials where the majority of C-H bonds have been 
replaced by C-F bonds. Fluorinated solvents can be used as reaction medium 
when an undesired reaction occurs in water and are usually used in a biphasic 
system. A fluorous biphasic system consist of a fluorous phase with the 
fluorous soluble reactants and catalyst, and a second organic or inorganic 
phase that has limited solubility with the fluorous phase.64 The catalyst can be 
dissolved in a fluorinated solvent by linking fluorocarbon substituents to it.64 
Certain solvents can turn to a single phase by heating in a fluorous biphasic 
system65, for example n-hexane, toluene, or c-C6F 11 CF3 at 36.5 °C, which can 
therefore combine the advantage of conducting the reaction in single phase at 
higher temperature and retaining the ease of separation by phase separation at 
lower temperature. The schematic of a fluorous biphasic catalytic system is 
shown in Scheme 1-4. 
Organic Phase REACTANTS 
Warm 
Fluorous Phase 
Lower Temperature: Higher Temperature: 
Biphasic 
I 
Monophasic 
(Permilling Reaction) 
Possibility of recycling reagent ($) 
PRODUCTS 
Cool 
Lower Tef1l)erature: 
Blphasic 
I 
Scheme 1-4. Fluorous biphasic catalysis.66 The reaction can be performed 
in single phase at higher temperature and the separation in a biphasic 
system at lower temperature in a system that becomes a single phase by 
increased temperature. 
A disadvantage of fluorous biphasic catalysis is the high pnce of the 
fluorinated ligands and solvents and the environmental impact of these 
materials is also of concem.67 A review from 2007 summarises the result 
obtained in the field to that date.52 
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1.4. Supercritical Fluids (SCFs) 
Supercritical fluids (SCFs) are materials in a particular state above their critical 
pressure (Pc) and critical temperature (Tc) but below the pressure required to 
form a solid.68 The pressure required to solidify for example carbon dioxide is, 
however, very high, 5700 bar at the critical temperature (31.1 oC).69 A phase 
diagram with schematic density profile of the different phases can be seen in 
Figure 1-1. 
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T COC) 
• Critical point 
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Figure 1-1. Phase diagram of carbon dioxide68 with a schematic density 
proftle in different phases. The triple point of a substance is the 
temperature and pressure at which three phases (gas, liquid, and solid) of 
that substance may coexist in equilibrium. The critical point is the phase 
termination point where the phases become indistinguishable. 
Near to the critical point the gas becomes more dense and the liquid becomes 
less dense, and at the critical point the meniscus turns to indistinguishable 
between the two phases. The phase change to supercritical is demonstrated in 
Figure 1-2. 
11 Chapter 1 
i n - - - - - - - - - - - - - - - - - - - - ~ ~ a 
A B c 
vapour \ ~ ~
. . ~ ~ . . 
. ~ ~
. 
supercritic 
.". liquid 
Figure 1-2. Phase change of a substance. A: Two phases, the liquid and the 
vapour phases are completely distinguishable at lower temperature and 
pressure, B: at increased temperature and pressure, near the critical 
point, the liquid becomes less dense and the vapour more dense, C: the 
meniscus becomes indistinguishable at the critical point.7o 
The critical pressure and temperature is specific to each compound. The 
critical properties of several key supercritical solvents are listed in Table 1-3. 
Table 1-3. The critical properties of some commonly used SCFS.71 
Fluid 
Fluoroform 
Carbon dioxide 
Ethane 
N20 
Propane 
NH3 
EtOH 
Water 
Critical Pressure 
48.2 
73.8 
48.8 
72.6 
42.6 
112.8 
63.8 
221 
Many of the properties of SCFs are intermediate between liquid and gas, for 
instance the density, diffusivity, and viscosity, but not all properties of SCFs 
are intermediate, for instance compressibility and heat capacity. These are 
much higher in the near critical region and even in the supercritical phase than 
those in either liquid or in gas phase.68 The density of supercritical fluids 
changes with applied pressure, particularly sharply in the compressible region 
(near critical point).68 The dielectric constants (€) of polar SCFs also change 
sharply with pressure in the near critical region, an effect connected with 
changes in density.68 The effect is large in water72,73 and fluoroform74 but the 
dielectric of constant of CO2 does not change much with pressure75 . The 
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dielectric constant is a tuneable property of polar SCFs which can be utilised 
when working with SCFs but there are still gaps in the knowledge of this field. 
The main advantage of SCFs is their liquid like solvent power and gas like 
diffusivity. Other important advantageous properties of SCFs are that many of 
them have no harmful environmental effect, they are non-toxic and 
non-flammable, they have high diffusivity, low viscosity, adjustable solvent 
power and density, and they are miscible with gases.68 
1.4.1. Supercritical Carbon Dioxide (scC02) 
Carbon dioxide (C02) is the most commonly used SCF because of its 
availability, low cost and properties. CO2 is a greenhouse gas but if the 
by-product CO2 from different industries is utilised for the production of 
chemicals, there will be no net increase in C02. It can be recovered from 
ammonia and hydrogen production, and also from flue gases.76-78 
The easily attainable critical parameters of CO2; temperature of 31.1 °C and 
pressure of 73.8 bar are mild in comparison with other SCFs (Table 1-3). 
Using supercritical C02 for conducting chemical transformations eliminates 
the production of solvent waste from the reaction medium. Many of the fluid 
properties of CO2, such as diffusion rate, viscosity, solvent power, and density 
are adjustable by changing the pressure and temperature which also makes 
SCC02 widely attractive. The properties such as high diffusivity, complete 
miscibility with gases, high compressibility, no solvent residue production can 
also be highly beneficial. C02 is widely used in extraction processes. It is also 
used to conduct chemical transformations, including continuous flow processes 
when combined with a heterogeneous catalyst, and in multi phase catalysis. 
1.4.2. Reactions in Supercritical Carbon Dioxide 
Reactions with gaseous reactants in SCC02 can occur at higher rates due to the 
complete miscibility of scC02 with gases such as H2 and O2. This miscibility 
reduces the mass transport limitations that can occur at the catalyst surface 
with traditional solvent systems.79, 80 Supercritical flow reactors are suitable for 
performing high pressure reactions. Effective gas mixing occurs with the lab 
scale dosing equipment used within the group at Nottingham. 
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1.5. Aims and Objectives 
The areas of catalysis and use of alternative solvents are important topics 
within the field of Green Chemistry. The objective of this Thesis was to 
investigate continuous flow reactions with heterogeneous catalysts in scC02 in 
the following areas: 
• Continuous asymmetric hydrogenation with supported homogeneous 
Rh catalysts modified with bisphosphine ligands in scC02. 
• Continuous kinetic resolution of secondary alcohols with immobilised 
Cal B in scC02. 
• Chemo-enzymatic catalytic cascade reaction In a continuous flow 
scC02 system. 
• Continuous oxidation of cholesterol with combi-CLEA of cholesterol 
oxidase and catalase in SCC02. 
The final aim was to draw conclusions on the compatibility of immobilised 
catalysts for continuous reactions in SCC02. 
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Chapter 2 
Experimental 
This Chapter describes: 
i) The immobilisation techniques used for prepanng supported 
homogeneous metal- and biocatalysts. 
ii) The enzyme assays used for determining the activity of 
immobilised biocatalysts. 
iii) The high pressure equipments used for examining the activity of 
supported catalysts in scC02. 
iv) The analytical techniques used throughout this study. 
The immobilisation techniques used in this work include carrier-bound and 
carrier-free techniques. The metal catalysts, Rh and Pd were supported on 
different carrier materials while the enzymes, lipase B from Candida 
antarctica, cholesterol oxidase from Nocardia sp. and catalase from bovine 
liver were supported in a carrier-free form (Cross-Linked Enzyme Aggregate, 
CLEA). The Rh catalysts were further modified by the addition of a 
bisphosphine ligand. The aim of the study was the investigation of the activity 
of heterogeneous catalysts in a continuous flow scC02 system. The catalyst 
activity was also examined in a batch SCC02 system in some cases. All SCC02 
systems used in this study were small scale due to the high cost of the 
catalysts. The scale-up of the system is possible but optimisation has to be 
performed. 
2.1. Catalyst Immobilisation 
This section describes the immobilisation techniques used throughout this 
research project. Rh catalysts and enzymes were immobilised in different ways 
on a carrier material or via cross-linking in a carrier-free form. The Rh 
catalysts were also modified by the addition of a bisphosphine ligand either 
before or after the immobilisation of the catalyst. 
19 Chapter 2 
2.1.1. The Preparation of Alumina or Carbon Supported Chiral Rh 
Catalysts 
Chiral Rh catalysts supported on a solid support (alumina or carbon), 
[Rh(COD)(R2P*-PR2*)t[BF4rtPTNAlumina or Carbon (COD = 1,5-cyclo-
octadiene, R2P*-P*R2 = bisphosphine ligand, PTA = phosphotungstic acid 
H30 40PW 12), a gift from Johnson Matthey (UK), were used to perform 
asymmetric hydrogenation in a continuous flow SCC02 system. The chiral 
modification of the commercial alumina or carbon supported Rh catalyst was 
performed by us. The bisphosphine ligand (R2P*-PR2*) (Josiphos type ligands, 
Solvias AG, Basel, Switzerland) was added after the immobilisation of the 
achiral catalyst. The ligand exchange reaction occurred between one of the 
COD ligands of Rh(COD)2 (COD = 1,S-cyclo-octadiene) and the bisphosphine 
ligand (Scheme 2-1). Calculations to determine the appropriate amount of 
[Rh(COD)2t[BF 4rtPT AI Alumina (CAT AXAI Alumina) or [Rh(COD)2t[BF 4r 
/PT AlCarbon (CATAXAICarbon) and Ligand were based upon the Rh content 
(determined by Johnson Matthey), 35 ~ m o l l of Rh in each gram of 
CAT AXN Alumina and less than o.s % of Rh in each gram of 
CAT AXAlCarbon. A 1: 1.S molar ratio of Rh to ligand was used in each case, 
which is expected to provide a sufficient excess for the ligand exchange to be 
completed. Due to the air and moisture sensitivity of the Rh catalysts and the 
ligands, all preparation procedures were performed under an argon or nitrogen 
atmosphere in dry solvents. 
Scheme 2-1. The ligand exchange reaction. The chiral catalyst is 
[Rh(COD)(R2P*-P*R2) t[BF 4PPT Ai Alumina (COD =1,5-cyclo-octadiene, 
R2P*-P*R2 = bisphosphine ligand, PTA = phosphotungstic acid 
H3040PW 12). 
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2.1.1.1. Preparation of IRh(COD)(ligand)]+IBF4rJPTAlAlumina 
The experiments were performed in a two-neck glass flask (oven dried, 
volume: 100 mL). The [Rh(COD)2t[BF4FPTAlAlumina catalyst 
(9.19 x 10-6 mol Rh) and ligand (1.38 x 10-5 mol) were mixed in anhydrous 
ethanol (99.8 %, Aldrich, 50 mL) using a suspended stirrer (Lab egg, lKA, 
Germany) overnight (16 hours) at ambient pressure and room temperature 
under an argon atmosphere. The following quantities of the Rh catalyst and 
ligand were used for preparing the supported homogeneous chiral catalysts. 
• Josiphos 001 (0.0088g) : Rh[(COD)2t[BF4FPTA/Alumina (0.26 g) 
• Josiphos 005 (0.009 g) : Rh[(COD)2t[BF4 f/PTAlAlumina (0.26 g) 
• Walphos 002 (0.009 g): Rh[(COD)2t[BF4r1PTAlAlumina (0.26 g) 
• Mandyphos 001 (0.01l3 g) : Rh[(COD)2t[BF4FPTA/Alumina (0.26 g) 
• Taniaphos 001 (0.0095 g) : Rh[(COD)2t[BF4r1PTAlAlumina (0.26 g) 
• Taniaphos 002(0.0098 g) : Rh[(COD)2t[BF4F PTAlAlumina (0.26 g) 
The next morning, the solvent was removed and the catalyst was dried under 
vacuum (for approximately 15 minutes) . The catalyst was then stored under an 
argon atmosphere until use. The structure of the Rh catalyst and the ligands are 
shown in Figure 2-1 and Figure 2-2, respectively. 
Alumina / Carbon 
Figure 2-1. General structure of the supported homogeneous Rh catalyst 
[Rh(COD)(R2P*-PR2*)t[BF4r/PTAlAJurnina or Carbon where COD = 
1,5-cyclo-octadiene, R2P*-PR2* = bisphosphine ligand, PTA = 
phosphotungstic acid H30 40PW12• 
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Figure 2-2. The structures of the Solvias Josiphos type ligands. The 
general structure of the supported homogeneous chiral Rh catalyst is 
[Rh(COD)(R2P*-PR2*)]+[BF4rtPTA/Alumina (COD = 1,5-cyclo-octadiene, 
R2P*-PR2* = bispbosphine ligand, PTA = phosphotungstic acid 
H3040PW 12). 
2.1.1.2. Preparation of [Rh(COD)(ligand) ]+[BF 4)"1PT A/Carbon 
The carbon supported Rh catalyst was modified with only one bisphosphine 
ligand, Josiphos 001 . [Rh[(CODht [BF 4r/PT AlCarbon (0.25 g, 12.1 !J.mol Rh) 
and Josiphos 001 ligand (0.012 g, 18.2 !J.mol) were mixed in anhydrous ethanol 
(50 mL) using a two-neck glass flask (oven dried, volume: 100 mL). The 
solution was stirred with a suspended stirrer overnight (for 16 hours) at 
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ambient pressure and room temperature under an argon atmosphere. The next 
morning, the solvent was removed and the catalyst was dried under vacuum 
(for approximately 10 minutes). Due to the fine powdery consistency of the 
carbon supported Rh catalyst, the solvent was removed using a cannula filter to 
prevent any loss of catalyst. The vacuum drying was performed with a filter 
introduced in the line to prevent catalyst loss. The catalyst was then stored 
under an argon atmosphere until use. 
2.1.2. Preparation of Aerogel Supported Chiral Rh Catalysts 
This work which was carried out as part of this PhD project is not presented in 
this Thesis in detail, however, the methodology of the catalyst immobilisation 
is described here. 
Both achiral and chiral Rh catalysts were immobilised in Si02 aerogels with 
5 % (w/w) catalyst loading (1.25 % (w/w) Rh). Due to the air and moisture 
sensitivity of the catalyst, all preparation procedures were performed under an 
argon or nitrogen atmosphere in dry solvents. The ligand exchange was 
performed prior to the immobilisation of the catalyst. The immobilisation of 
the catalyst was performed in parallel with the aerogel preparation. 
The Rh catalyst [Rh(COD)2t[BF4r or [Rh(COD)(Josiphos 001)t[BF4r 
(achiral catalyst: 0.05 g, 0.123 mmol or chiral catalyst: 0.1 g, 0.226 mmol) was 
dissolved in anhydrous methanol (99.9 %, Merck, 5 mL) and the ligand 
Josiphos 001 (to chiral catalyst: 0.08 g, 0.123 mmol) was added (as required). 
AI: 0.5 molar ratio of [Rh(COD)2t[BF4r: Josiphos 001 was used. The 
ligand exchange reaction was performed in anhydrous methanol overnight 
(16 hours) at ambient pressure and room temperature under an argon 
atmosphere. 
The aerogel was synthesised using the following procedure: Si02 aerogel was 
obtained using Si(OMe)4 (TMOS) (Sigma, 1 mol), MeOH (99.8 %, Aldrich, 6 
mol), deionised H20 (4 mol) and N ~ O H H (Fisher, 0.005 mol). The calculations 
were based upon the Rh loading: the quantity of Si02 was first determined and 
the quantities of the MeOH, H20 and NH40H were then calculated considering 
the molar ratios described above. The quantities of the materials used are listed 
in Table 2-1. 
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Table 2-1. The quantity of reagents used in the preparation of aerogel 
supported Rh catalysts. The catalyst: ligand molar ratio was 1 : 0.5. 
Entry Catalyst loading (w/w %) 
0.95 2.41 3.04 1.14 0.003 
2 5 % [Rh(COD)(Josiphos OOl)t[BF4r** 3.38 8.57 10.82 4.05 0.01 
* Achiral catalyst: 0.05 g, 0.123 mmol 
** Chiral catalyst: [Rh(CODh]+[BF4r (0.1 g, 0.226 mmol) and 
Josiphos 001 (0.079 g, 0.123 mmol) 
The precursor, TMOS was dissolved in water and was added to the Rh catalyst 
[Rh(COD)2t[BF4r (Fluka, cat.no. 14694) dissolved in anhydrous methanol 
(quantity: see Table 2-1). The solution was then stirred using a magnetic stirrer 
bar. Once a homogeneous solution was obtained, the NH40H was added. 
Intense stirring was provided during the gel formation step to ensure a 
homogeneous solution and therefore presumably a homogeneous distribution 
of the Rh catalyst. Once the gelation was completed, the material was poured 
into a tube (open at both ends) and left until it solidified. The gel was removed 
from the tube and placed in methanol (250 mL), and aged for 2 days. 
Supercritical drying using scC02 was performed to replace the liquid in the 
pores by gas. I The drying was performed using alL volume high pressure 
vessel. The gel was placed in the vessel and the vessel was filled with 
methanol. The system was closed and the methanol was slowly flushed away 
by charging the system with C02 up to 100 bar and it was heated to 40 °C. The 
C02 was circulated in the system to completely remove the methanol. Wash 
samples (of methanol) were taken before and after drying to determine the 
catalyst loss during the preparation. The aerogel supported Rh catalyst was 
stored under an argon atmosphere until use. 
In conclusions, the immobilisation technique was successful as low leaching of 
Rh was determined during the preparation (determined with ICP-MS). 
Although H20 was used for making the aerogel supported catalyst, the achiral 
catalyst [Rh(CODht[BF 4rlSi02 aerogel showed high activity in the 
continuous asymmetric hydrogenation of dimethyl itaconate in SCC02 
(conversion to 100 %). The chiral catalyst [Rh(COD)(Josiphos 001)t[BF4r 
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/Si02 aerogel showed low enantioselectivity for the continuous asymmetric 
hydrogenation in scC02 (eeR < 10 %). The catalyst stability, however, was 
high in a continuous flow SCC02 system as the Rh leaching of both achiral and 
chiral catalysts remained under 1 ppm in the continuous reactions at all 
conditions (determined with ICP-MS). 
2.1.3. Preparation of Ionic Liquid Supported Chiral Rh Catalysts 
Chiral Rh catalysts immobilised in ionic liquids (ILs) were examined for the 
hydrogenation of dimethyl itaconate in a continuous flow scC02 system. The 
ILs [BMIM][BF4], [BMIM][T6N] and [BMIM][N(CN2)] were used as support 
material for [Rh(COD)2t[BF4r and [Rh(COD)(Josiphos 00It[BF4r. The 
chiral catalyst was prepared prior to the immobilisation of the catalyst using a 
1 : 0.5 molar ratio of [Rh(CODht[BF 4r : Josiphos 001. The ionic liquids were 
prepared at Nottingham.2 Due to the air and moisture sensitivity of the catalyst, 
all preparation procedures were carried out under an argon atmosphere in dry 
solvents. 
The achiral Rh catalyst [Rh(COD)2t[BF4r (0.02 g, 50 ~ m o l ) ) was dissolved in 
anhydrous ethanol (10 mL) and an appropriate amount of Josiphos 001 ligand 
(to chiral catalyst: 0.016 g, 25 J..Lmol) was added to the solution (as required). 
The ligand exchange reaction was performed in ethanol at room temperature 
and ambient pressure overnight (for 18 hours) with stirring. Once the ligand 
exchange reaction was completed, the IL (3 mL) was added to the solution and 
this was stirred for a further 30 minutes. The ethanol was then evaporated 
using vacuum. In order to remove the majority of contaminants including 
water, the vacuum drying was continued for a further 30 minutes. A sample of 
ethanol collected in the trap of the Schlenk line was kept to determine the 
catalyst loss during the preparation. The catalyst was stored under an argon 
atmosphere until use. 
2.1.4. Preparation of Cross-Linked Enzyme Aggregate (CLEA) 
Individual CLEA of cholesterol oxidase (cholesterol oxidase from 
Nocardia sp. (batch 1: 19.5 U/mg protein - protein content 77.4 % or batch 2: 
20.1 U/mg protein - protein content 84.2 %, E.C. 1.1.3.6., Merck 228230) and 
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catalase from bovine liver (batch 1: 2140 U/mg protein - protein content 63 % 
or batch 2: 4540 U/mg protein - protein content 65 %, E.C. 1.11.1.6, Sigma 
C-9322), and combi-CLEA of the two enzymes were prepared. Lipase from 
Candida antarctica (lipase B, E.C.3.1.1.3) CLEA (28000 U/g solid, batch 
no 5790) was received as a gift from CLEA Technologies (Delft, Netherlands). 
All procedures were performed at 4 °C using chilled solvents. 
The "CLEAtion" consists of two steps, physical aggregation and 
cross-linking? The first step, the precipitation of the enzyme is commonly 
performed using organic solvents. The precipitants (ethanol, iso-propanol, 
acetone, dimethoxyethane (ethyleneglycol dimethyl ether), acetonitrile and 
ammonium sulfate) were screened for both cholesterol oxidase and catalase 
using a 1 to 5 volume ratio of enzyme aliquot to precipitant. The precipitation 
screen was performed using cholesterol oxidase from Nocardia sp. 
(33.3 U/mL, 0.3 mL, 10 U - batch 1) and catalase from bovine liver 
(11167 U/mL, 0.3 mL, 3348 U - batch 1) dissolved in phosphate buffer (5 mM, 
pH 7.0). Cholesterol oxidase was used in low concentration due to its high 
price. The precipitant (1.8 mL) was measured in a microfuge tube and the 
enzyme solution (0.3 mL, cholesterol oxidase: 10 U, catalase: 3348 U) was 
added dropwise while an intense stirring (using magnetic stirrer bar, 600 rpm). 
The solution was stirred for 30 minutes and centrifuged at 600 x g for 10 min 
(Denver Instrument, Force 13). The supernatant was decanted and the pellet 
was redissolved in phosphate buffer (5 mM, pH 7.0, 1.8 mL). The enzyme 
activity was assayed in both the supernatant and the enzyme aliquot of the 
redissolved pellet. The details of the enzyme assays are discussed below in this 
Chapter. 
The enzymes were used in larger quantities for making CLEA. Individual 
cholesterol oxidase CLEA was prepared using cholesterol oxidase (100 U 
dissolved in 5 mM phosphate buffer, 0.5 mL, pH 7.0) with ammonium sulfate 
as precipitant (saturated, 2.5 mL) (total volume: 3 mL). The catalase CLEA 
was prepared using catalase (batch 1: 335000 U, batch 2: 737500 U, dissolved 
in 5 mM phosphate buffer, 5 mL, pH 7.0) with ammonium sulfate (saturated, 
25 mL) or dimethoxyethane (25 mL) as precipitant (total volume: 30 mL). The 
combi-CLEA was prepared using cholesterol oxidase (100 U dissolved in 
5 mM phosphate buffer, 0.5 mL, pH 7.0) and catalase {batch 1: 335000 U, 
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batch 2: 737500 U, dissolved in 5 mM phosphate buffer, 5 mL, pH 7.0) with 
ammonium sulfate (saturated, 24.5 mL) as precipitant (total volume: 30 mL). 
The precipitant (ammonium sulfate or dimethoxyethane) was measured in a 
centrifuge tube (volume: 10 or 50 mL) and the enzyme solution was added 
dropwise with intense stirring. The solution was stirred for 30 minutes. 
The second step of the CLEAtion is the cross-linking of the solid enzyme 
particles. In this study, glutaraldehyde (25 % w/w, Fluka) and dextran 
polyaldehyde (prepared by us) were investigated as cross-linkers. Dextran 
(from Leuconostoc mesenteroides, average mol wt 5M-40M kDa, Sigma) was 
oxidised using sodium iodide (Montplet and Esteban SL. Barcelona).4 The 
procedure for the preparation of dextran polyaldehyde is discussed below in 
this Chapter. Glutaraldehyde was used in 10 mM and 50 mM concentrations. 
Dextran polyaldehyde (DP A) was used in the following quantities 200 ilL 
DP A solution /mL enzyme solution (DP A 200) and 400 ilL DPA solutionlmL 
enzyme solution (DPA 400). The cross-linking was performed in the same 
solution as the precipitation: the cross-linker was added to the suspension of 
the precipitated enzyme and was stirred overnight (18 hours) at 4°C. The next 
morning, the CLEA was centrifuged at 1250 x g for 10 min (Fisher Accu 
spin 400) and washed twice with phosphate buffer (5 mM, pH 7.0) to remove 
the unreacted cross-linker (the volume of the phosphate buffer used for 
washing was half of the total volume). The supernatant was decanted and kept 
for further analysis. The CLEA was resuspended in phosphate buffer (5 mM, 
pH 7.0, total volume: 3 mL or 30 mL) and stored at 4 cC. 
In some cases, a reduction step was also included in the preparation procedure 
following the cross-linking, using NaBH4 (95+ %, Merck) as reducing agent. 
Before the reduction step, the CLEA was centrifuged at 1250 x g for 10 min 
and the supernatant was removed. The chilled borohydride solution 
(0.5 mg/mL, 2 mL for cholesterol oxidase CLEA, and 20 mL for catalase 
CLEA and combi-CLEA) was added to the suspension of the CLEA which 
was stirred for 30 minutes. The CLEA was centrifuged at 1250 x g for 10 min 
and washed twice with phosphate buffer (5 mM, pH 7.0) (the volume of the 
phosphate buffer used for washing was half of the total volume). The 
supernatant was decanted and kept for further analysis. The CLEA was 
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resuspended in phosphate buffer (5 mM, pH 7.0, total volume: 3 mL or 30 mL) 
and stored at 4°C. 
Combi-CLEA can be prepared by co- or separate precipitation of the enzymes 
of interest. Here, we examined both methods. When the enzymes were 
co-precipitated, ammonium sulfate was used as precipitant. When the enzymes 
were precipitated separately, ammonium sulfate (cholesterol oxidase and 
catalase) and dimethoxyethane (catalase) were used as precipitants and the 
aggregates were mixed before cross-linking. Glutaraldehyde and dextran 
polyaldehyde were examined as cross-linkers and a reduction step was 
included in some cases. The amount of the enzymes used for the particular 
batches is described in detail in Chapter 7. The procedure for preparation of the 
combi-CLEA was identical to the preparation procedure of individual CLEA 
as described above. 
2.2. Preparation of dextran polyaldehyde 
Dextran polyaldehyde (DPA) was prepared by the oxidation of dextran 
(Scheme 2-2). Dextran from Leuconostoc mesenteroides (1.65 g, average mol 
wt 5-40 kDa, Sigma) was dissolved in dH20 (100 rnL) and sodium iodine 
(3.85 g, Montplet and Esteban SL. Barcelona) was added. The resulting 
solution was stirred at room temperature for 90 minutes. Subsequently, the 
solution was dialysed five times, using MW cutoff of 12 kDa dialysis sacks 
(Sigma, Cat. no D6191) against 5 L dH20 each time at room temperature 
during >2 hours and under stirring.4, 5 DPA was used as cross-linker in the 
following quantities: 200 J.lL DPA solution/mL enzyme solution (DPA 200) or 
400 J.lL DPA solution/mL enzyme solution (DP A 400). 
H l i ; f - A o ~ c H 2 20)l 
o ~ ~ / 
6 OH ~ H H H ~ ~ a n 
o 0 n 
Scheme 2-2. Preparation of dextran polyaldehyde from dextran. 
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2.3. Enzyme Assays 
The activity of the immobilised enzymes was determined to evaluate the 
relative activity of the CLEA compared to the activity of the non-immobilised 
enzyme. The oxidation of cholesterol (96%, Alfa Aesar) to 4-cholesten-3-one 
(98%, Acros) (Scheme 2-3) with 02 as oxidant was used to assay cholesterol 
oxidase activity. For catalase, two different assays were developed. One of 
them determined the amount of H20 2 (30 % w/w, Sigma-Aldrich) reduced 
directly by measunng the H202 concentration using a UV -Vis 
spectrophotometer (Agilent) at 240 nm. The other method consisted of two 
steps. First, catalase was incubated in a H202 solution for exactly 1 min and the 
remaining H20 2 was then determined in a coupling reaction catalysed by 
another enzyme horseradish peroxidise (HRP, Type II: 150-250 U/mg, Sigma). 
2.3.1. Cholesterol Oxidase Assay 
The oxidation of cholesterol (Scheme 2-3) was performed in sodium phosphate 
buffer (20 mM, pH 7.0) containing Triton X-IOO surfactant (Sigma, 0.5 mLIL). 
Cholesterol was dissolved in iso-propanol (12 mM, IPA, 99.6 %, Fluka). An 
aqueous solution of cholesterol oxidase from Nocardia sp. (33.3 U/mL) was 
prepared in phosphate buffer (5 mM, pH 7.0,3 rnL). 
The reaction was performed in a round bottom flask (volume: 100 mL) at room 
temperature using O2 (99+ %, BOC) as oxidant. The reaction mixture consisted 
of phosphate buffer (20 mM, pH 7.0, 27.3 mL), alcoholic solution of 
cholesterol (in IPA, 12 mM, 2.5 mL) and aliquot of cholesterol oxidase 
solution or suspension of cholesterol oxidase CLEA (0.2 mL, 6.67 U). The 
flask was sealed with a septum (Suba-Seal) that allowed charging the flask 
with O2 using a syringe. The reaction mixture was stirred with a magnetic 
stirrer bar. The reaction was run up to 5 hours. The samples for HPLC analysis 
(described below in this Chapter) were prepared by mixing a sample from the 
oxidation reaction (750 ~ l ) ) and NaOn (0.2 M, 250 ~ l ) . . The NaOH solution 
effectively stopped the enzymatic reaction and therefore allowed real time 
analysis and different time points to be taken from the same reaction. 
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Scheme 2-3. The oxidation of cholesterol in a coupled-enzymatic reaction 
of cholesterol oxidase and catalase. 
2.3.2. Catalase Assay 
Two different catalase assays were used throughout this study. Both activity 
tests were perfonned in sodium phosphate buffer (20 mM, pH 7.0) containing 
Triton X-IOO surfactant (0.5 mLIL). H202 (30 % w/w in water) was used as 
received. An aqueous solution of catalase from bovine liver (batch 1 : 
11167 U/mL, batch 2: 24583 U/mL) was prepared in phosphate buffer (5 mM, 
pH 7.0). 
In assay 1, the H20 2 concentration was monitored directly using a UV -Vis 
spectrophotometer. The reaction was perfonned in a round bottom flask 
(volume: 50 mL) at room temperature. The reaction mixture consisted of 
sodium phosphate buffer (20 mM, pH 7.0, 6.8 mL), H202 (30 % w/w in water, 
3 ml) and aliquot of catalase solution or suspension of catalase CLEA (0.2 mL, 
batch 1: 2233 U). The reaction was run for up to 1 hour with stirring. The 
decrease in absorbance was measured at 240 nm. 
The other catalase assay consisted of two steps. The first reaction was carried 
out in a round bottom flask (volume: 100 mL) at room temperature. The 
reaction mixture consisted of sodium phosphate buffer (20 mM, pH 7.0, 
8.6 mL), H20 2 (30 % w/w in water, 0.4 mL) and enzyme aliquot of catalase 
solution or suspension of catalase CLEA (0.2 mL, batch 2: 4917 U). The 
enzyme was added to a H202 solution and incubated for exactly 1 min at room 
temperature with stirring. The reaction was stopped by the addition of an 
inhibitor sodium azide (1 mL, Fluka, 2 mg/mL). The remaining H20 2 was 
detennined with a coupling reaction. A coloured product (dye) was fonned by 
the reaction occurring between 4-aminoantipyrine (97 %, Alfa Aesar) and 
phenol (99 + %, Alfa Aesar) catalysed by horseradish peroxidise (HRP) 
(Scheme 2-4). The reaction was perfonned at 37 °C in a 5 mL vial for 
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20 minutes with stirring. The reaction mixture consisted of sodium phosphate 
buffer (20 mM, pH 7.0, 0.9 mL), HRP reagent (1 mL), HRP enzyme solution 
(500 U/mL, 0.1 mL, 50 U) and sample (3 mL). The HRP reagent consisted of 
4-aminoantipyrine (6.25 mM in 5 mM phosphate buffer pH 7.0) and phenol 
solutions (100 mM in 5 mM phosphate buffer pH 7.0) in 1 : 1 volume ratio. 
The amount of dye formed in the reaction was measured by UV -Vis at 500 nm. 
The activity of the enzyme was calculated from the absorbance data obtained 
for the second reaction of the assay (dye formation). This assay was also used 
to determine the remaining H202 in the coupled-enzymatic reaction. 
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Scheme 2-4. Dye formation. The dye is formed by a reaction between 
4-aminoantipyrine and phenol catalysed by horseradish peroxidise 
(HRP).6,7 
2.4. Equipment Description 
This section gives a detailed schematic diagram and description, and a standard 
operating procedure (SOP) for each reactor. Attention! Experiments performed 
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at high pressures and high temperatures require careful execution. The safety 
of the equipment is always the responsibil ity of the researcher. 
2.4.1. The Small Scale Hydrogenation Apparatus 
2 
11 
7 12 
reactor 
H2 
4 
10 
D Thermocouple 
8 
substrate 
II Pressure monitor ~ ~
Figure 2-3. The small scale continuous flow hydrogenation apparatus. 
Parts are labelled as follows. 1: CO2 cylinder, 2: Jasco CO2 pump (C02 
cooling unit and HPLC pump in one) (PU-1580-C02), 3: SSl tap, 4: H2 
cylinder, 5: Maximator (H2), 6: Rheodyne gas dosage, 7: SSI tap, 8: 
Substrate reservoir, 9: Gilson pump (306-HPLC), 10: SSl tap, 11: Static 
mixer, 12: Reactor, 13: Jasco Back pressure regulator (BPR) (Jasco BP-
1580-81), 14: Collection vial. All components were connected by 1116" 316 
stainless steel tubing. The feed streams were mixed in a heated, static 
mixer before being passed through the reactor (1.5 cm3 in volume). 
Products were collected by continuous depressurisation of the reaction 
mixture using an electronic BPR, and analysed by chiral GLC. 
Figure 2-3 shows the reactor setup used to perform asymmetric hydrogenation 
in a continuous flow scC0 2 system. The system consisted of several cy linders, 
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pumps and taps and all components were connected by 1116" 316 stainless 
steel tubing (Swagelok). The CO2 (98 + %, BOC) was supplied via a cylinder 
(1) to a supercritical fluid Jasco C02 cooler and pump (PU-1580-C02) (2). The 
pump cooled down the CO2 to -10°C and fed it to a heated static mixer (11). 
The H2 (99.99 %, BOC) was supplied via a cylinder (4) to a gas booster pump 
(5) that could generate an overpressure of the H2 using compressed air. The H2 
was fed in a Rheodyne gas dosage unit (6) that forwarded the gas to a heated 
static mixer (11). The description of the Rheodyne system can be found below 
in this Chapter. The organic substrate was supplied using a Gilson pump (306-
HPLC) (9) and fed to a heated static mixer (11). All reagents and C02 were 
mixed and heated in a static mixer (11) filled with glass beads before entering 
the reactor (12) filled with catalyst. A metal filter 'frit' (Supelco, pore size: 0.5 
~ m , , diameter: W') was placed in the bottom of the reactor to ensure that the 
catalyst remained in the reactor. The system pressure was controlled using an 
automatic Jasco back pressure regulator (BPR) (BP-1580-81) (13) that also 
allowed the continuous depressurisation of the system and product collection. 
The Jasco CO2 pump (2) and the BPR (13) both had a build-in pressure 
monitor. For further safety, the pressure of the system was monitored by 
external pressure monitors attached to membrane pressure transducers 
(RDP-A105). The temperature of the static heater (11) and the reactor (12) 
were heated using a band heater (230 V) and aluminium heating blocks 
(230 V) equipped with thermocouples, respectively, and monitored by a 
temperature monitor. (The pressure monitors, temperature monitors and 
heaters were manufactured at the School of Chemistry, the University of 
Nottingham.) The pumps and heaters were connected to a trip system 
controlled by a set overpressure and overtemperature (on the pressure and 
temperature monitors). The trip switched off all pumps and heaters if 
overpressure or overtemperature was recorded. 
The standard operating procedure (SOP) of the small scale hydrogenation 
reactor was the following (see Figure 2-3 for numbering of taps, pumps, etc.). 
Start up: 
1. Fill up the reactor with a weighed amount of catalyst 
2. Attach the reactor to the apparatus and tighten the fittings 
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3. Set BPR to the desired pressure 
4. Open the C02 cylinder and let the Jasco pump cool down the C02 
5. Open tap 3, start pumping the C02 with 3 mLimin flow rate and leave 
the system to reach the set pressure 
6. Set the desired C02 flow rate 
7. Leak test all pressurized fittings at operating pressure 
8. Open the H2 cylinder and set overpressure on valve 5 (usually 50 bar 
over the system pressure) 
9. Set the pre-calculated H2 dosage rate on the Rheodyne (6) (data from 
The National Institute of Standards and Technology (NIST) databaseS 
were used to calculate H2 correct dosage rate) 
10. Attach heating blocks and secure thermocouples 
11. Turn heaters and temperature monitors on and set to the desired 
temperatures 
12. Leave C02 and H2 flowing to reduce the catalyst and allow the system 
to reach a steady state for approximately 20 minutes 
Reaction: 
13. Prime the Gilson pump (9) with the substrate and set to the desired 
flow rate 
14. Open tap 10 to allow the substrate flowing and start pumping 
15. Allow the substrate to flow for approximately 20 minutes to establish a 
steady state 
16. Take a sample 
17. Leave the substrate flowing and once a sufficient amount of sample has 
been obtained submit for analysis 
18. Stop the substrate flow 
19. If the reaction conditions are to be altered set the new parameters and 
repeat steps 13-18 
Shutdown: 
20. Close tap 10 
21. Stop H2 dosing by switching off Rheodyne 
22. Decompress and shut off the maximator (5) and close the H2 cylinder 
23. Turn the heaters off and let the system cool down 
24. Leave C02 flowing to flush the system through for 15-20 minutes 
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25. Stop pumping C02, close tap 3 and close the C02 cylinder 
26. Depressurise the system by decreasing the pressure on the BPR (13) 
stepwise. 
2.4.2. The Small Scale Enzyme Reactor 
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Figure 2-4. The small scale enzyme reactor. Parts are labelled as follows. 
1: COl cylinder, 2: Jasco COl pump (COl cooling unit and HPLC pump 
in one) (PU-lS80-COl), 3: SSI tap, 4: Substrate reservoir,S: Gilson pump 
(306-HPLC), 6: SSI tap, 7: Static mixer, 8: Reactor, 9: Jasco Back 
pressure regulator (BPR) (Jasco BP-lS80-81), 10: Collection vial. All 
components were connected by 1116" 316 stainless steel tubing. The feed 
streams were mixed in a heated, static mixer before being passed through 
the reactor (1.5 cm3 in volume). Products were collected by continuous 
depressurisation of the reaction mixture using an electronic BPR, and 
analysed by chiral GLC. 
The equipment used for conducting enzymatic reactions in flow SCC02 was 
similar to the small scale hydrogenation apparatus that is described above in 
this Chapter in detail. The only difference compared to the hydrogenation rig 
was the lack of the H2 line, otherwise all parts of the enzyme reactor were 
identical with the parts used for the small scale hydrogenation reactor. 
The SOP of the continuous flow enzyme reactor was as follows (see Figure 2-4 
for numbering of taps, pumps, etc.). 
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Start up: 
1. Fill up the reactor with a weighed amount of catalyst 
2. Attach the reactor to the apparatus and tighten the fittings 
3. Set BPR to the desired pressure 
4. Open the C02 cylinder and let the Jasco pump cool down the C02 
5. Open tap 3, start pumping the CO2 with 3 mLimin flow rate and leave 
the system to reach the set pressure 
6. Set the desired C02 flow rate 
7. Leak test of all pressurized fittings at operating pressure 
8. Attach heating blocks and secure thermocouples 
9. Turn heaters and temperature monitors on and set to the desired 
temperatures 
10. Leave CO2 flowing to allow the system to reach a steady state 
Reaction: 
11. Prime Gilson pump (5) with the substrate and set to the desired flow 
rate 
12. Open tap 6 to allow the substrate flowing and start pumping 
13. Allow the substrate to flow for approx 20 minutes to establish a steady 
state 
14. Take a sample 
15. Leave the substrate flowing and once a sufficient amount of sample 
obtained submit for analysis 
16. Stop the substrate flow 
17. If the reaction conditions are to be altered set the new parameters and 
repeat steps 11-16 
Shutdown: 
18. Close tap 6 
19. Turn the heaters off and let the system cool down 
20. Leave CO2 flowing to flush the system through for 15-20 minutes 
21. Stop pumping CO2 and close tap 3 and close the C02 cylinder 
22. Depressurise the system by decreasing the pressure on the BPR (9) 
stepwise. 
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2.4.3. The Small Scale Two-Stage Reactor 
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Figure 2-5. The small scale two-stage reactor. Parts are labelled as follows. 
1: C02 cylinder, 2: Jasco CO2 pump (C02 cooling unit and HPLC pump 
in one) (PU-1580-C02), 3: SSI tap, 4: H2 cylinder, 5: Maximator (H2), 6: 
Rheodyne gas dosage, 7: SSI tap, 8: Substrate (1) reservoir, 9: Gilson 
pump (1) (306-HPLC), 10: SSI tap, 11: Static mixer, 12: Reactor (1), 
13: Substrate (2) reservoir, 14: Gilson pump (2) (306-HPLC), 15: SSI tap, 
16: Reactor (2),17: Jasco Back pressure regulator (BPR) (Jasco BP-1580-
81), 18: Collection vial. All components were connected by 1116" 316 
stainless steel tubing. The feed streams were mixed in a heated, static 
mixer before being passed through the reactor (1.5 cm] in volume). 
Products were collected by continuous depressurisation of the reaction 
mixture using an electronic BPR, and analysed by chiral GLC. 
The reactor shown in Figure 2-5 was used to perform series reactions in a 
continuous flow SCC02 system. The system was slightly different from the 
hydrogenation apparatus. The changes were in the number of reactors and 
number of substrate streams. The system description is the following. The CO2 
was supplied via a cylinder (1) to a supercritical fluid Jasco CO2 cooler and 
pump (2). The pump cooled down the C02 to -10°C and fed it to a heated 
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static mixer (11). The H2 was supplied via a cylinder (4) to a gas booster pump 
(5) that could generate an overpressure ofH2using compressed air. The H2 was 
fed in a Rheodyne gas dosage unit (6) that forwarded the gas to a heated static 
mixer (11). The organic substrate 1 (8) was supplied using a Gilson pump 
(306-HPLC) (9) and fed to a heated static mixer (11). C02, H2 and substrate 1 
were mixed and heated in a static mixer (11) filled with glass beads before 
entering the first reactor (12) filled with catalyst. Another organic stream (13) 
was introduced in the system after the first reactor which was supplied using a 
Gilson pump (306-HPLC) (14). The entry position of the second substrate was 
carefully chosen in order to avoid any reaction that could be catalysed by the 
catalyst loaded in the first reactor. The stream of substrate 2 and all other 
streams met in a cross-piece mixer before passing through the second reactor 
(16) filled with catalyst. A metal filter 'frit' (Supelco, pore size: 0.5 J.lm, 
diameter: 1,4") was placed in the bottom of each reactor to ensure that the 
catalyst remained in the reactor. The system pressure was controlled using an 
automatic Jasco back pressure regulator (BPR) (BP-1580-81) (17) that also 
allowed the continuous depressurisation of the system and the product 
collection. The pressure monitors, temperature monitors and heater were 
identical to the ones used for the small scale hydrogenation apparatus. 
The SOP of the two-stage reactor was the following (see Figure 2-5 for 
numbering of taps, pumps, etc.). 
Start up: 
1. Fill up the reactors with weighed amount of catalysts 
2. Attach the reactors to the apparatus and tighten the fittings 
3. Set BPR to the desired pressure 
4. Open the C02 cylinder and let the Jasco pump cool down the CO2 
5. Open tap 3 and start pumping the CO2 with 3 mLlmin flow rate and 
leave the system to reach the set pressure 
6. Set the desired C02 flow rate 
7. Leak test of all pressurized fittings at operating pressure 
8. Open H2 cylinder and set overpressure on valve 5 (usually 50 bar over 
system pressure) 
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9. Set the pre-calculated H2 dosage rate on the Rheodyne (6) (data from 
The National Institute of Standards and Technology (NIST) database8 
were used to calculate H2 correct dosage rate) 
10. Attach heating blocks and secure thermocouples 
11. Tum heaters and temperature monitors on and set to the desired 
temperatures 
12. Leave CO2 and H2 flowing to reduce the catalyst and allow the system 
to reach a steady state for approximately 40 minutes 
Reaction: 
13. Prime Gilson pumps (9 and 14) and set to the desired flow rates 
14. Open taps 10 and 15 to allow the substrates flowing and start pumping 
15. Allow the substrate flowing for approximately 40 minutes to establish a 
steady state 
16. Take a sample 
17. Leave the substrate to flow and once a sufficient amount of sample 
obtained submit for analysis 
18. Stop the substrate flows 
19. If the reaction conditions are to be altered set the new parameters and 
repeat steps 13-18 
Shutdown: 
20. Close taps 10 and 15 
21. Stop H2 dosing by switching off Rheodyne (6) 
22. Decompress and shut offthe maximator (5) and close the H2 cylinder 
23. Tum off the heaters and let the system cool down 
24. Leave C02 flowing to flush the system through for 20-25 minutes 
25. Stop pumping CO2 and close tap 3 and close the C02 cylinder 
26. Depressurise the system by decreasing the pressure on the BPR (17) 
stepwise. 
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2.4.4. The Small Scale Oxidation Reactor 
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Figure 2-6. The small scale continuous flow reactor. Parts are labelled as 
follows. 1: CO2 cylinder, 2: CO2 cooling unit and HPLC pump, 3: Parker 
ball valve, 4: O 2 cylinder,S: Manual pressure regulator, 6: Waters 
switching valve for O2 dosage (two-position six-port switching valve), 7: 
Parker ball valve, 8: substrate/solvent reservoir, 9: HPLC pump, 10: 
Parker ball valve, 11: Water bath heater, 12: Vessel for CO2 saturation 
with H20, 13: Cholesterol vessel (dinner=1 cm, length 19 cm), 14: Reactor 
(y,." dinner=3 mm, length 10 cm), 15: GO valve - manual back pressure 
regulator (BPR), 16: Collection vial. All components were connected by 
1116" 316 stainless steel tubing. The feed streams were mixed in a heated 
T -piece mixer before being passed through the cholesterol vessel 
(14.92 cm3 in volume) and the reactor (0.7 cm3 in volume). The cholesterol 
extraction was performed up flow. Products were collected by continuous 
depressurisation of the system using a manual backpressure regulator, 
and analysed by reverse phase HPLC. 
The small scale oxidation reactor was slightly different from the equipments 
described above. The substrate was extracted ' in-flow' instead of introducing it 
into the system with a liquid pump. This part of the research was performed at 
a partner University (University of Valladolid, Spain) and therefore the 
components used were different from those at Nottingham. The continuous 
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flow oxidation equipment consisted of several cylinders, pumps and taps and 
all components were connected by 1116" 316 stainless steel tubing (Gyrolok). 
The C02 (99.9 %, Carburos Metalicos) was supplied via a cylinder (1) to a 
cold bath that fed the cold C02 to an HPLC pump (2). The cooling system 
cooled down the C02 to -20°C but the temperature was rising during the 
continuous flow experiment up to -12°C. The CO2 passed thorough a vessel 
filled with wet glass wool (12) in order to obtained water-saturated C02. The 
water-saturated CO2 entered the cholesterol vessel (13) filled with alternate 
layers of cholesterol and glass beads, and 'extracted' cholesterol. The 02 
(99.9 %, Carburos Metalicos) was supplied via a cylinder (4) to a manual 
regulator (5) where the desired O2 pressure could be set (normally 20 bar 
overpressure to the system pressure). The 02 was fed in a Waters switching 
valve (6) that forwarded the gas to a heated T -piece mixer (7). The mechanism 
of the Waters switching valve (Waters Two-Position Six-Port Switch Valve) 
was identical to the one of the Rheodyne system and described below in this 
Chapter. The stream of CO2 saturated with cholesterol and mixed with 02 
passed thorough the reactor (14) filled with catalyst. A metal filter 'frit' 
(Supelco, pore size: 0.5 ~ m , , diameter: W') was placed in the bottom of the 
reactor to ensure that the catalyst remained in the reactor. An organic stream 
(8) was introduced after the reactor using a HPLC pump (9) in order to 
solubilise the oxidation product and the unreacted cholesterol. The system 
pressure was controlled using a manual BPR ('GO' valves) (15) that also 
allowed the continuous depressurisation of the system and product collection. 
The C02 pump (2) and the liquid pump (9) had build-in pressure monitors. For 
further safety, the pressure of the system was monitored by manometers 
attached to the beginning and the end of the continuous flow system. The 
heating of the system was performed using a water bath that provided a 
homogeneous temperature. 
The SOP of the oxidation reactor was the following (see Figure 2-6 for 
numbering of taps, pumps, etc.). 
Start up: 
1. Fill up the vessel (12) with wet glass wool 
2. Fill up the vessel (13) with weighed amount of cholesterol glass beads 
3. Fill up the reactor with weighed amount of catalyst 
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4. Attach the vessels (12) and (13), and the reactor to the system and 
tighten the fittings 
5. Close the GO valve (BPR) (15) approximately halfway 
6. Open the C02 cylinder and tap 3, let the cooling bath chill the C02 
7. Start pumping the C02 with 10 mLimin flow rate and leave the system 
to reach the working pressure 
8. Set the desired C02 flow rate and the operating pressure by adjusting 
the GO valve 
9. Leak test all pressurised fittings at the operating pressure 
10. Open the 02 cylinder and set overpressure on valve 5 (usually 20 bar 
overpressure compared to the system pressure) 
11. Set the pre-calculated 02 dosage rate on the switching valve (data from 
The National Institute of Standards and Technology (NIST) database8 
used to calculate O2 correct dosage rate) 
12. Fill up the bath with water, tum the heater and temperature monitors 
on, and set to the desired temperatures 
13. Start the flow of the organic solvent if needed (entry after the reactor in 
order to obtain the product in solution after depressurisation) 
14. Leave C02, 02 and the organic solvent flowing to reach a steady state 
Reaction: 
15. Take a sample after the system has reached steady state 
16. Leave all streams running and once a sufficient amount of sample 
obtained submit for analysis 
17. If the reaction conditions are to be altered, set the new parameters and 
repeat steps 13-15 
Shutdown: 
18. Stop 02 dosing by switching off 6 
19. Close the O2 cylinder and tap 7 
20. Stop the organic flow and close tap 10 
21. Tum the heater off and let the system cool down 
22. Leave C02 flowing to flush the remaining organic solvent in the system 
23. Stop pumping C02, close tap 3 and the CO2 cylinder 
24. Depressurise the system stepwise. 
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2.4.5. Gas Dosage 
Flow controller with low flow rates is not available commercially and therefore 
the gases (H2 and O2) were supplied using a dosage unit (Rheodyne or Waters 
switching valve). The pressure of the gases was always set higher than the 
system pressure (50 bar overpressure for H2 and 20 bar overpressure for 0 2) in 
order to ensure that the gas enters the system. Both dosage units were 
two-position six-port switching valves that could dose the gas into the system 
nearly in a continuous manner. The continuity depended on the volume of the 
loops and switch rate: the smaller volume loops and the faster switch rate, the 
'more continuous' the flow. The mechanism of the valves is shown in 
Figure 2-7. 
Sample 
Loop 
A 
Position 1 
System 
Loop A to system 
Loop B filling 
Position 2 
System 
Loop B to system 
Loop A filling 
Figure 2-7. The switch mechanism of the valves. 9 
Two loops of the same volume were attached to two ports of the six-port valve. 
There were two inlets of the gas (H2 or O2). One port was the entry to the 
system and the remaining sixth port was blanked. When the valve was in 
position 1, loop A was emptied into the system and loop B was filled up with 
gas. In position 2, loop A was filled with gas from the cylinder and loop B was 
emptied into the system. The switch rate was calculated using the database 
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provided by the National Institute of Standards and Technology8 to obtain the 
desired gas to substrate ratio. 
2.4.6. The Small Scale Screw Top Autoclave 
A small volume 60 mL screw top autoclave was used to perform batch 
hydrogenation reactions at Nottingham. The autoclave consists of a body and a 
head that can be screwed together with a force of 220 Nm. The autoclave had 
two inlets/outlets. A 1/8" pipe was attached to one of the inlets that allowed 
charging the vessel and monitoring the pressure during an experiment. A 
thermocouple was introduced through the other inlet to monitor the 
temperature inside the reactor. A 230 V band heater was attached to the body 
of the cell and heated to the desired temperature. Pressure and temperature 
monitors were attached to a trip that switched off the heating when an 
overpressure or overtemperature was recorded. The stirring of the reaction 
mixture could be provided by placing a magnetic stirrer bar in the cell that was 
controlled by a stirrer plate placed underneath the reactor. 
The operation procedure of the screw top autoclave was the following. 
Start up: 
1. Measure the appropriate amount of catalysts and substrate in the reactor 
2. Attach the head of the autoclave to the body and tighten it with a force 
of 220 Nm using a torque wrench 
3. Attach the outlet of the autoclave to the H2 cylinder equipped with a 
low pressure manual regulator (up to 10 bars) 
4. Open the H2 cylinder and set 1 bar pressure on the regulator 
5. Open the tap attached to the outlet pipe of the autoclave and charge the 
vessel 
6. Close the tap after approximately 30 seconds and disconnect the 
autoclave from the cylinder, close the regulator and the cylinder 
7. Open the tap and release the gas 
8. Repeat steps 3-7 to flush any residual air trapped in the autoclave 
9. Repeat steps 3-6 and charge the vessel with H2 up to the desired 
pressure (the amount of the gas needed was pre-calculated) 
10. Weigh the autoclave 
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11. Attach the outlet of the autoclave to outlet of the booster pump 
connected to a C02 cylinder 
12. Open the C02 cylinder, open the inlet of the reactor and then the outlet 
of the booster pump 
13. Open the taps attached to the pump and the autoclave 
14. Charge the autoclave with a small amount of CO2 
15. Weigh the autoclave and if more C02 is needed repeat steps 10-14 (the 
amount of CO2 was pre-calculated to obtain the desired pressure at a 
particular reaction temperature) 
16. Attach the band heater to the autoclave 
17. Place the autoclave on a stirrer plate and attach the outlet to a pressure 
monitor 
18. Open the tap attached to the autoclave 
19. Tum heaters and temperature monitors on and set to the desired 
temperatures 
20. Tum the stirring plate on and set the desired speed 
Reaction: 
21. Continue heating and stirring for a desired time 
Shutdown: 
22. Tum the heater and the stirring off and let the system cool down 
23. Disconnect the band heater 
24. Place the autoclave in dry ice and spill acetone on the ice for further 
cooling while monitoring the pressure of the cell continuously 
25. Once the system pressure reaches 1 bar the autoclave is safe to open 
26. Open tap of the autoclave and open the autoclave using a torque 
wrench 
27. Collect the product and the catalyst. 
2.4.7. The Small Scale Clamp Autoclave 
A small volume 8 mL clamp autoclave (Figure 2-8) was used to perform 
oxidation in batch at Nottingham. The body and the head of the autoclave were 
sealed together with a clamp with an a-ring as seal (BSL: EPDM 70, size: 42 x 
2 mm) between the two parts. The autoclave had one inlet and one outlet of a 
118" pipe. The temperature of the cell could be monitored by a thermocouple 
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inserted in the cell via another 118" pipe. A 230 V band heater was attached to 
the body of the cell and heated to the desired temperature. Pressure and 
temperature monitors were attached to a trip that switched off the heating when 
an overpressure or overtemperature was recorded. Stirring of the reaction 
mixture could be provided by placing a magnetic stirrer bar in the cell that was 
controlled by a stilTer plate placed underneath the reactor. 
Thermocouple 
Figure 2-8. The clamp autoclave. 
The standard operation procedure of the clamp autoclave was the following. 
Start up: 
1. Measure the appropriate amount of catalysts and substrate in the reactor 
2. Attach the head of the autoclave to the body, place in the O-ring seal 
and close it with the clamp 
3. Place the safety key in the cell 
4. Attach the inlet pipe of the autoclave to the O2 cylinder equipped with a 
low pressure manual regulator (up to 8 bars) 
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5. Open the O2 cylinder and set 0.5 bar pressure on the regulator 
6. Open the tap attached to the inlet pipe of the autoclave and charge the 
vessel 
7. Open the tap attached to the outlet pipe of the autoclave and flush the 
system to remove any residual air trapped in the cell 
8. Close the outlet tap of the autoclave and charge the cell with O2 up to 
the desire pressure and close the tap. Attention! It is important to 
consider the explosion limits! (Lower Explosive Limit for IPA is 
2.02 %, Upper Explosive Limit for IPA is 11.8 %, as percentage-by-
volume in air. 10) 
9. Attach the inlet and outlet pipes ofthe autoclave back to the system 
10. Attach the band heater to the autoclave and place the autoclave on a 
stirrer plate and start stirring 
11. Heat the autoclave to the desired temperature 
12. Once reaches the desired temperature, open the tap attached to the inlet 
pipe of the autoclave and charge the cell with C02 using a booster 
pump up to the desired pressure 
13. Close the tap attached to the inlet pipe of the autoclave and keep 
supervising the reaction 
Reaction: 
14. Continue heating and stirring for a desired time 
Shutdown: 
15. Tum the heater and the stirring off and let the system cool down 
16. Disconnect the band heater 
17. Place the autoclave in dry ice and spill acetone on the ice for further 
cooling while monitoring the pressure continuously 
18. Once the system pressure reaches 1 bar the autoclave is safe to open 
19. Open the outlet tap of the autoclave and open the autoclave by 
removing the safety key and opening the clamp 
20. Leave the body of the cell under a fume hood to let the CO2 evaporate 
21. Collect the product and the catalyst. 
48 Chapter 2 
2.4.8. The Variable Volume View Cell (VVVC) 
Experiments using a variable volume view cell (VVVC) were performed to 
investigate the solubility of a-tetralol in scC02 . Details of the VVVC have 
been described elsewhere 11 and therefore only a brief description is given here. 
The VVVC is a stainless steel vessel with two sapphire windows that allows 
the user to have a clear view of the cell contents. A white backlight is used to 
illuminate the cell. The rear sapphire window can be moved using a piston, and 
therefore can be used to alter the volume and thus the pressure of the cell 
(Figure 2-9). The body of the cell can also be heated. Different conditions can 
be investigated by changing the pressure and temperature. 
window (piston) front sapphire . 
body of the cell 
substrate 
Figure 2-9. Schematic diagram of the variable volume view cell (VVVC). 
The VVC is a stainless steel vessel with two sapphire windows. White light 
is used to obtain a clear view of the cell content for the user. As the rear 
piston can be moved, the volume of the cell and therefore the pressure 
inside can be altered. The body of the cell can be heated. The heaters are 
located in the body of the cell. Different conditions can be investigated by 
changing the pressure and temperature. 
2.5. Analytical Techniques 
In this section, the analytical techniques used throughout this study are 
detailed. Different chromatography (GLC, HPLC) and spectroscopy 
techniques (UV-Vis, NMR, ICP-MS), dynamic light scattering (DLS), 
scanning electron microscopy (SEM), gel electrophoresis (SDS-PAGE) and 
Karl Fischer titration were used to analyse the reaction products and to 
characterise the immobilised catalysts. The more commonly used analytical 
techniques are described in less detail than the ones less commonly used. 
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2.5.1. Gas-Liquid Chromatography (GLC) 
The products of the hydrogenation reactions examined throughout this study 
were analysed by chiral gas-liquid chromatography (chiral GLC). Shimadzu 
GCl7A and GC2010 chromatographs equipped with a Shimadzu 2011 
autosampler were used. Chiral columns beta-dex 225 and beta-de x 110 type 
(Supe\co) were used for the analysis of the samples from the hydrogenation 
and the kinetic resolution reactions, respectively. 
The beta-dex 225 column contains 25% modified ~ - c y c l o d e x t r i n n (CD) (2 ,3-di-
O-acetyl-6-0- T B D M S - ~ - C D ) ) embedded in SPB-20 poly(20% phenyl/80% 
dimethylsiloxane). The beta-dex I) 0 column 10% consists of permethylated 
~ - c y c l o d e x t r i n n in SPB-35 (poly (35% diphenyl/65% dimethylsiloxane). 
Enantiomers can be separated physically due to the fact that one of the 
enantiomers has a slightly higher affinity for the column and hence it is 
retained longer. Figure 2-10 represents a GC chromatogram where the two 
enantiomers of a compound were separated. 
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Figure 2-10. Enantiomer separation by Gc. The chromatogram shows the 
separation of two enantiomers of a compound. 
A flame ionization detector (FID) heated to 300 DC was used for the analysis. 
Helium was used as the carrier gas. The samples were prepared in 2 mL 
septum-capped glass vials in appropriate concentrations using acetone as the 
solvent. 
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The response factor of the FlO is linear in a certain range and can be 
detennined by plotting standards. Therefore calibration had to be perfonned 
for all compounds analysed to give accurate analysis. As all compounds are 
ionised to different extents, standard samples in known concentration have to 
be prepared. 12 The retention time obtained from the analysis of standards 
enables to identify the target compound in the reaction mixture. The 
relationship between the concentration and area % can be established by 
analysing standards in known concentration. 
The enantiomeric excess (ee) was calculated by using peak area values 
measured for each of the enantiomers (Equation 2-1). 
[enantiomer (a) - enantiomer (b)] 
ee (%,) = x 100 
[enantiomer (a) + enantiomer (b)] 
Equation 2-1. The calculation of the enantiomeric excess (ee). 
2.5.2. High Performance Liquid Chromatography (HPLC) 
The samples from the oxidation of cholesterol were analysed using HPLC. The 
difference in polarity of cholesterol and its oxidation product 4-cholest-3-one 
allowed the separation. 
A HPLC instrument (Merck Hitachi gradient 0-7000 or Waters isocratic 1515) 
equipped with an autosampler (Merck Hitachi L-7200 or Waters 717) was 
used. The column was a reverse phase C18 column (XTerra by Waters, 
150mm length, 3.0 mm 1.0. or Waters 150 mm length, 0.5 mm 1.0.). The 
mobile phase was 100 % acetonitrile at flow rates 0.4 mLimin or 0.6 mLimin. 
The column was heated to 40°C or 60 DC. A UV detector was used at 210 nm. 
The samples were prepared in 1.5 mL septum-capped glass vials in appropriate 
concentrations. 
2.5.3. Ultraviolet-Visible Spectroscopy (UV -Vis) 
UV-Vis (200-700 nm) spectroscopy was used to monitor the activity of 
catalase by measuring the absorbance of H202 at 240 nm and also to analyse 
the dye fonnation reactions at 500 nm (UV spectrometer: Agilent 8453). The 
reaction medium of both activity assays was sodium phosphate buffer (20 mM, 
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pH 7.0) containing Triton X-IOO surfactant (0.5 mLlL) which was used as UV 
blank. 
2.5.4. Inductively Coupled Plasma - Mass Spectrometry (ICP-MS) 
ICP-MS was used to determine the Rh leaching during the catalyst 
immobilisation and the continuous flow hydrogenation reactions. The ligand 
leaching could also be determined by analysing the Fe content of the samples. 
ICP-MS is the combination of inductively coupled plasma and mass 
spectrometer that can be used to detect traces of metals. An aqueous sample is 
introduced into the plasma that evaporates any solid and breaks the sample into 
its component atoms. The plasma temperature is very high, of the order of 
10000 K which ionises most atoms of many chemical elements. The mass 
spectrometer receives the ions from the plasma and separates them according 
to their mass-to-charge ratio. The ion signal received by the mass spectrometer 
detector is proportional to the concentration. \3 
An ICP-MS instrument (Thermo-Fisher Scientific X-SeriesII) with a 'hexapole 
collision cell' (7 % H2 in helium) upstream of the analytical quadrupole was 
used for the analysis. Samples were introduced from an autosampler 
(Cetac ASX-520) through a concentric glass venturi nebuliser (Thermo-Fisher 
Scientific; 1 mL/min). Samples of 10 mL were prepared (standards and 
unknown samples) using a 2 % nitric acid solution. The calibration standards 
ofRh and Fe were run covering the range 0 to 100 ppb. The samples collected 
during the continuous flow experiments and catalyst immobilisation were 
diluted to the concentration range 0 to 100 ppb. Three replicates were 
measured for each sample. The data processing was undertaken using 
Plasmalab software (version 2.5.4; Thermo-Fisher Scientific) set to employ 
separate calibration blocks and, where necessary, instrument cross calibration 
was used to calculate results for those samples that had tripped from pulse 
counting detection mode to analogue mode. 
2.5.5. Dynamic Light Scattering (DLS) 
It was attempted to measure the particle size of the CLEA using dynamic light 
scattering technique. The description of the technique can be found in detail in 
another Thesis 14 and therefore only a brief description is given here. Dynamic 
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light scattering is used to determine particle size distribution by measuring the 
fluctuation of the scattered light. The intensity of the scattered light depends on 
the size of the particles. The instrument used here was a Malvern Zetasizer 
Nano S equipped with a back scattering detector and a He-Ne laser as light 
source. 
Unfortunately, the particle size determination of the CLEA using DLS was 
unsuccessful. The suspension of the CLEA was very unstable and settled too 
quickly. The suspension was then diluted, but its stability was still very poor 
and the results of the DLS analysis were not reproducible. Flow DLS 
equipment may be suitable for analysing the particle size of CLEA but it was 
not available to us. Scanning electron microscopy (SEM) has been shown 
previously to be appropriate for analysing the morphology and particle size of 
CLEA3 and was also used in this work. 
2.5.6. Scanning Electron Microscopy (SEM) 
Scanning electron microscopy (SEM) was used to determine the size and 
morphology of the CLEA. In SEM, a high energy electron beam is focused on 
the sample. The electrons interact with the atoms of the sample and the 
electrons scattered or emitted by the sample are detected. ls 
The samples were prepared using a single drop of liquid from the top portion 
of each sample (suspension of CLEA) that was pipetted onto a glass cover slip 
and dried at room temperature. The samples were then gold coated under 
vacuum. High vacuum mode using secondary electron detection was used for 
viewing the samples. The images were taken using a FEI Quanta 600 or 
Quanta 200 scanning electron microscope. The image shown in Figure 2-11 
represents an SEM image of Candida antarctica lipase CLEA. 
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Figure 2-11. SEM image of Candida antarctica lipase AlB CLEA.3 
2.5.7. Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
SDS-PAGE analysis was used to quantify the released protein from catalase 
under different conditions, which was used to evaluate the efficiency of the 
cross-linking. In SOS-PAGE, the protein fractions can be separated according 
to their size (electrophoretic mobility). 
By boiling the samples, the catalase tetramer breaks to subunits of which size 
can be determined by electrophoresis. The samples of the supernatant collected 
during the preparation of the CLEA were analysed. 
Precast gels (Criterion XT) and synthesized gels were used for the analysis. 
The 'home made' gels were prepared using an 8 % resolving gel and a 6 % 
stacking gel. The samples were prepared using 30 f..LL sample mixed with 
30 ilL loading dye (2x concentrated) or with 10 f..LL loading dye (4x 
concentrated) on the 'home made' or the precast gels, respectively. The 
mixture of the sample and Loading dye was boiled for 5 minutes before loading 
on the gel. 30 f..LL sample was loaded on the gel in both cases. A marker 
(30 f..LL, BioRad Precision Plus Protein Standards, Blue Prestained) was also 
loaded on each gel. The gel was run at 100 V for 180 minutes in order to 
obtain a good quality separation. To visualize the bands on the gel, a Comassie 
Blue staining solution was used. The gel was placed in the staining solution 
and left there for 1 hour with agitation. (The precast gel was washed before the 
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staining step using a dilute MeOH solution in order to remove the membrane 
of the gel.) The following step was destaining. The gel was agitated in the 
destaining solution (containing 20% MeOH) for 30 minutes and it was 
repeated 3 times using a fresh solution or until the bands became clearly 
visible. The gel was then photographed and analysed considering the standard. 
A sample gel is presented below for further explanation (Figure 2-12). 
St SI S2 S3 S4 S5 S6 St 
kDa 
250 
150 
100 
75 
50 
37 
25 
Figure 2-12. SDS-PAGE analysis of protein samples.16 In this Figure 'St' 
stands for standard (protein standard) and 'SI '-'S6' are unknown 
samples. The size of the protein fractions contained in the standards is 
marked in the Figure on the left hand side that was considered for the size 
determination of the proteins in the unknown samples. 
2.5.8. Karl-Fischer Titration 
Karl-Fischer titration was used to quantify the water content in the solvents 
used for conducting kinetic resolution. The aim of the research was to 
investigate enzymatic reactions in a non-aqueous medium and therefore the 
amount of water present was important. 
The titration is based on a reaction between an alcohol (ROH) and sulfur 
dioxide (S02), and a base (R'N) to form an intermediate (alkylsulfite salt) . The 
intermediate alkylsulfite salt is oxidised to an alkylsulfate by iodine. Sulphur 
dioxide (i), pyridine (i) and iodine (ii) are contained in the Karl Fischer 
reagent. Methanol was used as alcohol (ROH) (i) and water (ii) was present as 
water content of the solvent to be analysed. The oxidation reaction consumes 
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water and once all the water is used, the iodine excess IS detected 
voltametrically by the titrator indicator electrode. To obtain an accurate 
analysis, triplicates of the same samples were analysed. The Karl-Fischer 
titration is based on the reaction shown in Equation 2-2. 
ROH + S02 + R'N -"(R'NH)S03R + 12 + H20 + 2 R ' ~ ~ (R'NH)S04R + 2(R'NH)1 
alcohol base alkyl sulfite 
salt 
iodine 
water 
ii 
alkylsulfate 
salt 
III 
hydroiodic 
acid salt 
Equation 2-2. The reaction on which the Karl-Fischer titration is based. 
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Chapter 3 
Continuous Asymmetric Hydrogenation using Alumina 
Supported Homogeneous Chiral Rh Catalysts in scC02 
This Chapter begins with an overview of catalytic asymmetric hydrogenation 
in scC02 reported to date. It then describes the progress achieved in 
continuous flow asymmetric hydrogenation during this research project. 
3.1. Catalytic Asymmetric Hydrogenation 
The production of enantiomerically pure compounds has become increasingly 
important because the two enantiomers of the same compound can have 
completely different biological activities, which is of great concern in the 
pharmaceutical industry. One of the most widely known examples of the 
different effect of two enantiomers is thalidomide which was used in the 1960s 
to reduce nausea and vomiting during pregnancy. One enantiomer in the drug 
is causing birth defects (monster making) such as missing or stunted limbs. 1 
Until the 1970's, the primary method for obtaining pure enantiomeric 
compounds was the resolution of racemic mixtures.2 Through the development 
if asymmetric catalysis, a small amount of chirally modified catalyst can 
produce large amounts of enantiopure product. 3.4 
Hydrogenation is one of the most common reactions in the chemical industry.s 
Catalytic asymmetric hydrogenation enables the production of 
enantiomerically pure compounds in a single step from a prochiral substrate3• 4 
One of the first examples of asymmetric catalytic hydrogenation to produce 
enantiomerically pure compounds was performed by Noyori and co-workers 
applying a bisphosphine ligand in 1980. The pioneering research of Sharpless, 
Knowles and Noyori was recognised by Nobel Prize for Chemistry in 2001: 
"the development of catalytic asymmetric synthesis". The enantioselective 
hydrogenation of a-( acylamino )acrylic acids using a Rh catalyst modified with 
2,2'-his(diphenylphosphino)-I,1 '-binaphthyl (BINAP) ligand was performed 
in EtOH and high enantioselectivity was observed (Scheme 3_1).6 
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(Z)-2-(benzamido )-3-phenylacrylic acid 
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Rh-BINAP 
o PhiH H 
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H 
yield: 97 % 
ee> 99 % 
(S)-2-(benzamido )-3-phenylpropanoic acid 
Scheme 3-1. An example for the asymmetric hydrogenation of 
a-(acylamino)acrylic acids using an Rh(I)-BINAP catalyst.6 
Reaction conditions: H2 pressure: 3-4 bar, 0.5-1.0 mmol of substrate in 
20-30 mL EtOH. 
There are two classes of enantioselective catalysts: homogeneous metal 
complexes containing chiral ligands and heterogeneous metal catalysts in the 
presence of chiral modifiers. The metal component is the activating function 
while the ligand is responsible for the enantiocontrol. The most commonly 
used metals are Cu, Ir, Mn, Os, Pd, Pt, Rh, Ru, and Ti. The majority of the 
ligands used presently in asymmetric catalysis are phosphorous based?' 7. 8 The 
review by Tang list a large number of phosphorous ligands that can be used for 
the asymmetric hydrogenation of various substrates.9 
3.2. Continuous Catalytic Asymmetric Hydrogenation in SCFs 
Hydrogenation has been shown to be possible under classical conditions (in 
organic solvents: gas-phase hydrogenation, liquid-gas system) and also in 
supercritical fluids (SCFs ).10-13 Despite the need for high pressure reactors 
when using SCFs as solvent for conducting chemical transformations, SCFs 
(especially supercritical C02) have become increasingly important as 
alternative reaction medium. The advantages of supercritical CO2 (SCC02) for 
hydrogenation reactions are the following. \0 
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i) Complete miscibility of scC02 with H2 that reduces the mass 
transport difficulties compared to a liquid-gas system. 
ii) Adjustable solvent density (viscosity, and solute solubility) by 
altering the pressure and temperature. 
iii) Easy separation of the solvent from the product by simple 
decompression of the high pressure system. 
iv) Reduction in the use of volatile organic solvents. 
The production of fine chemicals in a flow system gives the advantage of 
continuous manufacture and also a reduced risk due to smaller reactor size and 
reduced amount of reactants present at anyone time as compared to a batch 
system. 
A number of papers have been published on homogeneously catalysed 
asymmetric hydrogenation in SCFS I4-17 but only a few have reported 
continuous enantioselective hydrogenation in SCFs I8-20 including two papersl9• 
20 published by our group. The l a t t e ~ O O describes the results presented here. The 
continuous asymmetric hydrogenation of ethyl pyruvate in continuous flow 
SCF system was performed by Baiker and co-workers with continuous feed of 
the chiral modifier (Scheme 3_2).18 The hydrogenation of ethyl pyruvate (and 
other substrates) has also been performed in a non-supercritical continuous 
flow toluene or toluene + acetic acid system using a H-Cube r e a c t o ~ l l with the 
chiral modifier continuously fed, as shown previously in SCFs by Baiker. 
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Scheme 3-2. Continuous asymmetric hydrogenation of ethyl pyruvate in 
SCFs over cinchonidine modified Pt catalyst performed by Baiker and 
co-workers.18 
3.3. Supported Homogeneous Chiral Rh Catalysts 
The reason why there are very few publications on continuous asymmetric 
hydrogenation in a flow system may be the poor availability of heterogeneous 
chiral catalysts. Recently, Augustine et af. developed a technique to anchor 
homogeneous catalysts22 that has been shown to work successfully for 
enantioselective hydrogenation?3 The Augustine anchored catalyst, with 
general formula of [Rh(nbd)2/PTNAluminat[BF4]"/PTA/Alumina 
(nbd = 2,5-norbomadiene, PTA = phosphotungstic acid H30 40PW 12) and brand 
name of CAT AXA, is a Rh based catalyst immobilised on alumina?2 The Rh 
is bound to alumina via phosphotungstic acid binder. The schematic structure 
of the chiral catalyst is shown in Figure 3-1. 
61 Chapter 3 
2 C! = = = ~ > >
Alumina 
Figure 3-1. General structure of the Augustine anchored catalyst. 
IRh(nbd)(PR2-PR2)\+IBF4r/PTA/Alumina where nbd: 2,5-norbornadiene, 
PR2*-PR2*: bisphosphine ligand, PTA: phosphotungstic acid H3040PWI2. 
The numbers (in red) in Figure 3-1 indicate the positions of possible cleavage 
to loss of chiral or total activity. The stabi lity of the chiral catalyst 
[Rh(nbd)(Skewphos)t[BF4f/PTAI Alumina has been investigated previously 
in a continuous flow hydrogenation reaction in scC02 by Stephenson at 
Nottingham?4 The Rh and W content of the product collected by continuous 
depressurisation of the flow system was determined using JCP-MS analysis. 
The tungsten leaching was found to be very low (below I ppm) at all reaction 
conditions (reaction conditions: pressure: \ 00 bar, temperature up to 100 °C, 
C02 flow rate: 0.5 ml/min, substrate flow rate: 0.2 mllmin (dimethyl itaconate 
in IPA 2.5 M), H2 : substrate ratio = 2.5: I). As there was no tungsten 
leaching observed, the tungsten-alumina link (I in Figure 3-1) should be stable 
and the rupture of Rh(nbdh/PTA or Rh(nbd)(ligand)/PTA from the alumina 
should not be expected. The Rh leaching was above 8 ppm at higher 
temperatures (above 100 °C) which suggests that the PTA-Rh link (2 in Figure 
3-\) should be less stable at high temperatures. The ligand leaching, the 
stability of the Rh-ligand link (3 in Figure 3-1) was not studied at this time. 
The achiral CATAXA ([Rh(nbd)2t[BF4f/PTA/Alumina) can be modified with 
bisphosphine ligands, which produces supported homogenous chira l catalysts. 
The chiral 'motif of the catalyst is obtained via a ligand exchange between the 
original nbd (or COD) ligand and the bisphosphine ligand. The Augustine 
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supported homogeneous chiral catalyst can be prepared in two ways: 1) 
synthesis of the chiral species before immobilisation and 2) immobilisation of 
the achiral species before the addition of the ligand (Scheme 3-3). A variety of 
bisphosphine ligand can be added to the Augustine catalyst25 , and therefore 
various substrate specific chiral catalysts can be prepared. 
BF4- ~ ~
C C ~ ~ /j] * PR2 • PR2 Rh+ .. ,/ "'-f Route I 
Route 2 
Alumina / Carbon Alumina / Carbon 
Scheme 3-3. The preparation of the supported homogeneous Rh catalyst. 
Route 1: the synthesis ofthe chiral species before immobilisation, Route 2: 
the immobiJisation of the achiral species before the addition of the ligand. 
Route 1 was investigated by Johnson Matthey (JM) and various supported 
homogeneous chiral catalysts were prepared. Route 2 was investigated at 
Nottingham. Comparing the results of the asymmetric hydrogenation of 
dimethyl itaconate m a continuous flow scC02 system with 
[Rh(nbd)(Skewphos)t[BF4r/PTAIAlumina prepared via route 1 (by JM) and 
route 2 (at Nottingham), the viability of the catalyst preparation in route 2 
could be evaluated. The conversion and enantioselectivity of the reaction were 
similar with both chiral catalysts. Having confirmed that route 2 is viable for 
preparing supported homogeneous chiral catalyst24, this method was used 
throughout this research project. A detailed procedure for the chiral catalyst 
preparation is described in Chapter 2. 
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3.4. Continuous Asymmetric Hydrogenation of Dimethyl Itaconate 
in scC02 
The activity of supported homogeneous chiral Rh catalysts was examined for 
the asymmetric hydrogenation of alkenes in a continuous flow scC02 system 
at Nottingham prior to this research project.19• 24 The asymmetric 
hydrogenation of dimethyl itaconate (Scheme 3-5, page 66) was chosen as 
model reaction to study continuous enantioselective hydrogenation because 
dimethyl itaconate has been widely used previously to evaluate 
enantioselective hydrogenations.26. 27 
The suitability of dimethyl itaconate for hydrogenation conducted in 
continuous flow SCC02 has already been demonstrated with a commercially 
available catalyst, Johnson Matthey Type 31 (2 % Pd on silica/alumina). The 
catalyst was found to be selective for the reduction of C=C bond with high 
conversion up to 100 % at temperatures greater than 100°C (reaction 
conditions: pressure: 100 bar, C02: flow rate: 0.5 mllmin, substrate flow rate: 
0.2 mllmin (dimethyl itaconate in IP A 2.5 M), H2 : substrate ratio = 2.5: 1).24 
The asymmetric hydrogenation of dimethyl itaconate in a continuous flow 
SCC02 system was investigated using different supported homogeneous chiral 
Rh catalysts [Rh(nbd)2t[BF4rtPTAIAlumina or [Rh(COD)ztBF4-
IPT AI Alumina modified with different bisphosphine ligands such as 
Skewphos, Josiphos 001, BoPhoz, Prophos, BINAP, DIOP, TANGPHOS and 
a Phosphine-Phospite ligand.24 The structures of the ligands are depicted in 
Figure 3-2. 
64 Chapter 3 
fr 
~ \ \ \ " \ \ ' '
I '" PPh2 PPh2 
--- 5, ~ ~ "'11/ 
I Fe PPh2 Q 
BoPhoz 
Skewphos Josiphos 001 ProPhos 
)<0 
M 
PPh2 Ph2P 
BINAP DIOP TANGPHOS 
Chiral phosphine-phosphite ligand (LigBank) 
Figure 3-2. The structure of the ligands used for preparing supported 
homogeneous chiral catalyst [Rh(nbd)(Skewphos))+[BF4rtPTAlAlumina 
or [Rh(COD)(R2P*-PR2*))+[BF4rtPTAlAlumina where nbd: 2,5-
norbornadiene, COD: 1,5-cyclo-octadiene, R2P*-PR2*: hisphosphine 
ligand, PTA: phosphotungstic acid H3040PW 12. The activity of the chiral 
catalysts was investigated in the asymmetric hydrogenation of dimethyl 
itaconate in continuous flow scC02. 
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The results of the asymmetric hydrogenation using supported homogeneous 
chiral Rh catalysts [Rh(nbd)(Skewphos)t[BF4]"/PTAIAlumina or 
[Rh(COD)(PR2*-PR2*)t[BF4]"/PTAIAlumina are listed in Table 3-1. 
Table 3-1. The results of the asymmetric hydrogenation of dimethyl 
itaconate in continuous flow SCC02.19,24 
Entr 
1*· 
2· 
3· 
4 b 
5 b 
6 b 
7 c 
SC 
9 c 
10 C 
H C 
12 c 
B C 
14 C 
Li and 
Skewphos 
Josiphos 00 1 (batch 1) 
Josiphos 001(batch 1) 
BoPhoz 
Prophos 
Prophos 
BINAP 
BINAP 
DIOP 
DIOP 
TANGPHOS 
TANGPHOS 
Phosphine-phosphite 
Phosphine-phosphite 
25-70 
30-75 
30-50 
30-150 
30-70 
30,40 
30-60 
30-50 
35-55 
35-55 
35-55 
35-55 
50-100 
30-70 
P (bar) 
100 
100 
160 
100 
100 
200 
100 
200 
100 
160 
100 
160 
100 
200 
Cony (%) 
22-41 
8-22 
25-35 
0-15 
27-34 
14-37 
5-19 
20-26 
42-61 
45-67 
0-17 
0-24 
0-93 
0-80 
ee(%) 
6-31 
3-53 
48-77 
0-3 
0-1 
0-1 
0-11 
9 
10-18 
10-12 
0-1 
o 
0-4 
0-4 
* The catalyst was [Rh(nbd)(Skewphos)]+[BF4rtPTAlAlumina where 
nbd: 2,5-norbornadiene, PTA: phosphotungstic acid H304oPWI2. In all 
other cases the catalyst was [Rh(COD)( R2P*-PR2*»)+[BF4]"1PTAlAlumina 
where COD: 1,5-cyclo-octadiene, PR2*-PR2*: bisphosphine ligand. 
a) Reaction conditions: C02 flow rate: 0.5 mL/min, substrate flow rate: 
0.2 mL/min (DMIT in IPA 2.5 M), H2 : substrate ratio = 2.5 : 1. 
b) Reaction conditions: CO2 flow rate: 0.25 mL/min, substrate flow rate: 
0.1 mL/min (DMIT in IP A 2.5 M), Hz : substrate ratio = 2.5 : 1. 
e) Reaction conditions: CO2 flow rate: 0.5 mL/min, substrate flow rate: 
0.15 mL/min (DMIT in IPA 2.5 M), H2 : substrate ratio = 4: 1. 
The supported homogeneous chiral Rh catalyst modified with Josiphos 001 
ligand, [Rh(COD)(Josiphos 001)t[BF4]"/PTAIAlumina, was found to be the 
most successful for the continuous asymmetric hydrogenation of dimethyl 
itaconate in SCC02. This catalyst was the most active at temperatures between 
35°C and 55 °C at 100 bar (reaction conditions: CO2 flow rate: 0.5 mVmin, 
substrate flow rate: 0.2 mVmin (dimethyl itaconate in IP A 2.5 M), H2 : 
substrate ratio = 2.5: 1). Above 55°C, the enantioselectivity and the 
conversion both reached a plateau. The effect of the pressure was also 
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examined between 60 bar and 180 bar at 60°C. A peak was observed in the 
enantioselectivity and conversion at 120 bar but lower activity was found with 
a further increase in pressure. The reaction gave the best results at 60°C at 
120 bar: enantiose1ectivity (S) 73 % and conversion 39 %. 
As the best results were obtained with Josiphos 001 among the other 
bisphosphine ligands examined by Stephenson. it was thought that similar 
ligands to Josiphos 001 may be highly active. Several bisphosphine ligands 
similar to Josiphos 001 have been developed at Solvias AG (Basel, 
Switzerland), which were investigated for continuous asymmetric 
hydrogenation of dimethyl itaconate in scC02 in this work. 
3.5. The Development of the Josiphos Type Ligands 
The discovery of the Josiphos type ligands began at the Central Research 
Laboratories of the former Ciba-Geigy. The starting point was the preparation 
of ferrocenylligands carrying different side chains.2s It was found later that the 
acetate group at the stereogenic centre could be replaced (upper right part in 
Scheme 3-4, X = PPh2).28. 29 This finding led to the idea of introducing 
different PR2 groups (lower right part in Scheme 3-4). The first example of a 
Josiphos ligand was X = H. The synthetic route of the first Josiphos type 
ligand is shown in Scheme 3_4.30• 31 The first catalytic test was the 
Rh-catalysed enamide hydrogenation, which showed high success with 
enantioselectivity > 99 % and a Tum-Over Number (TON, moles of product 
per mole of catalyst) of around 1000 h-1•30 The whole ligand family was named 
after a technician Josi Puelo who prepared the first example for the novel 
chelating ligands bearing two different PR2 groups. 
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first Josiphos 
X=H 
peY2 = secondary phosphine 
Scheme 3-4. Synthetic route of the first Josiphos ligand. Substitution 
reactions at the stereogenic centre of ethyl ferrocene derivatives.3o 
The synthesis of Josiphos type bisphosphine ligands has continued because the 
substituents of the ligands are modular and tuneable. This property allows 
further development of the ligands to obtain high enantioselectivity for a 
particular reaction.31 
3.6. Results and Discussion 
Solvias AG, the trader of the Josiphos type ligands, kindly offered to donate 
several Josiphos type ligands to determine their activity for continuous 
asymmetric hydrogenation in SCC02. Their performance is evaluated here for 
the hydrogenation of dimethyl itaconate (Scheme 3-5) using supported 
homogeneous chiral catalysts [Rh(COD)(R2P*-PR2*)t[BF4]"/PTAJAlumina or 
Carbon (Figure 3-3) where PR2*-PR2* was a Josiphos type ligand 
(Figure 3-4). The results of the research performed prior to this study 
determined a range of temperature and pressure where the asymmetric 
hydrogenation of dimethyl itaconate was the most successful in SCC02.24 The 
Josiphos type ligands were examined in this 'optimal' temperature and 
pressure range. 
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Scheme 3-5. The enantioselective hydrogenation of dimethyl itaconate 
using supported homogeneous chiral Rh catalyst. 
Alumina / Carbon 
Figure 3-3. General structure of the supported homogeneous Rh catalyst 
IRh(COD)(R2P*-PR2*)t[BF4rtPTA/Alumina or Carbon where COD = 
1,5-cyclo-octadiene, R2P*-PR2* = bisphosphine ligand, PTA = 
phosphotungstic acid H3040PW 12. 
The continuous asymmetric hydrogenation of dimethyl itaconate was 
investigated using [Rh(COD)(PR2*-PR2*)t[BF4T/PTAlAlumina modified 
with six different Josiphos type ligands: Josiphos 001 , Josiphos 005, 
Walphos 002, Mandyphos 001, Taniaphos 001 , Taniaphos 002. The structures 
of the ligands are shown in Figure 3-4. The preparation of the chiral catalyst 
was performed via immobilisation of the achiral species before the addition of 
the bisphosphine ligand (Route 2, Scheme 3-3). The procedure for preparation 
of the chiral catalysts is described in detail in Chapter 2. Dimethyl itaconate is 
solid at room temperature and therefore a cosolvent was needed to bring the 
material into solution. Iso-propanol (IP A) and methanol were used in this 
work. 
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Figure 3-4. The structures of the Solvias Josiphos type ligands. The 
general structure of the supported homogeneous chiral Rh catalyst is 
[Rh(COD)(R2P*-PR2*)]+[BF4rtPTAlAlumina (COD = 1,5-cyclo-octadiene, 
R2P*-PR2* = bispbosphine ligand, PTA = phosphotungstic acid 
1 I 3 ( ) 4 0 P ~ 1 2 ) . .
This research focused on achieving highly enantioselective hydrogenation via 
two key routes i) altering the temperature and pressure of the continuous flow 
SCC02 system and ii) changing the bisphosphine ligand attached to the Rh 
catalyst (CAT AXA). The bisphosphine ligands examined here belong to the 
Solvias Josiphos family. The ligands differentiate in electronic properties and 
size, which can influence the activity of the whole catalyst system. In addition, 
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different cosolvents (used to bring the solid dimethyl itaconate into solution) 
were also examined. The polarity and dielectric constant of the solvent may 
influence the hydrogenation. Furthermore, different support materials, alumina 
and carbon, were also investigated. The enantioselectivity will be discussed 
here in more detail as the main aim of this work was achieving high 
enantioselectivity for the continuous asymmetric hydrogenation of dimethyl 
itaconate in SCC02. 
3.6.1. The Effect of the Bisphosphine Ligand on the Enantioselectivity 
The chiral Rh catalysts modified with Josiphos type ligands (Figures 3-3 and 
3-4) were examined for the continuous asymmetric hydrogenation of dimethyl 
itaconate in flow SCC02 (Scheme 3-5) at temperatures 35-55 °C at 100 bar and 
170 bar. Small amount of each chiral catalyst was used because a limited 
amount of CAT AXA was available in the lab. The quantity of the catalyst used 
in the particular experiment could affect the conversion of the substrate but it 
could be increased by using a larger amount of catalyst and/or increasing the 
residence time (by decreasing the flow rate). It has been shown previously that 
an increase in C02 flow rate did not affect greatly the enantioselectivity of the 
reaction, while it significantly decreased the conversion of the substrate to 
product. 24 Figure 3-5 shows the experimental results of the continuous 
asymmetric hydrogenation of dimethyl itaconate In flow scC02 with 
[Rh(nbd)(Skewphos) t[BF 4]"/PT N Alumina.24 
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Figure 3-5. The effect of the flow rate on the enantioselective 
hydrogenation of dimethyl itaconate in continuous flow scCOz with 
[Rh(nbd)(Skewphos) )+[BF 4r/PT A/Alumina.24 
Reaction conditions: temperature: 60 °C, substrate flow rate: 0.2 ml/min 
(DMIT in [PA 2.5 M), Hz : substrate ratio = 2.5 : 1. 
Before the screening of the Josiphos type ligands for the continuous 
asymmetric hydrogenation of dimethyl itaconate in SCC02, the reproducibility 
of the results of Stephenson24 was examined using freshly prepared 
[Rh(COO)(Josiphos 00 l)t [BF4r /PTA/Alumina. The experiments were 
performed using a small scale hydrogenation equipment described in 
Chapter 2. The samples were analysed by chiral GC and the enantioselectivity 
was calculated as described in Chapter 2. The results are shown in Table-3-2. 
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Table 3-2. The results of the asymmetric hydrogenation of dimethyl 
itaconate using [Rh(COD)(Josiphos 001)]+[BF4rJPTAlAlumina. The 
results of the research performed prior to the current study are marked 
as Josiphos - batch 1.24 The results of this work are shown as Josiphos -
batch 2. 
Entry Ligand T (OC) P (bar) Conv(%) ees (0/0) 
1 Josiphos - batch 1 30 100 12 3 
2 Josiphos - batch 1 35 100 10 8 
3 Josiphos - batch 1 40 100 8 18 
4 Josiphos - batch 1 45 100 10 39 
5 Josiphos - batch 1 50 100 19 52 
6 Josiphos - batch 1 55 100 19 51 
7 Josiphos - batch 1 60 100 22 52 
8 Josiphos - batch 1 65 100 21 52 
9 Josiphos - batch 1 70 100 21 52 
10 Josiphos - batch 1 75 100 22 53 
11 Josiphos - batch 1 60 120 39 73 
12 Josiphos - batch 1 60 160 40 63 
13 Josiphos - batch 1 60 180 38 59 
14* Josiphos - batch 2 35 100 29 26 
15* Josiphos - batch 2 45 100 29 47 
16* Josiphos - batch 2 55 100 65 83 
17* Josiphos - batch 2 35 170 17 16 
18* Josiphos - batch 2 45 170 29 74 
19* Josiphos - batch 2 55 170 80 77 
Reaction conditions: CO2 flow rate: 0.5 mVmin, substrate flow rate: 
0.2 mVmin (DMIT in IPA 2.5 M), H2 : substrate ratio = 2.5: 1. 
* Reaction conditions: C02 flow rate: 0.5 mVmin, substrate flow rate: 
0.2 mVmin (DMIT in IPA 2.5 M), H2 : substrate ratio = 3 : 1. 
For better visualization of the results, the enantioselectivity is shown in a 
graph as well (Figure 3-6). 
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Figure 3-6. The enantioselectivity of the asymmetric hydrogenation of 
dimethyl itaconate using IRh(COO)(Josiphos 001)1+IBF4 r/PTA/Alumina. 
The results of the research preformed prior to this work are marked as 
batch 1.Z4 The results of this work are shown as batch 2. 
Reaction conditions: CO2 flow rate: 0.5 ml/min, substrate flow rate: 0.2 
mUmin (DMIT in IPA 2.5 M), Hz : substrate ratio = 2.5 : 1 for batchl, 
and 3 : 1 for batch 2. 
The enantioselectivities di splayed by the chiral catalyst 
[Rh(COO)(Josiphos 00l)t [BF4P PTA/A lumina with Josiphos 001 from 
different batches were di fferent, but showed a imilar trend : the 
enantioselectivity increased with an increase in the reaction temperature. (It is 
not unusual that the catalyst acti vity varies when it originates from di fferent 
batches.) Normally, higher enantioselectivity is ex pected at low temperature, 
the energetic di fference between the paths leading to the two enantiomers is so 
small that it is reasonable to assume that low energy would lead to a higher 
enantioselecti vity. The reason for higher enantioselectivity at higher 
temperature might be due to changes in the phase behav iour of the system 
because the solubility of substrates normally increases with an increase in 
temperature. The phase behaviour of dimethyl itaconate/lPA/scC0 2 mixture 
was determined at Nottingham24 and is shown in Figure 3-7. The addition of 
H2 to the system slightly shifted the phase boundary line upwards but only a 
slight di ffe rence (up to 5 bar at H2 : substrate ratio = 8 : I) was observed 
(conditions used in this work: maximum H2 : substrate ratio = 3 : 1 ).24 
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Figure 3-7. Phase behaviour of dimethyl itaconate/IP AlscC02 mixture.24 
Most conditions examined here lay in the single phase region. The asymmetric 
hydrogenation using Josiphos 001 from the first batch reached a plateau above 
50°C at 100 bar. The highest enantioselectivity (73 %) was obtained at 60°C 
at 120 bar where the reactants and SCC02 were present in a single phase. From 
all the work with [Rh(COD)(Josiphos 00l)t[BF4]"IPTAlAlumina, the best 
result was obtained using the chiral catalyst modified with Josiphos 001 ligand 
from the second batch at 55°C at 100 bar: ees = 83 %. The phase boundary 
line goes through the point of 55°C at 100 bar which might influence the 
reaction. However, high enantioselectivity was observed with the chiral 
catalyst modified with Josiphos 001 ligand from the first batch at 60°C and 
120 bar ees = 73 %, and from the second batch at 55°C and 170 bar 
ees = 77 %, which were both in the one phase region. Therefore, the phase 
behaviour of the system should not have a significant effect on the reaction. 
The enantiose1ectivity of the asymmetric hydrogenation increased with an 
increase in temperature at both pressures examined here (100 bar and 170 bar) 
using [Rh(COO)(Josiphos 001)t[BF4]"IPTAlAlumina (this study). The reason 
for higher enantioselectivity at higher temperature may be due to changes in 
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the density of CO2: it decreases with an increase in temperature, which 
therefore results in a slight flow rate change as 'weaker' reaction medium 
flows through the system. The removal of the product from the catalyst surface 
may also be faster at higher flow rates and higher temperatures, which can 
improve the performance of the chiral catalyst. The effect of an increased 
pressure was not clearly shown here. 
The hydrogenation with [Rh(COD)(Josiphos 001)t[BF4]"/PTAIAlumina with 
Josiphos 001 from the second batch was performed 3 times using a freshly 
made chiral catalyst in each case. The description of the process for 
preparation can be found in detail in Chapter 2. The ligand exchange was 
performed over 16 hours (overnight) with stirring under an argon atmosphere. 
One of the batches was prepared with a 4-hour ligand exchange reaction rather 
than 16 hours. In another case, technical problems occurred during the 
preparation (the stirrer stopped after circa 8 hours). In both cases a very low 
enantioselectivity was obtained for the asymmetric hydrogenation. The results 
presented here are from the experiments using the chiral catalyst 
[Rh(COD)(Josiphos 001)t[BF4rIPTAIAlumina prepared in the route 
described in Chapter 2 without any malfunction. It therefore suggests that the 
catalyst preparation may have a significant effect on the catalyst performance, 
and therefore the chiral catalyst must be prepared with a great care. 
The chiral catalysts [Rh(COD)(ligand)t[BF4rIPTAIAlumina using Josiphos 
type ligands were examined at temperatures 35°C, 45 °C and 55°C and at 
pressures 100 bar and 170 bar. The enantioselectivity values are plotted in two 
graphs. The enantioselectivity obtained at 100 bar is shown in Figure 3-8. 
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Figure 3-8. The enantioselectivity of the asymmetric hydrogenation of 
dimethyl itaconate using CAT AXA modified with bisphosphine ligands 
(Rh(COO)(ligand)\+IBF4 r/PTA/Alumina at 100 bar. 
Reaction conditions: pressure: 100 bar, COz flow rate: 0.5 ml/min, 
substrate flow rate: 0.2 mt/min (OMIT in IPA 2.5 M), Hz : substrate 
ratio = 3:1. 
It can be seen from Figure 3-8 that the enantiose lectivity of the hydrogenation 
was highly dependent on the ligand attac hed to the Rh complex. (The 
conversion is shown in Figure 3-1 I, page 83) The enantiose lecti vity increased 
with an increase in temperature uSing Josiphos 001 , Taniaphos 00 I, 
Taniaphos 002 and Mandyphos 00 I. The enantiose lectivity uSing 
Mandyphos 001 was very low which is within the experimenta l error. The 
enantiose lectiv ity produced using Jos iphos 00 I, Taniaphos 00 I and 
Taniaphos 002 ligands increased with increas ing temperature. This increase in 
counter-in tuiti ve, the energetic difference between the paths producing the two 
enantiomers is very small and therefore it can be assumed increasing energy 
would lead to lower enantioselecti vity. The results of the reaction uSing 
[Rh(COD)(Josiphos 001)t[BF4r /PTA/A lumina are a lso described in deta il 
above. The expected trend, decreas ing enantiose lecti vity w ith increas ing 
temperature, was observed w ith Josiphos 005 and Walphos 002 ligands. 
The vari ation in enantioselectivity using di fferent ligands can be rati ona li sed 
on the bas is of the e lectron w ithdrawing/donating properti es and size of the 
ligands. All of the ligands used in thi s work have electron donating groups 
attached to the phosphine. The most strongly e lectron donating ligand was 
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assumed to be Walphos 002 which gave an enantioselectivity up to 58 %. The 
highest enantioselectivity was obtained using Josiphos 001 ligand, which was 
thought to have the weakest electron donating properties of the six ligands. 
Therefore the size and steric effects also need to be considered. The sterics of 
the two might have a more significant effect than size on the chiral catalyst 
performance. Josiphos 001 is the smallest ligand in size among these six 
Josiphos type ligands and it showed the highest enantioselectivity. 
Walphos 002 is slightly larger than Josiphos 001 and it showed the second 
highest chiral activity. The remaining four ligands (Josiphos 005, Mandyphos 
001, Taniaphos 001 and Taniaphos 002) are all larger in size than either 
Josiphos 001 or Walphos 002 and gave lower enantioselectivities. Small 
differences in size may change the effect of the ligand on the chiral 
performance of the catalyst via steric inhibition. Furthermore, steric problems 
could also cause incompatibility of some ligands with the CAT AXA system, 
which could be the origin of the low activity in some cases. The 
incompatibility of a ligand could have been determined by analysing the iron 
(from the ligand) present in the samples collected during the chiral catalyst 
preparation but unfortunately, there was no access to an ICP-MS instrument at 
the time these experiments were conducted. Even if the ligand could be 
attached to the Rh, steric inhibition could still be the source of the low 
enantioselectivity: the substrate might not reach the active centre of the 
catalyst because it was blocked by the ligand. 
Molecular modelling (Spartan, Semi Empirical using PM3) of the Josiphos 
type ligands (the structures of the ligands is shown in Figure 3-4) was 
performed to demonstrate the differences in size (Figure 3-9). 
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Jos iphos 00 1 (ees = 83 %) Jos iphos 005 (ees = 37 %) 
Walphos 002 (eeR = 57 %) Taniaphos 001 (eel? = 10 %) 
Taniaphos 002 (eeR = 18 %) Mandyphos 00 I (eeR = 3 %) 
Figure 3-9. The structures of the Solvias Josiphos type ligands. The 
calculations were performed on Spartan, Semi Empirical using PM3. (The 
highest enantioselectivity obtained with the particular ligand is shown in 
brackets.) 
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Although, the 3D dimensions of the ligands are not available, the difference in 
size of the ligands can be seen clearly and is in a good agreement with the 
enantioselectivity observed in the asymmetric hydrogenation of dimethyl 
itaconate in SCC02: (order of size and enantioselectivity): Josiphos 001 > 
Walphos 002 > Josiphos 005 > Taniahos 002 > Taniaphos 001 > 
Mandyphos 001. Although Josiphos 005 ligand is the second smallest ligand, 
it has conjugated substituents that will decrease the electron 
withdrawing/donating properties, which can explain why it produced lower 
enantioselectivity than Walphos 002 (no conjugated system) which is larger in 
size. 
A mechanism for the homogenously catalysed hydrogenation of dimethyl 
itaconate has been proposed previously?- 32 The orientation and therefore the 
selectivity of the reaction is dependent on how the substrate binds to the 
catalyst. 2 In Scheme 3-6, the binding of H2 is prior to the binding of the 
substrate which is presumably occurring in the continuous asymmetric 
hydrogenation of dimethyl itaconate in SCC02 because H2 was used in excess 
to the substrate. If the bisphosphine ligand is too large the substrate might not 
go through the catalytic cycle. 
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Scheme 3-6. The mechanism of the homogenous catalytic asymmetric 
hydrogenation in conventional solvents. 
The continuous asymmetric hydrogenation of dimethyl itaconate in scC02 was 
also examined at a higher pressure. The results of the experiments at 170 bar 
are shown in Figure 3-10. 
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Figure 3-10. The enantioselectivity of the asymmetric hydrogenation of 
dimethyl itaconate using CAT AXA modified with bisphosphine ligands 
[Rh(COD)(ligand)I+[BF4 r/PTA/Alumina at 170 bar. 
Reaction conditions: pressure: 170 bar, CO2 flow rate: 0.5 mllmin, 
substrate flow rate: 0.2 mt/min (DMIT in [PA 2.5 M), H2 : substrate ratio 
= 3 : 1. 
Comparing the results show n in Figures 3-8 and 3-10, it can be observed that 
the enantioselecti vity was lower with all chira l catalysts at higher pressure. 
(The conversion is shown m Figure 3- 11 , page 83) T he enantiose lectiv ity 
increased with an increase m temperature using e ither liga nd , however, the 
enantiose lectiv ity was very low in most cases . The experiments at 170 bar 
were performed after those at 100 bar in the same set. The cata lyst might have 
become deactivated via the reverse water gas-shift reaction CO2 + H2. ---+ 
H20 + CO . I I The negative effect of the reverse water gas-shift reacti on might 
poss ibly be more significant on the chira l cata lyst if it had been kept under 
C0 2 and H2 for a longer period of time . Furthermore, the ligand could be 
washed away during the experiment and therefore the enantioselec ti vity might 
drop with time. 
The conversIon of dimethy l itaconate uSll1g [Rh(COD)(ligand)t[BF4r 
IPTA/Alumina w ith Josiphos 001 and Walphos 002 ligands are presented in 
Figure 3-11. 
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Figure 3-11. The level of conversion obtained in the asymmetric 
hydrogenation of dimethyl itaconate using IRh(COD)(ligand)I+IBF4r 
/PTA/Alumina modified with Josiphos 001 and Walphos 002 ligands. 
Reaction conditions: CO2 flow rate: 0.5 ml/min, substrate flow rate: 
0.2 ml/min (DMIT in IPA 2.5 M), H2 : substrate ratio = 3 : 1. 
The results in Figure 3-11 show that the convers ion of the substrate 111 the 
continuous asymmetri c hydrogenation increased by an increase in temperature 
in most cases. An increased pressure increased the conversion of dimethyl 
itaconate uS1l1g [Rh(COD)(Jos iphos 00 I )t[B F 4rtPT Ai Alumina, whil e 
decreased the convers ion uSll1g [Rh(COD)(W alphos 002)t[BF4r 
/PT Ai A lumina. An increase in pressure increases the density of the C0 2 and 
therefore the res idence time of the reaction. An increased res idence time can 
lead to higher conversion as it has a lso been shown prev iously (F igure 3-5). 
The conve rsIOn of dimethyl itaconate decreased uS1l1g 
[Rb(COD)(Walphos 002)t[B F4r at 100 bar w ith temperature, whi ch might be 
due to catalyst leaching during the reaction. The highest conversion obtained 
at 170 bar did not exceed significantly the lowest conversion at 100 bar, which 
supports this hypothes is. 
3.6.2. The Effect of the Cosolvent on the Enantioselectivity 
The cosolvent used might affect the reaction as a change in solvent po larity 
influences the dielectric constant of the reaction medium . Iso-propano l was 
used as a cosolvent in the experiments described so far. To inves ti gate the 
effect of the cosolvent on the reaction, the asymmetric hydrogenation of 
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dimethyl itaconate in continuous fl ow scC02 was a lso performed usmg 
methano l as coso lve nt. 
The polari ty indexes of IPA and methano l are 3.9 and 5. 1, respective ly. T he 
di electric constants of CO2 (liquid), IPA and methanol are 1.6, 18 and 33, 
respecti ve ly.33 Although, scC0 2 is a favoured so lve nt due its low die lectric 
constant, a medium with higher di elect ri c constant may improve the 
enantiose lecti vity of asymmetri c hydrogenations. T he enantiose lectiv ity of the 
asymmetri c hydrogenation of d imethyl itaconate in continuous fl ow scC02 
using [Rb(COO)(Walphos 002)t[B F4F PTA/Alumina w ith 
cosolvents is shown in Figure 3-1 2 . 
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Figure 3-12. The enantioselectivity of the asymmetric hydrogenation of 
dimethyl itaconate using CATAXA modified with Walphos 002 ligand 
[Rh(COD)(Walphos 002)tIBF4 rtPTA/Alumina and different cosolvents. 
Reaction conditions: COz flow rate: 0.5 mt/min, substrate flow rate: 0.2 
mt/min (DMIT in [PA or MeOH 2.5 M), Hz : substrate ratio = 3 : 1. 
The enantiose lectivity of the reacti on was s li ghtly higher at 35 °C and 55 °C at 
100 bar w hen using methanol as cosolvent than that using IPA as cosolvent. At 
all other condi tions, the enanti oselecti v ity was lower us ing methanol than that 
using IPA as cosolvent. The inconsistency could due to experimenta l e rror. A 
reac tion medium with higher die lectri c constant can pos iti ve ly influence the 
chi ra l moti f of a catalyst by prov iding a more ioni c medium . In thi s case, the 
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dielectric constant was not clearly shown to be crucial for achieving high 
chiral performance. 
Unfortunately, there was limited amount of CAT AXAI Alumina available in 
the lab and further supplies of the same catalyst could not be obtained. A 
catalyst with similar structure to [Rh(COD)2t[BF4FPTAJAlumina was 
received from Johnson Matthey as a gift. The only difference was the support 
material. 
3.6.3. The Effect of the Support Material on the Enantioselectivity 
[Rh(COD)2t[BF4FPTAJCarbon was used to establish whether the support 
material has any effect on catalyst performance. The results of the 
hydrogenation (achiral) of dimethyl itaconate with [Rh(CODht[BF4r 
IPTAJAlumina are shown in Table 3-3, and those for [Rh(CODht[BF4r 
/PTAJCarbon are listed in Tables 3-4 and 3-5. Table 3-5 lists the level of 
conversion for the asymmetric hydrogenation with [Rh(COD)2tBF4" 
IPTAJCarbon examined at decreasing temperature from 80 °C to 35 °C. 
Table 3-3. The conversion of dimethyl itaconate using CATAXAIAlumina 
[Rh(COD)2]+[BF4r/PTAIAlumina. The temperature was increased from 
30°C to 70 °C.24 
Entry Temperature (OC) Conversion (%) 
1 30 68 
2 40 68 
3 50 51 
4 60 36 
5 70 22 
Reaction conditions: pressure: 100 bar, CO2 flow rate: 0.25 mllmin, 
substrate flow rate: 0.1 mllmin (DMIT in IPA 2.5 M), H2 : substrate 
ratio = 2.5 : 1. 
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Table 3-4. The conversion of dimethyl itaconate using CATAXAlCarbon 
(Rh(COD)2)+(BF4)"/PTAlCarbon. The temperature was increased from 
35°C to 80 °C. 
Entry Temperature (OC) Conversion (%) 
1 35 60 
2 
3 
4 
5 
45 
55 
65 
80 
98 
99 
99 
99 
Reaction conditions: pressure: 100 bar, CO2 flow rate: 0.5 mVmin, 
substrate flow rate: 0.2 mVmin (DMIT in IPA 2.5 M), H2 : substrate 
ratio = 3: 1. 
Table 3-5. The conversion of dimethyl itaconate using CATAXAlCarbon 
(Rh(COD)2)+(BF4rIPTAlCarbon. The temperature was decreased from 
80°C to 35 °C. 
Entry Temperature eC) Conversion (0/0) 
1 80 99 
2 65 98 
3 55 99 
4 45 98 
5 35 94 
Reaction conditions: pressure: 100 bar, C02 flow rate: 0.5 mllmin, 
substrate flow rate: 0.2 mllmin (DMIT in IPA 2.5 M), H2 : substrate 
ratio = 3: 1. 
While the converSIon of dimethyl itaconate usmg 
[Rh(CODht[BF4]"/PTAIAlumina decreased with increasing temperature, the 
conversion increased using [Rh(COD)2t[BF4rIPTAICarbon. The reason for 
lower conversion using [Rh(COD)2t[BF4]"/PTAIAlumina could be due to 
catalyst loss, however, no Rh leaching was observed below 100°C 
(determined by ICP-MS analysis).24 The activity of the carbon supported Rh 
catalyst remained high even when the reaction temperature was decreased 
from 80°C to 35 °C. The slight decrease with a decrease in temperature might 
be due to catalyst loss or reaction rate decrease. 
Following that the catalyst [Rh(COD)2t[BF4]"/PTAICarbon has been 
confirmed to be suitable for performing continuous hydrogenation in scC02, a 
chiral catalyst [Rh(COD)(Josiphos 001)t[BF4rlPTAICarbon was examined 
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for the enantioselecti ve hydrogenation of dimethyl itaconate. The 
enantioselectivities of the asymmetri c hydrogenation of dimethyl itaconate at 
different conditions with [Rh(CO O)(Jos iphos 00 I )t[B F4r /PT AI Alumina and 
Carbon are shown in Figure 3-13. 
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Figure 3-13. The enantioselectivities of the asymmetric hydrogenation of 
dimethyl itaconate using IRh(COD)(Josiphos 001)1+IBF4 r/PTA/Alumina 
or Carbon at 100 bar and 170 bar. 
Reaction conditions: CO2 flow rate: 0.5 ml/min, substrate flow rate: 0.2 
ml/min (DMIT in IPA 2.5 M), H2 : substrate ratio = 3:1. 
The carbon supported chiral catalyst displayed much lower enantioselectivity 
than the alumina supported catalyst, at a ll conditions. 
[Rh(COOht[BF 4r /PT AlCarbon has a very fine powdery consistency and it 
might have become compacted under pressure. Therefore the catalyst could 
become a monolith and the reactants might fl ow around rather than through 
the catalyst bed. However, the achiral catalyst was highly ac ti ve in the 
continuous flow scC02 system. The chiral modification might be the source of 
the low activity rather than the compaction of the catalyst bed under pressure. 
3.7. Conclusions 
The work in this Chapter demonstrates one of the first examples of continuous 
asymmetric hydrogenation using heterogeneous chiral catalyst without the 
need for the addition of the chiral modifier. 
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The following parameters were examined here for the continuous asymmetric 
hydrogenation of dimethyl itaconate in scC02 i) the ligand attached to the Rh 
complex, ii) the cosolvent used for the reaction, and iii) the support material of 
the chiral catalyst. Among these parameters, the ligand was shown to be the 
most important factor. The electron withdrawing/donating properties, the size, 
and the sterics of the bisphosphine ligand could all highly influence the 
enantioselectivity, but the size and sterics of the ligand might have a more 
significant effect on the catalyst performance. 
The temperature of the continuous flow scC02 system greatly influenced the 
asymmetric hydrogenation. The system pressure had less significant effect. An 
unexpected trend, an increase in enantioselectivity by an increase in 
temperature was observed in some cases which can be explained by the 
changes in the properties of CO2 (density, viscosity, and solvent power). The 
highest enantioselectivity (eeR = 83 %) was obtained at 55°C at 100 bar with 
[Rh( CO D)(J osiphos 001) t[BF 4 ]"IPT AI Alumina. 
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Chapter 4 
Continuous Asymmetric Hydrogenation with Ionic Liquid 
Supported Homogeneous Chiral Rh Catalysts in scC02 
This Chapter outlines the advantages of ionic liquids and their application for 
catalytic reactions in a biphasic system with scC02• The performance of chiral Rh 
catalysts immobilised on alumina in a continuous flow scC02 system was 
discussed in Chapter 3. In this Chapter, [Rh(COD)(Josiphos OOl)t immobilised in 
ionic liquids was examined for the continuous asymmetric hydrogenation of 
dimethyl itaconate in a biphasic system ionic liquid/scC02• 
4.1. Ionic Liquids 
Ionic liquids (ILs) are liquids that contain only ionic species and are liquid below 
100°C. (They are termed as room temperature ionic liquids, R TILs, if they are 
liquid at room temperature or below). I, 2 ILs are composed of anions and cations, 
which can be widely varied to allow the properties of the IL to be tuned. The large 
number of the known anions and cations make a huge number of potential 
combinations possible. l The most commonly used ionic partners are shown in 
Figure 4-1. 
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BF4- PF6-' N03-'SbF6-, 
CF3S03-, [CF3S03hN-, 
ArS03-, CF3C02-, CH3C02-
AIzCI7-
anions 
Figure 4-1. Typical ions found in common ionic liquids. Most common ILs 
are composed of an organic cation and a polyatomic anion. The properties of 
ILs vary depending on which ions are present, leading to them to be 
described as tuneable solvents. 
It is possible to choose the desired solvation and the physical-chemical properties 
of an ILs by combining the appropriate anions and cations. At the same time, ILs 
are immiscible with several organic solvents and therefore can be used in a 
biphasic system. ILs possess several advantageous properties such as negligible 
vapour pressure, non-flammability, high thermal stability, and large liquid range. 
ILs are as essentially non-volatile and therefore the evaporative loss of solvent to 
the environment is avoided.3-6 The disadvantage of ILs is that they may be toxic. 
The least toxic ILs have alkylsulfate anions and they are biodegradable. ILs have 
been used in many areas for example as solvents in catalytic synthesis, as supports 
for the immobilisation of catalysts, as electrolytes in electrochemistry, in fuel and 
solar cells, and as lubricants. I. 4.7-9 
4.2. Reactions in Biphasic Systems Ionic Liquid/scC02 
The recovery of the product and the recycling of the catalyst are problems 
associated with catalysis in ILs. The product may be recovered by distillation or 
extraction, or a biphasic system can be used. If an organic solvent is used for the 
extraction or in a biphasic system the overall benefit will decrease. If scCOz is 
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used instead of an organic solvent in a biphasic system, where the catalyst remains 
in the IL phase and product is extracted by SCC02, the problem of catalyst 
recycling and product recovery can be solved in a green way.IO 
Another advantage of using COz and ILs is that C02 is soluble is ILs but ILs are 
not appreciably soluble in C02, therefore allowing extraction of the product with 
SCC02 without contamination by IL.l I Extraction of materials from the ionic liquid 
phase with scCOz has been successfully performed, including soil remediation12, 
f h . I . 13 d h . I 14-Z0 d b· I· product recovery 0 a c emlca reactIOn ,an c emlca - an locata ybc 
reactions.4,21-23 
The first report on asymmetric hydrogenation in [BMIM][PF6] with extraction of 
the product by scC02 was published by Jessop and co-workers.20 High 
enantioselectivity (up to 99 %) was obtained and the product could be cleanly 
extracted from the IL with scC02 without contamination of the product by IL. The 
reaction and the catalyst are depicted in Scheme 4-1. 
/ (O,H_R_U_{_O ... 2C_M_e ).;;..2{_to_lB_I_N_A_P_) ... 
[BMIM][PF 6]lHzO, scC02 
RU(02CMeh({R)-tolBINAP) = 
R=Me 
ee to 91 % 
Scheme 4-1. The asymmetric hydrogenation of tiglic acid using 
Ru(02CMe)2«R)-tolBINAP) in [BMIM][PF6J. The product was extracted 
with SCC02.20 
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. Reports of continuous catalytic reactions in a biphasic system ILlscC02 can also 
.. be found. The first example was demonstrated by Cole-Hamilton and 
co_workers.8,17,18,24 They investigated the Rh-catalysed hydroformylation of 
l-octene using [BMIM][PF6] (Scheme 4-2). The catalyst was found to be highly 
. stable (Rh leaching into the scC02/product stream was less than 1 ppm) over a 
lOIig period oftime (33 h) . 
[Rh2(OAc )4]IP(OPhh 
• 
[BMIM][PF 6]/SCC02 + 
nliso=3.1 
TON> 200 over 33 h 
CHO 
CHO 
Scheme 4-2. The continuous hydroformylation of 1-octane using a 
[Rh(OAc)4]/P(OPh)J in the biphasic system of [BMIM][PF6]/scC02!7, 24 
During the continuous reaction, the alkene, CO, H2 and CO2 were separately fed 
into the reactor which contained the IL catalyst solution. The products, 
non-converted substrate and reactants were removed from the IL still dissolved in 
SCC02. After decompression, the liquid was collected and analysed. The 
description of the reactor for the continuous hydroformylation in a biphasic system 
ILlscC02 can be found in Reference 17 , which was indeed very similar to the 
reactor used in this study. 
Enzymatic reactions have also been successfully demonstrated in a biphasic 
system ILlscC02. Leitner and co-workers investigated continuous enzyme 
catalysed kinetic resolution of alcohols in I-butyl-3-methylimidazolium 
bis(trifluoromethylsulfonyl)amide [BMIM][BTA] with subsequent extraction of 
the ester derivatives by SCC02 (Scheme 4-3), and achieved high 
enantioselectivity?3,2S The reactor used by Leitner to investigate the continuous 
enzymatic reactions was very similar to the reactor used in this study. 
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[BMIM][BTA]'''c"o, 0 + + ~ O O
eeR-acetate> 99 % 
Scheme 4-3. Continuous enzymatic kinetic resolution of I-phenylethanol 
using ionic liquid/scCOz media.z3 
Another approach to perform continuous reactions with IL as catalytic phase is the 
use of solid, silica supported ionic liquid phase (SILP) catalysts. It has already 
been demonstrated to be successful. The first application of SILP catalysts was 
reported by Fehrmann: the continuous gas-phase carbonylation of methanol with 
[BMIM] [Rh(COhh]-[BMIM]I-SiOz.26 
Continuous asymmetric reactions in a biphasic system ILlscCOz have been 
demonstrated successfully by various research groups, however, this research field 
is still to be extended. The aim of this study was to investigate the continuous 
asymmetric hydrogenation of dimethyl itaconate with a chiral Rh catalyst in a 
biphasic system ILs/scCOz and to determine the effect of the IL on the catalyst 
performance. 
4.3. Experimental 
The ILs [BMIM] [BF4] (l-butyl-3-methylimidazolium tetrafluoroborate), 
[BMIM] [NTfz] (1-butyl-3-methylimidazolium bis(trifluoromethylsulfonyl) 
imide), and [BMIM][N(CN)2] (1-butyl-3-methylimidazolium dicyanamide) were 
used to immobilise the chiral Rh catalyst [Rb(COD)(Josiphos OOl)t[BF4r. The 
choice of these ILs was according to their properties discussed below in this 
Chapter. The structures of the ILs used here are shown in Figure 4-2. 
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1 butyl-3-methylimidazolium 
tetrafluoroborate 
[BMlM][BF 4] 
I-butyl-3-methylimidazolium 
bis(trifluoromethylsulfonyl)imide 
[BMlM] [NTf2] 
I-butyl-3-methylimidazolium 
dicyanamide 
[BMIM] [N(CN)2] 
Figure 4-2. The structure of the ionic liquids used in this work. 
The solubility of C02 and H2 is different in these ILs and therefore allows to 
compare the performance of the catalyst under different conditions. In general, the 
solubility of C02 in ILs decreases with an increase in temperature, and increases 
with an increase in pressure. The solubility of C02 in ILs also depends on the 
properties of the IL.27 It has been shown that C02 solubility is dependent on the 
anion in imidazolium based ILs and they can be classed in three main groups.27.28 
i) The solubility of CO2 in [BMIM] ILs is the highest when a fluoroalkyl 
group is the anion, for example [TID], [NTf2], [methide]. 
ii) The solubility of C02 in [BMIM] ILs is the lowest when a 
non-fluorinated group is the anion, for example [N03],[N(CNh]' 
iii) Inorganic fluorinated anions belong to group possessing intermediate 
solubility of CO2 in [BMIM] ILs ([BF4], [PF6]). 
The solubility of H2 in [BMIM][BF4] (0.86 x 103 [H2]1M) is higher than in 
[BMIM] [NTf2] (0.77 x 103 [H2]1M)?8. 29 (No data were found for 
[BMIM][N(CN)2].) The solubility of H2 in these ILs is approximately 4.5 fold 
lower than that in MeOH (3.75 x 103 [H2]1M)?8.29 
In the continuous hydrogenation in a biphasic system ILlscC02, the catalyst was 
dissolved in the IL phase ([BMIM][BF4], [BMIM][NTf2] or [BMIM][N(CN)2]). 
The C02 stream carried the substrate and H2 to the catalyst dissolved in IL, and 
then extracted the product and unreacted reactants. The stream of C02 was 
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bubbled through the IL phase. The reactor used in th is work to inve ti gate 
continuous asymmetric hydrogenation in a biphas ic system of I L/scC02 is shown 
in Figure 4-3. 
reactants 
H2 
CO2 
- - - I " ~ I I mixer I 
cata lys t in I L 
metal fi Iter 
I F=<eD, 1 BPR ""-...product 
• 
• 
• 
• 
• 
• 
'--_-' ..- cap 
Figure 4-3. The reactor for continuous asymmetric hydrogenation in a 
biphasic system IL/scC02• 
4.4. Results and Discussion 
The reaction of interest was the asymmetric hydrogenation of dimethyl itaconate 
(Scheme 4-4). It has been investiga ted previou ly 111 a continuous fl ow SCC0 2 
system uSll1g an alumina supported chiral Rh catalyst which gave 
enantioselecti vity to 83 % (S) (Chapter 3). Here, the continuous asymmetric 
hydrogenation was investigated with a chiral Rh catalyst in a biphas ic system 
I LS/SCC0 2 where the chiral Rh catalyst was immobilised in the IL phase . Different 
ILs were used to immobilised the cata lyst to determine effec t of the IL on the 
catalyst perfo rmance. 
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OMe 
chiral catalyst 
OMe 
MeO MeO 
Dimethyl itaconate Methyl ester di methyl succ inate 
Scheme 4-4. The enantioselective hydrogenation of dimethyl itaconate using a 
chiral Rh catalyst. 
First, the suitability of the reactor and the cata lyst was eva luated . The continuous 
hydrogenation (achiral) of dimethyl itaco nate wa in vesti gated with 
[Rh(COD)2t[BF4r in a biphas ic system [BMlM][BF4]/scC0 2 using the reacto r 
shown in Figure 4-3. The results a re shown in Figure 4-4. 
conversion (%) 
-+- Ist run -- 2nd run 
100 
80 ~ ~ 7 1 73 
67 
..---- ~ ~69 64 • 72 60 
52 
40 
20 
O - - - - - - - - - - - - - - - - - - - - - , r - - - - - - - - - - - - - - - - - - - - - - - - - - - ~ - - - - - -
30 35 40 45 50 
temperature (0C) 
55 60 65 70 
Figure 4-4. The conversion of the continuous hydrogenation of dimethyl 
itaconate with (Rh(CODhl+ in the biphasic IBMIMIIBF41/scC02 system. 
Reaction conditions: system pressure: 100 bar, CO2 flow rate: 0.5 ml/min, 
substrate flow rate: 0.1 ml/min (2.5 M DMIT in IPA), H2 : substrate molar 
ratio = 3 : 1, catalyst: 16.7 mM (The molarity of the catalyst was calculated 
assuming the presence of 50 /lmol catalyst in 3 mL ionic liquid. The 
procedure for preparation is discussed in Chapter 2). 
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The conversion obtained with [Rh(COD)2t[BF4r in the biphasic system 
[BMIM][BF4]/scC02 was comparable with the conversion obtained in the 
continuous hydrogenation with [Rh(COD)2t[BF 4r;PT AI Alumina in scC01 
(Chapter 3, Table 3-3). Having confirmed that the reactor and the catalyst were 
suitable, the asymmetric hydrogenation of dimethyl itaconate was then 
investigated. The ILs [BMIM][BF4], [BMIM][NTfl] and [BMIM][N(CN)l] were 
examined to immobilise the chiral catalyst [Rh(COD)(Josiphos 00l)t[BF4r. The 
enantioselectivity of the continuous asymmetric hydrogenation in a biphasic 
system ILlscC01 is shown in Figure 4-5. 
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Figure 4-5. The enantioselectivity and level of conversion of the continuous 
asymmetric hydrogenation of dimethyl itaconate with 
IRh(COD)(Josiphos 00t)t1BF4r in a biphasic system ILlscCOz. 
Reaction conditions: system pressure: 100 bar, COz flow rate: 0.5 mt/min, 
substrate flow rate: 0.1 ml/min (2.5 M DMIT in I PA), 
H2 : substrate molar ratio = 3 : 1, catalyst concentration: 16.7 mM. 
* [Rh(COD)(Josiphos 001)tIBF4 r/PTA/Alumina, Reaction conditions: 
pressure: 100 bar, CO2 flow rate: 0.5 ml/min, substrate flow rate: 0.2 ml/min 
(OMIT in IPA 2.5 M), H2 : substrate ratio = 3:1 , chiral catalyst: 16.7 mM 
(The molarity of the chiral catalyst was calculated assuming the presence of 
50 flmol chiral catalyst in 3 mL ionic liquid. The procedure for preparation is 
discussed in Chapter 2). 
The enantiose lectivity of the reaction varied between the different I L u ed to 
immobili se the chiral cata lyst. The H2 olubili ty i higher in [BM IM][BF4] than 
that in [BMIM][NTf2J. (No literature data was found fo r the olubili ty of H2 in 
[BMIM][N(CN)2J. The enantioselectivity was higher u ing [BMIM][NTf2] than 
that using [BMIM][BF4J, and much higher than that using [BMIM][N(CNh J. The 
enantioselectivity observed for the continuous a ymmetric hydrogenation in a 
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biphasic system ILlscC02 using the ILs [BMIM][BF4] and [BMIM][NT6] was in 
a good agreement with the H2 solubility in these ILs [BMIM] [BF4] > 
[BMIM] [NTf2]. The enantioselectivity In the biphasic system 
[BMIM][N(CN)2]/scC02 was lower than that using the other two ILs. This 
suggests the H2 solubility in [BMIM] [N(CN)2] may be lower than that in 
[BMIM][BF4] and [BMIM][NT6], and therefore the catalyst displayed lower 
enantioselectivity . 
The C02 solubility in the ILs used here is the following: [BMIM] [NTf2] > 
[BMIM][BF4] > [BMIM] [N(CN)2]. The introduction of CO2 in the IL phase 
improves the mass transport which can influence the performance of the catalyst, 
which was observed here: the enantioselectivity of the asymmetric hydrogenation 
of dimethyl itaconate was higher at higher C02 solubility. 
Another reason for the difference in enantioselectivity could be due to the 
difference in the estimated nucleophilicity/coordination strength of the IL anions. 
The enantioselectivity dropped with a decrease in nucleophilicity/coordination 
strength of the anion [NTf2] > [BF4] > [N(CN)2]. The anion choice was 
demonstrated to be crucial in achieving high enantioselectivity here and also by 
another research group19 for the asymmetric hydrovinylation of styrene. 
An interesting phenomenon was observed using [BMIM][NT6] to immobilise 
[Rh(COD)(Josiphos 001)t[BF4r. The enantioselectivity increased with an 
increase in temperature, when, generally the opposite is expected (decrease in 
enantioselectivity with an increase in temperature). An increase in temperature can 
increase the rate of the slower reaction of an asymmetric hydrogenation and 
therefore the enantioselectivity decreases. In a biphasic system ILlscC02, the 
solubility of the substrate in the IL may increase with an increase in temperature 
and, therefore higher enantioselectivity may result from lower mass transport 
limitations. The reason for this increase in enantioselectivity with temperature is 
not yet completely clear. However, the same trend was observed using 
Rh(COD)(Josiphos 001)t[BF4FPTNAlumina in the continuous asymmetric 
hydrogenation of dimethyl itaconate in SCC02. 
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The variation in conversion between different ILs was probably due to the 
differences in solubility of C02 in the particular IL. The conversion would be 
expected to increase when the mass transport limitations are lower which occurs 
with the introduction of C02 in the IL phase. The solubility of C02 in ILs was in a 
good agreement with the conversion observed [BMIM][NTf2] > [BMIM][BF4] > 
[BMIM] [N(CNh]. The nuc1eophilicity strength of the IL anion could also 
influence the performance of the catalyst: the higher the nuc1eophilicity strength 
the higher the conversion ([Tf2N] > [BF4] > [N(CN)2]), which was observed by US 
and previously by another research groUp.19 
In the biphasic system [BMIM][N(CN)2]/scC02, the enantioselectivity was low, 
while the conversion was high. This suggests that this IL might influence the 
chiral motif of the catalyst by interacting with Fe of the ligand. 
4.5. Conclusions 
The ILs [BMIM] [BF4], [BMIM] [NT6] , and [BMIM] [N(CNh] were used to 
immobilise [Rh(COD)(Josiphos 001)t[BF4r. The immobilised catalyst was 
examined for the continuous asymmetric hydrogenation of dimethyl itaconate in a 
biphasic system ILlscC02. The enantioselectivity and conversion of the reaction 
varied between using different ionic liquids in the biphasic system. The best 
results were observed in [BMIM][NT6]/scC02 with enantioselectivity up to 
76 % (5) and conversion up to 99 %. The solubility of H2 in the IL, the solubility 
C02 in the IL, and the anion nuc1eophilicity/coordination strength were found to 
be the main factors that might influence the performance of the chiral catalyst. 
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Chapter 5 
The production of enantiomerically pure compounds was investigated using 
. heterogeneous chiral Rh c ~ t a l y s t s s in SCC02 in Chapters 3 and 4. In this Chapter, 
immobilised enzymes are examined for enantioselective reactions in SCC02. The 
continuous kinetic resolution of a-tetralol was studied with Candida antarctica 
lipase B (Cal B) immobilised in the form of Cross-Linked Enzyme Aggregate 
(CLEA). 
5.1. Using Enzymes as Biocatalysts 
Enzymes fall into one of the six classes depending on the type of reaction they 
catalyse.1 The six classes are the following: 
i) Oxidoreductases 
ii) Transferases 
iii) Hydrolases 
iv) Lyases 
v) Isomersases 
vi) Ligases 
Enzymes as catalysts have two main advantages; they operate well at mild 
conditions, and they are highly chemo-, regio- and enantio-selective.2 Despite 
these advantages, enzymes have not been widely applied in industry. This is 
because, like phosphine ligands, they have high substrate specificity and therefore 
limited to perform reactions with few structurally analogous substrates.3 The ideal 
properties of an enzymelbiocatalyst would be high thermal stability, high stability 
against organic solvents, and high activity for many starting materials. Therefore 
the majority of applications of enzyme biocatalysts in synthetic chemistry have 
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been limited to few commercially available enzymes, namely lipases, proteases, 
and glycosidases.4 These enzymes belong to the family of hydrolases and are 
widely used because they are usually less substrate specific than other enzymes 
and they normally function without a cofactor. Hydrolases catalyse the hydrolysis 
of chemical bonds; lipases, proteases, and glycosidases break ester, amide and 
glycoside bonds, respectively. 
In this work, the activity of lipase from Candida antarctica (lipase B from 
Candida antarctica, Cal B) has been investigated for a transesterification reaction. 
Cal B is one of the most widely used lipases because it is active with a broad range 
of substrates.5, 6 Cal B hydrolyses triglycerides and is of particular interest because 
it displays strong stereospecificity on chiral substrates. The structure of Cal B 7 has 
been resolved and is shown in Figure 5-1. An Asp-His-Ser catalytic triad has been 
shown to be its active site.7 The reaction mechanism of the transesterification of 
alcohols by Cal B has been investigated by many groups and was shown to follow 
a ping-pong bi-bi ordering.8, 9 (The mechanism of the transesterification of 
a-tetralol by Cal B is shown below in Scheme 5-3, page 115). 
Although many enzymes have been shown to be active in organic solvents IO-12, 
their application still has the drawback of homogeneously catalysed reactions, the 
difficulty of the recovery and recycling of the enzyme. Immobilisation of the 
enzyme facilitates the recovery and also opens up the possibility of using the 
enzyme in a highly efficient continuous process.13 Besides the ease of recovery, 
immobilisation can also increase the stability.13 A discussion on catalyst 
immobilisation can be found in Chapter 1. The Cross-Linked Enzyme Aggregate 
(CLEA) technique l4 is a novel method to immobilise enzymes in a carrier-free 
form. It has already been demonstrated to be suitable for various enzymes I4-26, 
including lipases from different sources l5 (Candida antarctica lipase A and B -
Cal A and Cal B, Rhizomucor miehei lipase - Rml, Aspergillus niger lipase - AnI) 
which have already been shown to be active in conventional media. If the 
immobilised enzymes that work well in traditional solvents can be shown to work 
in alternative solvents, the sustainability of the reactions can be improved. 
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Figure 5-1. The structure of Candida antarctica lipase B (Cal B). Cal B has a 
molecular weight of 33.5 kDa and it is an a / ~ ~ type protein (build up of mostly 
parallel ~ - s h e e t t surrounded by a - helixes). It has two asymmetric units. The 
crystal structure was obtained from Protein DataBank.7 The picture was 
prepared using J mol. 
5.2. Enzyme cata lysed kineti c reso lution in scC0 2 
Kineti c resolution, an approach to produce enantiomeri ca ll y pure compounds, can 
also be catalysed by enzymes. In a kineti c reso lution, one of the enantiomer 
reacts more rapidly than the other. Due to the enhanced reaction rate of one of the 
enantiomers, a se lective reaction can be perfonned. In kineti c resolutions 
catalysed by enzymes, only one enantiomer of the sub trate is converted into the 
product and the other enantiomer is left unreacted or react considerab ly more 
slowly.26 Lipase B from Candida antarctica is selective fo r the (R) enantiomer. 
The products of the kinetic resolution of alcohols are therefore (R)-ester, unreacted 
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(S)-a1cohol, and a by-product from the acyl donor. Vinyl acetate is commonly 
used as acyl donor because the produced acetaldehyde cannot be re-acylated and 
therefore the reaction is driven towards the formation of the product. The kinetic 
resolution of I-phenylethanol catalysed by lipase is one of the most widely studied 
reactions in organic solvents and also in alternative solvents.5, 6, 11, 12, 27·33 The 
reaction is depicted in Scheme 5-1. 
A disadvantage of kinetic resolution is that only one of the enantiomers is 
transformed with a highly selective catalyst, and therefore the maximum 
conversion of the reaction is 50 %. If the unreacted alcohol is racemised in situ, 
full conversion of the substrate to product can he achieved. This technique is 
known as dynamic kinetic resolution (DKR). 
OH 
o 
) l ~ ~ o ~ ~
R selective lipase 
OH 
+ 
+ 
Scheme 5-1. The kinetic resolution of I-phenyethanol catalysed by an (R) 
selective lipase with vinyl acetate as acyl donor. 
The use of alternative solvents is of interest to in the fine chemical industry. 
Immobilised lipases have already been used for reactions in SCC02. The following 
advantages were found?7, 28, 30 
i) Highly enantioselective. 
ii) Work well at low temperatures and in a wide range of pressures. 
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iii) Applicable to a range of substrates. 
iv) Highly active requiring a small amount of catalyst. 
v) Use of an alternative solvent. 
vi) Can be used in continuous processes. 
Matsuda showed one of the first examples for the continuous kinetic resolution of 
I-phenylethanol (Scheme 5-1) in SCC02. The catalyst was Novozym 435 (Cal B 
adsorbed on a macroporous resin) which displayed high enantioselectivity and 
E-value (a measure of enantioselectivity, value > 100 indicate highly 
enantioselective reaction34, Note! E-value is different than E-factor) in a 
continuous flow SCC02 system?7 The conversion of R-phenyl alcohol was 
calculated using the equation shown in Equation 5-1. The results of Matsuda's 
work are presented in Table 5-1. 
c = ees-alcohol l(eeS_alCOhol + ee R-acetale) 
Equation 5-1. Calculation of the conversion of an enantioselective reaction. 
E = In[l- c(1 + ee R-acelale )] 
In[l- c{l- ee R-acelale)] 
Equation 5-2. Calculation of the E-value. 
Table 5-1. Results of Matsuda's continuous kinetic resolution of 
I-phenylethanol with vinyl acetate catalysed by Novozym 435 in SCC02.27 
Entry Ratio • P (bar) ee alcohol (0/0) ee acetate (Ofc,) Cony b (%) E-value c 
1 1: 0.5 130 89.6 99.7 47 >1000 
2 1: 0.6 130 98.8 99.2 50 >1000 
3 1 : 1.3 129 >99.5 99 50 >1000 
4 1 : 1.3 89 >99.5 99 50 >1000 
5 1 : 1.3 200 >99.5 99 50 >1000 
Reaction conditions: temperature: 42 - 43 °C, C02 flow rate: 1.0 mL/min, 
substrate flow rate: 0.2 mL/min. 
a: Ratio of I-phenyl ethanol: vinyl acetate 
b: Conversion was calculated using Equation 5-1. 
c: E-value was calculated using Equation 5-2. 
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The continuous kinetic resolution of I-phenylethanol in SCC02 was repeated at 
Nottingham and the results showed similarly high success (Table 5_2).35 
Table 5-2. Results of the continuous kinetic resolution of I-phenylethanol 
with vinyl acetate using Novozym 435 as catalyst in SCC02.35 
Entry T (OC) ee alcohol (0/0) ee acetate (%)) Conv(%) E-value 
1 35 94 95 50 140 
2 40 95 96 50 180 
3* 40 85 99 46 520 
4** 45 99 99 50 1060 
5 45 99 98 50 530 
6 50 97 98 50 420 
Reaction conditions: pressure: 110 bar, C02 flow rate: 1.0 mL/min, substrate 
flow rate: 0.2 mL/min (1 : 1 vol. ratio of I-phenyl ethanol: vinyl acetate). 
* Reaction conditions: pressure: 110 bar, CO2 flow rate: 1.0 mL/min, 
substrate flow rate: 0.2 mL/min (1 : 0.5 vol. ratio of I-phenyl ethanol: vinyl 
acetate). 
** Reaction conditions: pressure: 200 bar, CO2 flow rate: 1.0 mL/min, 
substrate flow rate: 0.2 mL/min (1 : I vol. ratio of I-phenyl ethanol: vinyl 
acetate). 
Nottingham has had a great interest in biocatalytic reactions in SCC02 and as the 
results of Matsuda's work could be reproduced at Nottingham, the investigation of 
the kinetic resolution of secondary alcohols was continued. CLEA of Cal B has 
been successfully prepared but their activity has not yet been widely studied. Here, 
their activity for the kinetic resolution of I-phenylethanol in a continuous flow 
SCC02 system has been investigated. The results are shown in Table 5-3. 
Table 5-3. Results of the continuous kinetic resolution of I-phenylethanol 
with vinyl acetate catalysed by Cal B CLEA in SCC02.3S 
1 
2 
3 
4 
60 
89 
92 
98 
99 
99 
99 
99 
E-value 
> 1000 
> 1000 
> 1000 
1000 
Reaction conditions: pressure: 110 bar, CO2 flow rate: 0.25 mL/min, 
substrate flow rate: 0.05 mL/min (I : I vol. ratio of I-phenyl ethanol : vinyl 
acetate). 
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The kinetic resolution of I-phenylethanol was successfully perfonned in a 
continuous flow SCC02 system using Cal B CLEA. The enantioselectivities 
obtained by Cal B CLEA were comparable with those obtained by Novozym 435. 
Following the success with Cal B CLEA in the continuous kinetic resolution of 
I-phenylethanol in SCC02, the investigation of the activity of Cal B CLEA 
continued at Nottingham. 
The kinetic resolution of I-phenylethanol has been widely studied but the kinetic 
resolution of other secondary alcohols has been explored less. The activity of 
Cal B CLEA (donated by the first mentor of Cal B CLEA Professor Roger 
Sheldon, CLEA Technologies, Delft, Netherlands) was examined here for the 
kinetic resolution of another secondary alcohol, a-tetralol, in a continuous flow 
SCC02 system. To achieve high enantioselectivity, different reaction conditions 
and acyl donors were examined. 
5.3. Results and Discussion 
a-tetralol (1,2,3,4-tetrahydro naphthol) is a secondary alcohol and is slightly 
larger than I-phenylethanol. The two compounds are different also in their 
solubility in SCC02: I-pheynethanot36 is highly soluble in SCC02, while a-tetraloe7 
is only slightly soluble in scC02 (52 mmollL at 40°C and 138 bar). 
The kinetic resolution ofa-tetralol was examined with Cal B (E.C. 3.1.1.3) CLEA 
(28000 U/g solid, batch no 5790) in a continuous flow SCC02 system. The 
continuous flow high pressure reactor is described in Chapter 2. The following 
parameters were investigated for the reaction. 
i) The effect of different acyl donors at different temperatures and pressures. 
ii) The effect of the immobilisation technique used to heterogenise Cal B at 
different temperatures. 
iii) The effect of the substrate to acyl donor ratio. 
iv) The effect of the use of a cosolvent. 
v) The effect of the phase behaviour. 
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In fac t, enzymatic esterifica ti on is a reversible reacti on and characteri zed by 
equilibrium constant. The reacti on can become irreversible when the acy l donor 
fo rms a non-nucl eophilic product (by-product in th e reaction) . To optimise the 
cata lyst pe rformance, different acyl donor were investi gated for th e kin eti c 
reso lution of a-tetra lo l (Scheme 5-2) in a continuous fl ow scC0 2 system. The 
results a re shown in Figure 5-2 .. 
OH 
acyl donor 
a: vinyl acetate 
o 
) ) o ~ ~
b: phenyl 0 ~ ~
acetate ~ ~
6 
c: p-nitro phcnyl 
acetate 0 
oA 
acy l donor (a,b,c) 
Cal B CLEA 
scCO! 
by- product 
remai ning Crom 
the acy l donor 
by-product 
6 
OH 
OH 
Scheme 5-2. The kinetic resolution of a-tetralol using different acyl donors 
catalysed by Cal B CLEA in scC02• 
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Figure 5-2. The enantioselectivity and the level of conversion of the 
continuous kinetic resolution of a-tetralol using different acyl donors 
catalysed by Cal B CLEA (60 mg, 1680 U) in scC02• 
Reaction conditions: pressure: 100 bar, CO2 flow rate: 1 mLimin, 
substra te flow rate: 0.2 mLimin (a-tetralol : acyl donor = 1 : 1.5 molar ratio). 
It can be een in Figure 5-2 that the enantioselectivity of the reaction increased 
with an increa e in temperature u ing all acy l donors. The olubili ty of a-tetralol 
in SCC02 i very poor but it increases with increased temperature37 , which might 
influence the enantiose lectivity. An increase in temperature can also increase the 
performance of the enzyme by prov iding more optimal conditions. 
The different acy l donor influenced the enantioselectivity. If the acyl donor is 
vinyl acetate the product enol, tautomerises to acetaldehyde, therefore the reaction 
i irrever ib le and high enantioselectiv ity is expected. The other two acy l donors 
used here were phenyl acetate and p-nitrophenyl acetate. These acyl donors do not 
render the reaction irrever ible but they can shift it towards the product where the 
dri ing force i the tab il ity of the leaving group. The abili ty to deprotonate the 
consumed acyl donor i Ie s fo r p-ni trophenyl acetate than that for phenyl acetate. 
Therefore the equili brium of the reaction i more shifted towards the product 
formation u ing p-nitrophenyl acetate than phenyl acetate. Additionally, the 
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carbonyl group of p-nitrophenyl acetate is easier to attack and therefore the 
formation of the acyl-enzyme intermediate is faster in this case than that is with 
the other two acyl donors. 
The enantioselectivity of the reaction was higher using p-nitrophenyl acetate than 
vinyl acetate. Although the kinetic resolution of a-tetralol becomes irreversible 
using vinyl acetate as acyl donor, the driving force of the reaction towards product 
might be stronger when using p-nitrophenyl acetate due to the high stability of the 
product. The enantioselectivity was the lowest using phenyl acetate. The 
formation of acyl-enzyme intermediate might be slower using phenyl acetate 
because the carbonyl group is less electrophilic than that of the other two acyl 
donors. The mechanism of the reaction including the formation of the 
acyl-enzyme intermediate is shown in Scheme 5-3. 
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acyl-enzyme ~ ! " 9 \ \ vinyl acetate aH \..1Il; I ~ / " a ~ ~
acyl-enzyme a 
aH ~ ~ phenyl acetate 
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Ser105 '-H+ 
acyl donor 
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(a 9 ~ ~H a ~ ~~ e r 1 0 5 5 aH 
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9 \11 H a ~ ~00 substrate ~ e r l O 5 5",,--aH / c6 substrate 
o :'1'9 i 0--------H 
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Scheme 5-3. The mechanism of the kinetic resolution of a-tetralol using 
different acyl donors: vinyl acetate (left) and phenyl acetate (right). The 
mechanism of Cal B is proposed to be ping-pong bi-bi. Cal B has an Asp187-
His224-Serl05 catalytic triad in its active site. 
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The level of conversion observed in the kinetic resolution of a-tetralol 
(Figure 5-2, page 113) was low (maximum conversion in an enzymatic kinetic 
resolution is 50 %) but only a small amount of enzyme was used. In all cases, the 
level of conversion increased with an increase in temperature. An increase in 
temperature increases the solubility of reactants in C02, which may result in a 
higher reaction rate, and therefore higher conversion can be obtained. Besides, the 
activity of the enzyme can be influenced by the changes in temperature because 
enzymes have an optimal temperature where they display their highest 
performance. 
The acyl donor had similar effect on the conversion of a-tetralol as on the 
enantioselectivity. The changes in both enantioselectivity and conversion suggest 
that the rate of the acyl-enzyme intermediate formation might have a significant 
effect on the kinetic resolution of a-tetralol. 
A cosolvent (toluene) had to be used to bring p-nitrophenyl acetate into solution. 
The presence of the cosolvent in the reaction medium could influence the solvent 
power of CO2 which might increase the reaction rate when using p-nitrophenyl 
acetate as acyl donor. The water present in toluene (210±4 ppm determined by 
Karl-Fischer titration) might also enhance the enzyme activity. However, further 
evidence is required to confirm these hypotheses. 
The phase behaviour might also influence the kinetic resolution of a-tetralol 
because a-tetralol is only slightly soluble in SCC02.37 As vinyl acetate is soluble in 
sccol8, a-tetralol and vinyl acetate may be present in two distinct phases in the 
a-tetraloVvinyl acetate/scC02 system. In a continuous flow SCC02 system, vinyl 
acetate might flow through the catalyst bed faster than a-tetralol, which therefore 
provides shorter reaction time. The solubility of phenyl acetate and p-nitrophenyl 
acetate in SCC02 are unknown. In the case of I-phenylethanol, all reactants and 
SCC02 are in a single phase. The kinetic resolution of I-phenylethanol in a 
continuous flow SCC02 system with vinyl acetate as acyl donor reached maximum 
conversion 50 % and high enantioselectivity eeR > 99 % (Tables 5-1, 5-2 and 5-3). 
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The kinetic re o lution of a -tetralol in a continuous flow scC02 system using vinyl 
aceta te as acy l donor reached conversion up to 13 % and enantioselectivity (R) up 
to 97 %. The diffe rences in conversion and enantioselectivity in the kinetic 
reso lution of these substrates suggest that the phase behaviour may have a 
significant effect on the reaction , however, further evidence is required to confirm 
th is. 
The effec t of the immobili sation method could be determined by comparing the 
results obta ined by Cal B CLEA (cross-linking of solid enzyme molecules) and 
Novozym 435 (adsorbtion on a carrier material) in the continuous kinetic 
reso lution of a -tetralol in scC02. The activity of Novozym 435 for the reaction 
was detemlined prev iously by Stephenson at Nottingham. 35 The 
enantio electi vities w ith Novozym 435 and Cal B CLEA are shown in Figure 5-3. 
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Figure 5-3. The enantioselectivity of the continuous kinetic resolution of 
a-tetralol in SCC02 using vinyl acetate as acyl donor catalysed by Cal B 
CLEA (25 mg, 700 U) and Novozym35 435 (25 mg, 87.5 U). 
Reaction conditions: pressure: 100 bar, C02 flow rate: 1.0 mLimin, 
ub trate flow rate: 0.2 mLimin (a-tetralol : vinyl acetate = 1 : 1.5 molar 
ratio). 
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The enantioselectivity of the kinetic resolution of a-tetralol was high using both 
catalysts in a continuous flow scC02 system. While the enantioselectivity of the 
reaction with Cal B CLEA was influenced by the changes in temperature, 
Novozym 435 displayed the same enantioselectivity at all temperatures examined. 
The immobilisation technique ofNovozym 435 (Cal B adsorbed on a macroporous 
resin) might be more beneficial for continuous flow reactions in scC02 as it 
showed higher enantioselectivity even using less enzyme (lower number of 
enzyme unit) ofNovozym 435 (87.5 U) than Cal B CLEA (700 U) under the same 
reaction conditions. 
In a continuous flow system, the conversion can increase by using a larger amount 
of catalyst and/or increasing the residence time. To investigate this, the continuous 
kinetic resolution of a-tetralol was also examined using different amounts of 
catalyst. The results are shown in Table 5-4. 
Table 5-4.The conversion of the continuous kinetic resolution of a-tetralol in 
SCCOl catalysed by Cal B CLEA (25 mg, 700 U or 60 mg, 1680 U). 
25 rng -700 U 60 rng - 1680 U 
Entry T(°C) ee acptate (%, ) Cony (%) ee acetate (%) Cony (%) 
1 30 88 4 95 7 
2* 30 91 4 94 6 
3 40 93 6 96 9 
4 50 95 8 97 13 
Reaction conditions: pressure: 100 bar, COl flow rate: 1.0 mL/min, substrate 
flow rate: 0.2 mL/min (a-tetralol: vinyl acetate = 1 : 1.5 molar ratio). 
* Reaction conditions: pressure: 200 bar, COl flow rate: 1.0 mL/min, 
substrate flow rate: 0.2 mL/min (a-tetralol: vinyl acetate = 1 : 1.5 molar 
ratio). 
Lower conversion was observed using less catalyst (25 mg, 700 U) than a larger 
amount of catalyst (60 mg, 1680 U) as expected. The enantioselectivity of the 
reaction was also lower using less catalyst. The enantioselectivity can increase by 
using a larger amount of catalyst because it may be a function of conversion. 
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An increa e in pressure can increase the solubility of substrates in SCC02 and can 
a lso change the properties of C02 (the density of CO2 increases with an increase in 
pre ure). The re ults of the kinetic resolution of a -tetralol at different pressures 
are hown in Figure 5-4. 
eeicOl1versiol1 % 
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Figure 5-4. The effect of the pressure on the enantioselectivity and conversion 
of the continuous kinetic resolution of a-tetralol catalysed by Cal B CLEA 
(60 mg, 1680 U) in scC02• 
Reaction conditions: temperature: 30°C, CO2 flow rate: 1 mLimin, 
ub trate flow rate: 0.2 mLimin (a-tetralol : vinyl acetate = 1 : 1.5 molar 
ratio ). 
An increa e in pre sure did not have a great influence on the enantioselectiv ity of 
the reaction u ing vinyl acetate and phenyl acetate as acyl donor. The 
enantio electi ity of the reaction improved with an increase in pressure using 
p-nitrophenyl acetate a acyl donor, however, the difference in enantioselectivity 
wa mall almost v ithin the experimental error (includes the errors originating 
from the inaccuracy of the pumps, sample preparation, and analysis) . 
The con er ion of the reaction decreased with an increase in pressure using all 
acyl donor . n mcrea e in pressure could create a more significant difference in 
o lubil ity betv een the ub trate and the acyl donor in a continuous flow scC02 
tern : one of the reactants (acetate) might be flu shed through the catalyst faster 
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with Ce02 than the other (substrate) and thus the res idence time could be 
reduced. Furthem10re, the cata lys t bed could become more compacted under 
higher pre ur which might cause higher mass transport limitations. 
The kinetic re olution of I-phenylethano l (Scheme 5-1 ) was investi gated w ith the 
acyl donor at ariou concentra tions by Matsuda and co-workers .27 It has been 
shown that the reaction improved using the acyl do nor in excess of the substrate 
(Tab le 5- 1). T he effect of the substrate to acyl donor ratio on the kineti c resolution 
of a -tetra lo l was examined using a molar ratio of I : 1.5 and 1 : I of substrate : 
acyl donor. The resu lts are shown in Figure 5-5. 
o 30 DC - ee • 40 °C - ee 0 50 °C - ee 
0 '0 ° - conversion • 40 °C - convers ion 0 50 °C - convers io n 
ee/conver ion % 97 100 95 96 95 95 
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molar ratio = I : 1.5 molar ratio = I : I 
Figure 5-5. The effect of the substrate : acyl donor ratio on the continuous 
kinetic resolution of a-tetralol catalysed by Cal B CLEA (60 mg, 1680 U) in 
SCC02. 
Reaction conditions: pressure 100 bar, CO2 flow rate: 1 mLimin, 
substrate flow rate: 0.2 mLimin (a-tetralol + vinyl acetate). 
imilarl to the kin tic re o lution of I-phenylethano l performed by Matsuda, the 
enantio lectivity and the conversion of kinetic resolution of a -tetralol increased 
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using the acyl donor in excess to the substrate. The concentrati on of acyl donor 
might influence the react ion rate and therefore higher enantioselectivity and 
conver ion could be obtained using the acyl donor in excess to the substrate. The 
study hould be extended to examine other conditions, which could prov ide 
further evidence to confinn thi s hypothes is. 
The kinetic reso lution of a -tetralo l was also examined in batch in n-hexane 
(without C02). All reactants are soluble in hexane and therefore a single phase 
ystem is obtained . The results are shown in Figure 5-6. 
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Figure 5-6. The enantioselectivity and the conversion of the kinetic resolution 
of a-tetralol in batch using n-hexane as solvent. 
Reaction conditions: temperature: 40 °C, hexane: 5 mL, substrate: 1 mL 
(a-tetralol : vinyl acetate = 1 : 1.5 molar ratio), catalyst: Cal B CLEA 
(5.2 mg, 146 U). 
The ki netic re olution of a -tetralol reached a plateau in enantioselectivity and 
conver ion after 3 hours. The enantioselectivi ty and conversion of the kinetic 
re o luti on of a -tetralol in hexane were lower than those in a continuous flow 
SCC02 sy tern de pi te a signi ficantly longer reaction time and a single phase 
system. The reacti on medium may influence the reaction and therefore the catalyst 
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performance can decrease. In order to determine whether the solvent has an effect 
on the reaction, the kinetic resolution of a-tetralol should be examined in a batch 
SCC02 system and also in other solvents. The reaction could also be inhibited by 
the presence of the product in batch. The product is continuously removed from 
the catalyst surface in a flow scC02 system and therefore no inhibition by the 
product is expected. An extensive investigation should be performed to determine 
the rate limiting step of the reaction but it could not be performed due to the 
limited amount of materials available. 
5.4. Conclusions 
The continuous kinetic resolution of a-tetralol has been performed successfully 
using different acyl donors (vinyl acetate, phenyl acetate, p-nitro phenyl acetate) 
catalysed by Cal B CLEA in SCC02. The enzyme displayed high enantioselectivity 
(eeR up to 99 %) for the reaction and was highly influenced by the acyl donor. The 
reaction might be driven towards the product more when the stability of the 
by-product remaining from the acyl donor was higher. The enantioselectivity was 
found to be a function of conversion in the continuous kinetic resolution of 
a-tetralol in SCC02. The same phenomenon was observed in the lipase catalysed 
kinetic resolution of secondary alcohols in propylene carbonate by another 
research group. 3 1 The conversion of the reaction remained low using all acyl 
donors but it could be increased by using a larger amount of catalyst. 
Both the enantioselectivity and the conversion increased with an increase m 
temperature using all acyl donors. It is possibly due to an increased solubility of 
the substrate in C02 at higher temperatures. The enzyme could also be more active 
if it was closer to its optimal temperature. An increase in pressure did not 
influence the catalyst performance significantly. 
Cal B CLEA gave lower enantioselectivity and conversion for the continuous 
kinetic resolution of a-tetralol than for the continuous kinetic resolution of 
I-phenylethanol, in scC02. Cal B CLEA may have higher specificity towards 
I-phenylethanol than for a-tetralol, which can be due to differences in their size: 
I-phenylethanol is smaller and therefore it may fit the active site of Cal B better 
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than a-tetralo1.39 The differences in phase behaviour may also affect the catalyst 
performance (l-phenylethanoe6 is completely miscible with CO2, while 
a-tetralol37 is only slightly soluble in CO2). 
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Chapter 6 
Two-Step Catalytic Cascade Reaction in a Continuous Flow 
scC02 system: Hydrogenation followed by the Kinetic 
Resolution of the Product 
One potential method to obtain a more environmentally viable process compared 
to the existing ones is to use a cheap raw material. The price of acetophenone is 
much lower than that of (R/S)-I-phenylethanol. If acetophenone is hydrogenated 
to (R)-I-phenylethanol and the formed intermediate is acylated to (R)-I-
phenyl ethyl acetate, the cost of the process for the production of (R)-I-phenylethyl 
acetate will decrease, especially if the catalysts can be recycled. The work in this 
Chapter investigated this process in a two-step catalytic cascade reaction with 
heterogeneous catalysts in a continuous flow SCC02 system. The Chapter also 
discusses the advantages of multistep catalytic cascade reactions and the 
importance of reactor design for these reactions. 
6.1. Multistep Catalytic Cascade Reactions 
A well known example for multistep reactions is the Rhodia process for vanillin 
manufacture starting from phenol that involves four steps each with heterogeneous 
catalyst.} This process involves a series of catalytic steps where the product of 
each step is isolated (and in many cases purified) before the next step. The 
ultimate aim is the combination of several steps, preferably in one pot. Multistep 
catalytic cascade reactions can possess the following advantages? 
i) No need for the separation of intermediates. 
ii) Fewer unit operation. 
iii) Less total reactor volume. 
iv) Higher volumetric and space time yield. 
v) Less waste (lower E-factor) (the E-factor is different than the enzymic 
E-value, E-factor: amount of waste per kg of product). 
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vi) The reaction equilibrium may be driven towards the favoured direction. 
vii) Lower energy consumption. 
viii) Lower cost. 
On the other hand, multistep catalytic cascade reactions have some limitations.2 
i) Incompatibility of the catalysts. 
ii) Different reaction rates. 
iii) Difficulty to optimise the reaction temperature, pressure, pH, and 
solvent. 
iv) Complicated catalyst recovery and recycling. 
An example for catalytic cascade reactions is dynamic kinetic resolution (DKR) 
that is the combination of kinetic resolution and racemisation and is commonly 
performed with a catalyst system of a metal catalyst and a biocatalyst. The 
incompatibility of the catalysts is often a problem associated with DKR. Another 
limiting factor in DKR is the racemisation step. The DKR of alcohols is widely 
investigated where the kinetic resolution is commonly performed with lipase that 
is combined with a racemisation Rh or Ru catalyst. Among the large number of 
publications on DKR3-8, one of the early results was reported by Backvall who 
performed the DKR of (RlS)-I-phenylethanol catalysed by lipase and a 
racemisation Ru catalyst (Scheme 6_1).3 By optimising the reaction conditions, 
high enantioselectivity and product yield was obtained. 
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Scheme 6-1. DKR of (R/S)-l-phenylethanol using lipase and Ru catalyst.3,9 
The catalyst recovery and recycling are essential for an efficient catalytic cascade 
reaction. Catalyst immobilisation, the use of thermoregulated catalysts or tunable 
solvents (e.g. fluorous solvents) can be successful approaches for achieving high 
efficiency.1O The work in this Thesis investigated a chemoenzymatic cascade 
reaction with heterogeneous catalysts. The cascade reaction was examined in 
series in a continuous flow scC02 system where a specially designed flow reactor 
was used to overcome the problem of the incompatibility of the catalysts. 
6.2. Reactor Design for Multistep Catalytic Cascade Reactions 
Multistep catalytic cascade reactions are normally performed in one pot where the 
incompatibility of the catalysts can cause limitations. Besides, the optimisation of 
the reaction conditions and the catalyst recycling can also be difficult. The 
incompatibility of the catalysts can be overcome by separating the catalysts. The 
physical separation of the catalysts can be solved for example by the use of a 
continuous flow system where the catalysts are separated in different reactors, 
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which also allows separate control of the temperature of each step and the ease of 
catalyst recovery and recycling. 
In this work, a multistep catalytic cascade reaction was examined in a continuous 
flow SCC02 system: hydrogenation followed by the kinetic resolution of the 
product. A heterogeneous metal catalyst Pd 2 % Type 31 (Johnson Matthey - UK) 
was used as catalyst of the hydrogenation step of the cascade. The catalyst of the 
second step (kinetic resolution) was a heterogeneous biocatalyst, Cal B CLEA. 
The Pd catalyst (Pd 2 % Type 31 by Johnson Matthey - UK) has been shown 
previously to be effective at higher temperatures (> 100 oC).ll The activity of 
Cal B drops significantly at temperatures above 100°C. 12 Two reactors were 
therefore used to control the temperature of each step separately. The reactor setup 
is shown in Figure 6-1. The acyl donor required by the kinetic resolution of 
(RlS)-I-phenylethanol was introduced after the hydrogenation reactor in order to 
avoid any reaction of the acyl donor over the Pd catalyst. It also helped to cool the 
main stream (150°C - 200°C). The temperature of the enzyme reactor was 
monitored in the reactor and the desired temperature was observed (40 °C, 50°C 
or 60 °C). 
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CO2 + H 2 + acetophenone ' 
Temperature 1 Pd 2 % (JM Type 31) 
~ ~ Vinyl acetate 
Temperature 2 
Product 
Figure 6-1. The reactor configuration for the continuous cascade reaction. 
COz, Hz and acetophenone were mixed and heated in a static mixer before 
entering the hydrogenation reactor. Vinyl acetate, the acyl donor required to 
the kinetic resolution was introduced after the hydrogenation reactor. A 
detailed description of reactor can be found in Chapter 2. 
All experiments were carried out using the reactor setup shown in Figure 6-1 
where the reaction temperature, system pressure and CO2 flow rate were changed. 
6.3. Results and Discussion 
The continuous hydrogenation of acetophenone to (R/S)-l-phenylethanol has been 
shown previously to be successful with Pd Type 31 catalyst (Pd 2 % Type 31 by 
Johnson Matthey - UK) in SCC02•11 The kinetic resolution of (R/S)-l-
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phenylethanol has also been performed previously in a continuous flow SCC02 
system.12-14 Novozym13 435 and Cal 8 CLEA14 both gave high enantioselectivity 
under mild conditions (30-50 °C, 100-170 bar). Here, a chemoenzymatic cascade 
reaction for the production of (R)-I-phenylethyl acetate was examined in a 
continuous flow in SCC02 system which combined the following two subsequent 
steps: 
• Step 1: hydrogenation of acetophenone to (RlS)-I-phenylenthanol 
• Step 2: kinetic resolution of (RlS)-I-phenylethanol to (R)-I-phenylethyl 
acetate. 
The schematic of the reaction is shown in Scheme 6-2. 
STEP I 
o 
STEP 2 OR 
Pd Type 31 
scC02 
CalBCLEA 
scC02 
o 
) l ~ ~
.. 
.. 
~ O O
OR 
o ~ ~
OR 
Scheme 6-2. Two step catalytic cascade reaction: hydrogenation of 
acetophenone over an achiral Pd catalyst to produce racemic I-phenylethanol 
that was kinetically resolved by Cal B CLEA (R selective). 
The performance of the hydrogenation of acetophenone was examined at different 
temperatures and pressures. The results are shown in Figure 6-2. 
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Figure 6-2 . Conversion of acetophenone catalysed by Pd (JM Type 31 : 
2 % on silica/alumina) (270 mg) (first step of the cascade reaction). 
Reaction conditions: CO2 flow rate: 1 mL/min, substrate flow rate: 
0.1 mLimin (acetophenone), H2 : substrate ratio = 4 : 1. 
An increa e in pressure had different effect at different temperatures. 
Acetophenone/H2/C02 fOnTIS one phase at all conditions examined here. II The 
pha e behav iour of the system should therefore not affect the reaction 
significantl y. The viscosity and density of CO2 decreases with an increase in 
temperature and it might produce higher conversion at higher temperatures 
because the ma transport of the substrate to the catalyst could improve. 
At 150 bar, the conversion of acetophenone was lower at 200 °C than at 150 dc. 
The continuous cascade reactions were examined at different conditions that were 
changed in a particular order. The experiment at 150 bar and 200 °C was the last 
in the row and therefore the catalyst had been under CO2 and H2 for a longer time 
than in other cases (1. 100 bar, 150 °C, 2. 130 bar, 150 °C, 3. 150 bar, 150 °C, 4. 
100 bar 200 °C, 130 bar, 200°C, 6. 150 bar, 200 °C). The catalyst might have 
been poi oned by the reverse water gas-shift reaction ( ( 2 + C O r - ~ ~ 2 0 + C O ) ) S , ,
which could cau e a drop in conversion. 
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The temperature of the kinetic reso lution catalysed by Cal B CLEA was vari ed 
betw een 40 - 60 °C. The results are shown in Figure 6-3. 
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Figure 6-3: The enantioselectivity (R-acetate) and the level of conversion 
(conversion of (R)-l-phenylethanol) at different temperatures catalysed by 
C al B C LEA (60-70 mg, 1680-1960 U) (second step of the cascade reaction). 
Reaction conditions: pressure: 100 bar, CO2 flow rate: 1 mL/min, substrate 
flow r ate: 0.1 mLlmin (acetophenone, I-phenyl ethanol, vinyl acetate). 
High enantioselectivity was observed in the kinetic reso lution of (R/S)-l-
phenylethanol at a ll conditions examined. The highest enantioselectivity (eeR acetate 
> 99 %) was ob erved at 60 °C which could be closer to the optimal temperature 
of the enzyme. 
The conver ion of (R)-l -phenylethanol decreased w ith an increase in temperature. 
Generally, the convers ion of a reaction in scC0 2 increases w ith an increase in 
temperature due to an increase in solubili ty of the reactants in scC0 2 at higher 
temperature which can improve the mass transport. Here, a decrease in 
con ersion with an inc rease in temperature was observed. Cal B may be affected 
by H2 ifkept for a longer peri od of time (the order of the reaction cond itions: \. 40 
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DC, 2. 50 ° ,3. 60 °C). Confom1ational changes of enzyme might be caused by 
the rupture of di ulfide bonds of cysteine res idues (discussed in deta il below), and 
therefore the enzyme ac tivity cou ld decrease . 
The effect of an increased pressure on the kinetic resolution of 
(RlS) - I-phenylethanol wa a lso examined. The results are shown in Figure 6-4. 
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Figure 6-4. The enantioselectivity (R-acetate) and the level of conversion 
(conversion of (R) -l-phenylethanol) at different pressures catalysed by Cal B 
CLEA (60-70 mg, 1680-1960 U) (second step ofthe cascade reaction). 
Reaction conditions: temperature: 40 °C, CO2 flow rate: 1 mL/min, substrate 
flow rate: 0.1 mLimin (acetophenone, I-phenylethanol, vinyl acetate). 
The enantio e lectivity of the kinetic reso lution did not change w ith pressure at 
40 °C, whil e the con er ion of (R)- l-pheny lethano l sli ghtly decreased with 
pres ure. The level of conversion in scC0 2 is expected to increase w ith an increase 
in pres ure due to an increase in the density of CO 2 that increases the residence 
time. On the other hand , high pressure could compress the catalyst and could thus 
create a Ie favour d flow profi le (the stream of the reactants fl ows around the 
cataly t bed rather than th rough), however, fu rther ev idence is needed to confirm 
thi . 
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The conversion of (R)-I-phenylethanol in the kinetic resolution step of the cascade 
reacti on reached 22 %, while the kinetic resolution of (RlS)- I-phenylethanol as 
individual reaction!3 di splayed 50 % conversion. The unused H2 from the first step 
(H2:acetophenone = 4: 1) could decrease the effic iency of the enzymatic reaction 
by cau ing conformational changes in the enzyme. Cal B contains six cysteines 
(Cy ) in it tructure. Cysteine contains a thiol group that can form disulfide bonds 
(F igure 6-5). Oi ulfide bonds help to stabi li se the catalytically active structure of 
the enzyme and therefore if a disulfide bond breaks for example by H2 treatment, 
the enzyme may become inactive because of conformation changes. 
Cysteine 
o ~ ~ " "
s . I dl ulfide 
~ ~
H ~ " "S bond 
o 
HN 
/ 
Figure 6-5. A 3D structure of Candida antarctica lipase B (Cal B). Cal B 
contain six cysteines in its structure Cys22 - Cys64, Cys216 - Cys258, 
Cys293 - Cys311 (marked with red). Disulfide bonds are formed by 
connecting two sulfurs contained in cysteine. If a disulfide bond is broken the 
3D structure of the protein might change and thus the enzyme could become 
inactivated. The structure of Cal B (1 TCA) was obtained from Protein 
DataBank. The figure was generated with Pymol 
(http: //pvmol.ourceforge.net). 
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The effect of different C02 flow rates was also examined. The results are listed in 
Table 6-1. 
Table 6-1. Two step catalytic cascade reaction: hydrogenation of 
acetophenone with Pd Type 31 (270 mg) followed by the kinetic resolution of 
the product, (R/S)-I-phenylethanol, with Cal B CLEA (60-70 mg, 1680-
1960 U). 
Entry 
1 
2 
ees (%) eep (%) 
19 
28 
98 
98 
Reaction conditions: pressure: 100 bar, substrate flow rate: 0.1 a / 0.05 b 
mLlmin (acetophenone/vinyl acetate), Hz:substrate ratio = 4:1, 
T (Pd): 150 oC, T (enzyme reactor): 40 °C. 
The conversion of both steps of the catalytic cascade reaction increased with a 
decrease in C02 flow rate, while the enantioselectivity of the kinetic resolution of 
(R)-I-phenylethanol did not change. By decreasing the CO2 flow rate, longer 
residence time is provided in the continuous flow reactor which expectedly 
resulted in higher conversion. 
The cascade reaction has been studied previously using Pd Type 31 and 
Novozym 435 by Stephenson at Nottingham. 14 The results are listed in Table 6-2. 
The results obtained in this work for first step of the cascade, the hydrogenation of 
acetophenone, were better than those obtained by Stephenson. The conversion of 
acetophenone could be improved by optimising reaction conditions (temperature, 
pressure, CO2 flow rate). The performance of the kinetic resolution of 
(RlS)-l-phenylethanol was higher with Novozym 435 14 than that with Cal B 
CLEA, which could be due to differences in the immobilisation of Cal B. The 
same phenomenon was observed in the kinetic resolution of a-tetralol using 
Novozym 435 and Cal B CLEA (Chapter 5). 
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Table 6-2. Results of the series reaction using Pd Tp>e 31 and Novozym 435 
(250 rng, 875 U) (Novozym 435: 3500 U/g) catalysts. l 
Entry T - Pd (DC) Conv(%) ees (%) o/c Cony (%) 
aceto henone eep ( 0) (R)-l- hen lethanol 
1 150 68 41 >99 29 
2 200 72 32 >99 24 
3 150· 71 54 >99 35 
4 150** 74 44 >99 30 
Reaction conditions: pressure: 100 bar, CO2 flow rate: 1 mL/min, substrate 
flow rate: 0.1 mL/min (acetophenone/vinyl acetate), H2:substrate ratio = 4:1, 
T (enzyme reactor) = 40°C. 
* Reaction conditions: pressure: 100 bar, C02 flow rate: 0.5 mL/min, 
substrate flow rate: 0.05 mL/min (acetophenone/vinyl acetate), H2:substrate 
ratio = 4:1, T (enzyme reactor): 40°C. 
** Reaction conditions: pressure: 100 bar, CO2 flow rate: 1 mL/min, 
substrate flow rate: 0.1 mL/rnin (Acetophenone/vinyl acetate), H2:substrate 
ratio = 4:1, T (enzyme reactor): 50°C. 
6.4. Conclusions 
A two step chemoenzymatic catalytic cascade reaction for the production of (R)-1-
phenylethyl acetate was investigated in a continuous flow SCC02 system: 
hydrogenation of acetophenone catalysed by Pd Type 31 followed by the kinetic 
resolution of the product catalysed by Cal B CLEA. High conversion and 
enantioselectivity were observed for the cascade reaction. The reaction 
temperature had a more significant effect on both catalysts than the pressure. The 
kinetic resolution step gave excellent enantioselectivity (eeR > 99%) at a higher 
temperature 60°C. A decrease in the CO2 flow rate increased the perfonnance of 
both the hydrogenation and the kinetic resolution. Further flow rate slow down 
and/or use of a larger amount of catalyst may give a more significant 
improvement. 
The continuous supercritical reactor designed to investigate catalytic cascade 
reactions possesses the following advantages. 
i) The catalysts can be physically separated. 
ii) The temperature of each step can be controlled separately. 
iii) The reactants can be introduced into the system at any point. 
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iv) The number of reactors attached to the system and therefore number of 
steps of a catalytic cascade is unlimited. 
v) Ease of catalyst recovery and recycling. 
Furthermore: 
vi) SCC02 can provide advantages in dissolution of reactants (substrates 
and gases). 
vii) Possibility of solvent recycling. 
viii) Continuous production. 
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Chapter 7 
Combi-CLEA of Cholesterol Oxidase and Catalase for the 
Continuous Oxidation of Cholesterol in scC02 
This Chapter describes the importance and characteristics of cholesterol oxidases, 
and gives an overview of enzyme catalysed coupled-/cascade reactions. The work 
in this Chapter investigates the oxidation of cholesterol catalysed by a 
combi-CLEA of cholesterol oxidase and catalase in scC02• 
7.1. Cholesterol Oxidases 
Bacterial cholesterol oxidases can be classified into two types: non-pathogenic 
(e.g. Streptomyces) and pathogenic (e.g. Rhodococcus). In non-pathogenic 
bacteria, cholesterol is used as carbon source, and the expression of cholesterol 
oxidase is induced by the presence of cholesterol. l • 2 In pathogenic bacteria, 
cholesterol oxidase is used for infecting the host macrophages and again 
cholesterol regulates the expression of the enzyme in the bacteria.3• 4 The pathway 
of infection in pathogenic bacteria is suggested to be the alteration of the physical 
structure of the lipid membrane (the lipid membrane contains cholesterol) by the 
conversion of cholesterol to 4-cholesten-3-one, but further evidence is needed to 
confirm this. The oxidation of cholesterol by cholesterol oxidase is shown in 
Scheme 7-1. 
Cholesterol 
oxidase 
Scheme 7-1. The oxidation of cholesterol by cholesterol oxidase. 
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Cholesterol oxidase requires the cofactor Flavin Adenine Dinucleotide (FAD, 
flavin semiquinone) (Figure 7-1). The cofactor FAD is reduced to FADH+ during 
the reaction and is regenerated via the reduction of 02 to H20 2. Cholesterol 
oxidases are classed into two groups: I: with the cofactor (FAD) tightly but 
non-covalently bound to the protein (e.g. Streptomyces sp. and Brevibacterium 
sterolicum), and II: with the cofactor covalently bound to the enzyme via histidine 
residues (e.g. Nocardia (Rhodococcus) erythropolis and Brevibacterium 
sterolicum).s.6 Although cholesterol oxidases from the two groups share the same 
catalytic activity, they show no sequence homology and have significant 
differences in their redox and kinetic properties. 7• 8 
Cholesterol oxidase is a bifunctional monomeric flavoenzyme that catalyses the 
oxidation and subsequent isomerisation of steroids that contain a 3-0H group and 
a double bond in the C-5 position of the steroid ring system. The oxidation of 
cholesterol is performed in 2 steps: cholesterol is oxidised to cholest-5-en-3-one 
and then isomerised to cholest-4-en-3-one.s The reaction mechanisms of 
cholesterol oxidases illustrating the key residues for catalytic activity are shown in 
Scheme 7-2. 
Figure 7-1. The structure of Flavin Adenine Dinucleotide (FAD). 
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Scheme 7-2. Reaction catalysed by cholesterol oxidases Type I (Streptomyces 
Sp.9 and Brevibacterium sterolicum 110, 11) and Type II (Brevibacterium 
sterolicum 1112). The proposed role of key active site residues is shown for the 
type I cholesterol oxidase. The analogous residues for the type II cholesterol 
oxidase are also illustrated.5,6 
In this work, cholesterol oxidase from Nocardia sp. was used. Cholesterol oxidase 
from Nocardia sp. has been classed as a Type II cholesterol oxidase13 and has 
already been used for determining total serum cholesterol13 and for oxidising 
cholesterol14 in organic solvents. The structure of cholesterol oxidase from 
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acardia sp. is not yet avai lable in the literature. The structure of cholesterol 
oxidase from Streptomyces sp. (Type 1) has been solved9 and is presented in 
Figure 7-2. 
Figure 7-2. The structure of cholesterol oxidase from Streptomyces sp. (lB4V). 
The FAD cofactor is shown with ball-stick representation. The structure was 
obtained from Protein DataBank. The picture was created using Jmol.9 
The major uses of cholesterol oxidases is in the quantification of serum cholesterol 
for the assessment of atherosclerosis, coronary heart disease and other lipid 
disorder , and also for the determination of risk of heart attack and thrombosis. 
The enzyme also is a potential larvicide l5 and a too1 16-18 in cell biology. The 
product of the oxidation of cholesterol, 4-cholest-3-one is a precursor of interest in 
the pharmaceutical industry.14 The great advantage of cholesterol oxidases is that 
they have broad substrate specificity and therefore can be used in the 
transformation of steroids that can be used as intermediates for the synthesis of 
steroid hormone or other teroids. 
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The aim of this work was the production of 4-cholest-3-one (Scheme 7-1) with 
combi-CLEA of cholesterol oxidase and catalase in a continuous flow scC02 
system. Cholesterol oxidase has been immobilised previously on glass beads and 
its activity has been studied for the oxidation of cholesterol19• 20, and for 
quantifying cholesterot21 in edible oil samples and fat-containing food samples, in 
a continuous flow SCC02 system. However, the immobilisation of cholesterol 
oxidase using a carrier-free immobilisation technique and the co-immobilisation of 
cholesterol oxidase with another enzyme in a carrier-free form have not yet been 
investigated. 
7.2. Enzyme Catalysed Coupled-/Cascade Reactions 
The advantages of enzymes as biocatalysts are discussed in Chapter 5. A general 
discussion of multistep catalytic cascade reactions can be found in Chapter 6. 
Here, enzymatic cascade reactions are covered. 
Enzymes have been shown to be suitable to catalyse chemical transformations and 
have also been used in cascade reactions.22.25 In catalytic cascade reactions, the 
product of each step is instantly converted in the next step, and the reaction can 
therefore shift towards the favoured direction. This can be advantageous in 
enzymatic reactions where the inhibition by product is limiting, besides all other 
advantages of catalytic cascade reactions. 
An example of enzymatic catalytic cascade reactions has been demonstrated by 
Sheldon.26 The one pot conversion of benzaldehyde to (S)-mandelic acid was 
investigated with combi-CLEA (Scheme 7_3).26 The limitations of this cascade 
reaction could be overcome by optimising the reaction conditions (pH and reaction 
medium). A major improvement could be achieved by using immobilised enzymes 
(S-selective oxynitrilase and a non-selective nitrilase) in the CLEA form. The 
enzymes were co-immobilised to make a combi-CLEA. The nitrile intermediate 
was immediately hydrolysed in the combi-CLEA particles, which suppressed 
diffusion into the water phase and possible racemisation. In addition, this process 
overcomes the limitations of the industrial process (the production of enantiopure 
2-hydroxy acids via a dynamic kinetic resolution of the chemically synthesise 
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cyanohydrin in the presence of an enantioselective nitrilase) that is restricted to 
(R)-2-hydroxy acids, because no (S)-selective nitrilases for cyanohydrin substrates 
have yet been identified. 
~ C H O Oo (S)-HnL 
Ht: · 
(S)-HnL: S selective hydroxy nitrilase 
Nitrilase 
• crOOH 
ee94% 
Scheme 7-3. Enzymatic route to the production of (S)-mandelic acid from 
benzaldehyde. A combi-CLEA of an S-selective oxynitrilase and a 
non-selective nitrilase in a two enzyme cascade.26 
Another example of enzymatic cascade reactions has been reported by the same 
group. The combination of acylation catalysed by Cal B (Novozym 435) and 
hydrolysis (deacylation) catalysed by penicillin G acylase from A. faecalis 
(CLEA) was conducted with high enantioselectivity and high conversion 
(Scheme 7_4)?5, 27 The production of enantiomerically pure amines with chemical 
hydrolysis usually generates a large amount of waste (strongly alkaline conditions 
that also is incompatible with sensitive functional groups). The cascade reaction 
reported by Sheldon for the production of chiral amines reduces the waste 
generation and provides mild reaction conditions (aqueous medium, pH 7.0). The 
cascade reaction was further developed to the fully enzymatic resolution of amines 
with Cal B for both steps of the cascade reaction.28 The schematic of the reaction 
is shown in Scheme 7-5. 
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Scheme 7-4. Two enzyme resolution of amines by two consecutive enzymesP 
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Scheme 7-5. Amine resolution with Cal B for acylation and deacylation.28 
The examples shown here demonstrate that catalytic cascade reactions have great 
potential and the limitations can be overcome by careful optimisation of the 
reaction conditions. Here the oxidation of cholesterol by cholesterol oxidase was 
investigated with a combi-CLEA of two enzymes because cholesterol oxidase can 
be inhibited by H202, the by-product of the oxidation. H202 was removed from the 
system with catalase (catalase from bovine liver, Figure 7-3) that reduces H202 to 
02 and H20. The final aim of the study was the use of a combi-CLEA of 
cholesterol oxidase and catalase for the production of 4-cholesten-3-one in a 
continuous flow SCC02 system. 
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Figure 7-3. The structure of catalase from beef liver (Scat). Catalase is a 
tetramer where each subunit contains an active heme group (ball and stick 
representation) that performs the transformation of peroxide using a cofactor 
NADPH (ball and stick representation). The structure was obtained from 
Protein DataBank. The picture was created using Jmol.29 
7.3. Resu lts and Discussion 
The preparation of cholesterol oxidase CLEA and combi-CLEA of cholesterol 
oxidase and cata lase was investi gated, and the immobili sed enzymes were 
examined for the oxidation of cholesterol in a continuous flow scC02 system. 
Cholestero l oxidase fro m Nocardia sp. was used in thi s study. A preliminary 
screening of cholestero l oxidases from different sources (Nocardia sp., 
Streptomyces sp., Pseudomonas sp., and Pseudomonas fluorescens) was 
performed and on ly cho lesterol oxidase from Nocardia sp. converted cholesterol 
to 4-cholesten-3-one. The immobilisation of catalase from bovine liver has a lready 
been tudied u ing the CLEA technique30 which is a promis ing starting point for 
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making a combi-CLEA of cholesterol oxidase and catalase. Cholesterol oxidase 
from Nocardia sp. (E.C. 1.1.3.6., Merck 228230) (batch 1: 19.5 U/mg protein -
protein content 77.4 %; batch 2: 20.1 U/mg protein - protein content 84.2 %) and 
catalase from bovine liver (E.C. 1.11.1.6, Sigma C-9322) (batch 1: 2140 U/mg 
protein - protein content 63 %; batch 2: 4540 U/mg protein - protein content 65 %) 
were used. The parameters used to the particular batches are presented along with 
the activity results. 
7.3.1. Results of the Precipitation Screen of the Enzymes 
The first step of the CLEAtion (detailed description in Chapters 1 and 2) is 
enzyme aggregation. The recovered activity after precipitation must be high 
(above 90%) for preparing CLEA with potentially high activity. Here, 
iso-propanol, acetone, ethanol, dimethoxyethane (ethyleneglycol dimethyl ether), 
acetonitrile 90 % (v/v) and ammonium sulfate were examined as precipitants for 
both cholesterol oxidase and catalase. (A detailed description of the process can be 
found in Chapter 2.) The activity tests of cholesterol oxidase and catalase were 
based on the oxidation of cholesterol to cholest-4-en-3-one and on the reduction of 
H202, respectively. A detailed description of the activity assays can be found in 
Chapter 2. The results of the precipitation screen are shown in Figure 7-4 
and Figure 7-5. 
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Figure 7-4. The activity of cholesterol oxidase from Nocardia sp. after 
precipitation. The precipitant was used in 1 : 5 volume ratio of enzyme 
aliquot to precipitant. The supernatant was removed and the pellet was 
red is olved in phosphate buffer. Cholesterol oxidase activity, conversion of 
cholesterol (%) is relative activity compared to native. 
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Figure 7-5. The activity of catalase from bovine liver after precipitation. The 
precipitant was used in 1 : 5 volume ratio of enzyme aliquot to precipitant. 
The supernatant was removed and the pellet was redissolved in phosphate 
buffer. Catalase activity, conversion of H202 (%) is relative activity compared 
to na tive (catalase assay 1). 
Chole terol oxidase from Nocardia sp. was found to be sensitive to the presence 
of most precipitants (more than 30 % activity loss). Only ammonium sulfate was 
uitable to precipitate cholesterol oxidase without any loss of activity. 
Dimethoxyethane produced 10 % activity loss. Catalase from bovine li ver could 
be precipitated without any activ ity loss with ammonium sulfate, dimethoxyethane 
and acetone. The enzyme was successfully precipitated using acetonitrile 
(90 % v/v), iso-propanol and ethanol but the activity loss was over 30 %. 
Chole terol oxidase CLEA was also prepared using dimethoxyethane as 
precipitant but the CLEA activity was very low in this case. Allowing 3 times 
longer reaction time, only 49 % conversion (relative to native) was obtained by the 
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CLE (precipi tant: dimethoxyethane, cross-linker: g lutara ldehyde 10 mM). 
Dimethoxy thane might produce large aggregates or aggregates in unfavoured 
form that were thu cross-linked, in wh ich the mass transport of the substrate to 
the acti e ite of chole terol oxidase could be highly limited. SEM was used to 
detemline the morpho logy and the particle size of the CLEA. Figure 7-6 shows the 
E image of chole terol oxida e CLEA prepared us ing dimethoxyethane as 
precipitant and glutaraldehyde (50 mM) as cross-linker. The image shows a 
pa te-like tructure that can indicate the presence of large aggregates. 
Figure 7-6. SEM image of the individual cholesterol oxidase CLEA. The 
CLEA was prepared using dimethoxyethane as precipitant and 
gluta raldehyde as cross-linker (50 mM) without a reduction step. The CLEA 
wa prepared using cholesterol oxidase from Nocardia sp. (19.5 U/m g protein, 
6.62 mg, 100 U). 
7.3.2. C LEA Activity 
In a CLE the solid enzyme particles are linked to each other using bi functional 
linker molecule , usua lly d ialdehydes. In th is study, glutaraldehyde and dextran 
polyaldehyde were used as cross-linkers (Scheme 7-6). G lutaraldehyde was used 
at 10 mM and 50 mM concentrat ions; dextran polya ldehyde (aqueous so lution of 
dextran po lya ldehyde) was used in the fo llowing amounts 200 ilL DPA 
olutionlmL enzyme so lution and 400 ilL DPA so lutionlmL enzyme solution. The 
activity of the enzyme wa exami ned by 
• holestero l oxidase: oxidation of cholesterol in aqueous medium with O2 
a oxidant 
• Catala e: reduction of H 20 2 in aqueous medi um. 
(Detailed description of the enzyme assays can be found in Chapter 2.) 
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Scheme 7-6. The cross-linkers: glutaraldehyde and dextran polyaldehyde. 
The third step of CLEAtion is reduction, however, it is not essential for making 
CLEA. The stability of CLEA can be enhanced by improving the stability of the 
linkages between the enzyme particles. It can be obtained by the reduction of 
'-N=CH-' bonds to '-NH-CH2-' with NaBH4 or Na(CN)BH3 (Scheme 1-2 in 
Chapter 1). The effect of the reduction was also studied in this work. 
Cholesterol oxidase CLEA were prepared with ammonium sulfate as precipitant, 
and glutaraldehyde and dextran polyaldehyde as cross-linker, with and without 
reduction. The results of the CLEA activity test are shown in Table 7-1. 
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Table 7-1. The activity of the individual cholesterol oxidase CLEA. The 
precipitation was performed with saturated ammonium sulfate solution. 
Glutaraldehyde (GA) (10 mM and 50 mM) and dextran polyaldehyde (DPA) 
(200 J.1L DPA solution/mL enzyme solution and 400 J.1L DPA solution/mL 
enzyme solution) were used as cross-linkers. Cholesterol oxidase from 
Nocardia sp. (GA - 19.5 U/mg protein, 6.62 mg, 100 U and DPA - 20.1 U/mg 
protein, 5.92 mg, 100 U) was used. Cholesterol oxidase activity, conversion of 
cholesterol (%) is relative activity compared to native. GA = glutaraldehyde, 
DPA = dextran polyaldehyde, nla = no measurement - the CLEA of the 
particular conditions was not prepared. 
Cholesterol Cholesterol oxidase 
oxidase CLEA 
no reduction 
GAI0 
GA50 
DPA 200 
DPA400 
Cholesterol 
oxidase CLEA 
with reduction 
DPA 200 
DPA400 
activity (%) 
90 
91 
91 
95 
Cholesterol oxidase 
activity (%) 
98 
74 
Cholesterol oxidase activity (%), 
20 days - fraction of 'fresh' 
fresh: ori inal activit 
nla 
nla 
100 (40 days) 
90 (40 days) 
Cholesterol oxidase activity (%) 
20 days - fraction of 'fresh' 
fresh: ori inal activit 
75 
100 
The results of the cholesterol oxidase CLEA activity tests (Table 7-1) showed no 
significant effect of the cross-linker on the CLEA activity, however, CLEA made 
with glutaraldehyde as cross-linker had slightly lower activity. This may be due to 
the fact that glutaraldehyde is a small and reactive molecule that might produce a 
more compact structure in the CLEA than dextran polyaldehyde that is larger and 
less reactive. Glutaraldehyde could also interact with key amino acids in the active 
centre of the enzyme or with the flavin cofactor, and therefore block the enzyme 
activity. The long term stability of the cholesterol oxidase CLEA was high when 
stored as suspension. Further data is required to confirm how the reduction 
influences the activity of individual cholesterol oxidase CLEA. 
SEM was used to determine the size and morphology of the CLEA particles. A 
number of enzyme molecules are expected to be packed together in an aggregate 
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which can have a significant influence on the activity as a whole. The SEM 
images ofthe cholesterol oxidase CLEA can be seen in Figures 7-7, 7-8 and 7-9. 
Figure 7-7. SEM image of the individual cholesterol oxidase CLEA. The 
CLEA was prepared using ammonium sulfate as precipitant and 
glutaraldehyde as cross-linker (10 mM) without a reduction step. Cholesterol 
oxidase from Nocardia sp. (19.5 U/mg protein, 6.62 mg, 100 U) was used for 
making the CLEA. The particle is 0.2 /lm in diameter with a small deviation 
but larger aggregates are also present. 
Figure 7-8. SEM image of the individual cholesterol oxidase CLEA. The 
CLEA was prepared using ammonium sulfate as precipitant and dextran 
polyaldehyde as cross-linker (A: 200 /lL DPA solution/mL enzyme solution, 
B: 400 /lL DPA solution/mL enzyme solution) without a reduction step. 
Cholesterol oxidase from Nocardia sp. (20.1 U/mg protein, 5.92 mg, 100 U) 
was used for making the CLEA. 
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Figure 7-9. SEM image of the individual cholesterol oxidase CLEA. The 
CLEA was prepared using ammonium sulfate as precipitant and dextran 
polyaldehyde as cross-linker (A: 200 J..lL DPA solution/mL enzyme solution, 
B: 400 J..lL DPA solution/mL enzyme solution) including a reduction step. 
Cholesterol oxidase from Nocardia sp. (20.1 U/mg protein, 5.92 mg, 100 U) 
was used for making the CLEA. The size of the particles is A: cannot be 
determined, B: 1.5 J..lm with a small deviation. 
Well defined particles were obtained in some cases while others showed paste-like 
material. The morphology should not have a great effect on the activity of the 
CLEA because the cholesterol oxidase activity in the CLEA was high in all cases. 
However, the presence of larger particles might affect the CLEA activity. Particles 
of 0.2 J..lm were obtained using ammonium sulfate as precipitant and 
glutaraldehyde as cross-linker (10 roM), which exhibited 90 % activity in the 
CLEA (relative to native). Larger particles, 1.5 J..lm, were obtained using 
ammonium sulfate as precipitant and dextran polyaldehyde as cross-linker 
(400 J..lVml solution), which exhibited 74 % activity (compared to native). The 
particle size might have an effect on the CLEA activity but further evidence is 
required to confmn this. 
Catalase CLEA has been reported previously.3o This work expands the 
examination of different factors, which could also be well utilised in the making of 
a combi-CLEA of cholesterol oxidase and catalase. Catalase CLEA was prepared 
using ammonium sulfate and dimethoxyethane as precipitant, and glutaraldehyde 
and dextran polyaldehyde as cross-linker. The results of the CLEA activity tests 
can be seen in Table 7-2. 
155 Chapter 7 
Table 7-2. Activity of the individual catalase CLEA. The precipitation was 
performed with saturated ammonium sulfate solution (amms) or 
dimethoxyethane (DME). Glutaraldehyde (GA) (10 mM and 50 mM) and 
dextran polyaldehyde (DPA) (200 JlL DPA solution/mL enzyme solution and 
400 JlL DPA solution/mL enzyme solution) were used as cross-linkers. 
Catalase from bovine liver (4540 U/mg protein, 250 mg, 737500 U) was used 
for making the CLEA. Catalase activity, conversion of H202 (%), is relative 
activity compared to native (catalase assay 2). Amms = ammonium sulfate, 
DME = dimethoxyethane, GA = glutaraldehyde, DPA = dextran 
polyaldehyde. 
Catalase CLEA Catalase activity 
no reduction (%) 
Amms-GAI0 0 7 
Amms-GA50 12 66 
DME-GA 10 46 77 
DME-GA50 39 100 
Amms - DPA 200 36 72 
Amms - DPA 400 20 75 
DME-DPA200 39 90 
DME-DPA400 43 100 
Catalase CLEA Catalase activity 
with reduction (%) 
Amms-GA 10 3 0 
Amms - GA 50 39 44 
DME-GAI0 40 0 
DME-GA50 29 0 
Amms - DPA 200 38 54 
Amms - DPA 400 54 57 
DME-DPA200 28 13 
DME-DPA400 29 0 
Catalase CLEA was more active and more stable with dimethoxyethane as 
precipitant than with ammonium sulfate as precipitant. The reason for lower 
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activity of catalase in the CLEA prepared using ammonium sulfate as precipitant 
could be due to a less favoured form of enzyme aggregation, which could also 
affect the efficiency of the cross-linking (the lysine residues of the protein might 
become unavailable for the cross-linker). The efficiency of the cross-linking, the 
determination of the amount of non-cross-linked protein was examined using 
SDS-PAGE (results are discussed below). 
Glutaraldehyde and dextran polyaldehyde were examined as cross-linkers for 
catalase CLEA. The CLEA prepared with glutaraldehyde as cross-linker exhibited 
lower activity than those prepared with dextran polyaldehyde as cross-linker in 
most cases. The effect of different cross-linkers due to their size and reactivity 
could affect the structure of the CLEA. The more significant parameter of the 
cross-linker may be its size when making catalase CLEA. Catalase is a large 
protein (250 kDa), that is a tetramer built of four subunits (62.5 kDa) with an 
active centre in each subunit (Figure 7-3). Dextran polyaldehyde may link the 
enzyme particles in a more favoured structure that may be closely bound by 
glutaraldehyde. The CLEA with dextran polyaldehyde can thus benefit of lower 
steric inhibition that may block less active sites, and also better mass transport. 
Differences in CLEA activity using different cross-linkers was also shown for 
cholesterol oxidase CLEA, however, only slight difference was observed there. 
Due to the more complex structure of catalase, the effect of the cross-linker can 
increase. 
The drop in the activity of catalase in the CLEA might also be due to loss of 
protein (non-cross-linked or loosely bound to the cross-linked bulk). The 
efficiency of the cross-linking was determined by Sodium Dodecyl Sulfate 
Polyacrylamide Gel Electrophoresis (SDS-PAGE, to determine the quantity and 
size of proteins). The protein samples were boiled before running on the gel which 
breaks the catalase tetramer to subunits that can be determined by electrophoresis. 
The supernatants collected during the preparation of the CLEA (detailed 
description of the procedure can be found in Chapter 2) were analysed, which 
should contain the non-cross-linked protein. The strength of the bands appearing 
in the gel should correspond to the efficiency of the CLEAtion: the less intense 
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bands (less protein loss) the more efficient cross-linking. The bands in the gel 
shown in Figure 7-10 have a size of approximately 60 kDa that corresponds to the 
size of catalase subunits, 62.5 kDa. Band appeared in the sample of CLEA 
prepared using ammonium sulfate as precipitant (1, 2 and 5, 6 in Figure 7-10), 
while no bands were found in the samples of CLEA prepared using 
dimethoxyethane as precipitant (3,4 and 7, 8 in Figure 7-10) with either 
cross-linker. The results of the SDS-PAGE suggest that the precipitant is 
important to produce CLEA with high retained activity. Dimethoxyethane may 
produce protein aggregates of catalase in a more favoured form to be cross-linked 
and/or it may be a more suitable the reaction medium for the cross-linking. Using 
ammonium sulfate as precipitant, dextran polyaldehyde was shown to be a more 
efficient cross-linker as the bands were less intense in these samples (1, 2 in 
Figure 7-10) than those with glutaraldehyde (5, 6 in Figure 7-10). (No band 
appeared in the samples of the CLEA made with dimethoxyethane as precipitant 
with either cross-linker (3, 4, 7,8 in Figure 7-10.)) Dextran polyaldehyde may link 
the enzyme particles that cannot be bound by glutaraldehyde due to its larger size. 
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Figure 7-10. SOS-PAGE analysis of the protein fractions of catalase. Samples 
are as follows: 1: GA10 - amms, 2: GA 50 - amms, 3: GA 10 - OME, 4: GA 50 
- DME, 5: DPA 200 - amms, 6: DPA 400 - amms, 7: OPA 200 - DME, 8: 
DPA 400 DME, St: standard. Amms = ammonium sulfate, 
DME = dimethoxyethane, GA = glutaraldehyde, DPA = dextran 
polyaldehyde. The samples of the supernatant collected during the 
preparation of the CLEA were analysed. 
Catalase is very unstable when stored in solution. Therefore the stability of the 
immobilised enzyme is important for industrial applications. The stability of 
catalase CLEA was high when stored as suspension in most cases, and therefore 
CLEA of catalase may have potential for industrial applications. 
The effect of the reduction on the catalase CLEA was also examined (Table 7-2). 
The activity of 'reduced' catalase CLEA varied when compared to the activity of 
' non-reduced' CLEA. Further chemical stability is expected by reduction but it 
was not observed clearly in this case. 
The morphology and particle size of the CLEA was investigated by SEM. The 
SEM images of catalase CLEA are presented in Figures 7-11 and 7-12. 
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Figure 7-11. SEM image of the individual catalase CLEA. The CLEA was 
prepared using ammonium sulfate as precipitant and glutaraldehyde as 
cross-linker (A: 10 mM, B: 50 mM) without reduction. The CLEA were 
prepared using catalase from bovine liver (2140 U/mg protein, 250 mg, 
335000 U). The size of the particles is A: 0.2 ~ m m with a small deviation and 
B: 0.2-0.6 ~ m . .
Figure 7-12. SEM image of the individual catalase CLEA. The CLEA was 
prepared using dimethoxyethane as precipitant and glutaraldehyde as cross-
linker (A: 10 mM, B: 50 mM) without reduction. The CLEA were prepared 
using catalase from bovine liver (2140 U/mg protein, 250 mg, 335000 U). The 
size of the particles is A: 1-1.5 ~ m , , B: cannot be determined. 
The SEM images of the individual catalase CLEA (Figures 7-11 and 7-12) showed 
well defined particles with particle size below 1.5 11m. The only exception was 
catalase CLEA prepared using dimethoxyethane as precipitant and glutaraldehyde 
(50 roM) as cross-linker (Figure 7-12 B), which showed paste-like structure. The 
precipitating agent and the cross-linker both were shown influence the size of the 
CLEA. The particles were smaller using ammonium sulfate as precipitant than 
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those using dimethoxyethane as precipitant, with glutaraldehyde as cross-linker. 
The particles were larger using glutaraldehyde in a higher concentration. 
Combi-CLEA of cholesterol oxidase and catalase were examined usmg 
ammonium sulfate as precipitant, and glutaraldehyde and dextran polyaldehyde as 
cross-linker. The results are shown in Table 7-3. 
Table 7-3. The activity of the combi-CLEA of cholesterol oxidase and 
catalase. The precipitation (co-precipitation) was performed with saturated 
ammonium sulfate solution and glutaraldehyde (GA) (10 mM and 50 mM) 
and dextran polyaldehyde (DPA) (200 JlL DPA solution/mL enzyme solution 
and 400 JlL DPA solution/mL enzyme solution) were used as cross-linkers. 
Cholesterol oxidase from Nocardia sp. (20.1 U/mg protein, 5.92 mg, 100 U) 
and catalase from bovine liver (4540 U/mg protein, 250 mg, 737500 U) were 
used. Cholesterol oxidase activity, conversion of cholesterol (%) is relative 
activity compared to native. Catalase activity, conversion of H202 (%) is 
relative activity compared to native (catalase assay 2). GA = glutaraldehyde, 
DPA = dextran polyaldehyde. 
* The activity assay was performed 2 weeks after the CLEA were prepared 
due to technical problems. The values in brackets are the activity data of the 
fresh combi-CLEA. 
Cholesterol Catalase Remaining H202 Combi-CLEA 
oxidase activity activity (% - fraction of the amount 
no reduction of H202 produced by the (%) (%) 
native oxidase 
GAIO 47* (66) 12 10 
GA50 17* (16) 17 0 
DPA 200 69* (83) 53 6 
DPA400 60* (47) 40 10 
Cholesterol Catalase Remaining H202 Combi-CLEA 
oxidase activity activity (% - fraction of the 
with reduction (%) (%) amount of H202 produced b the native oxidase 
GAI0 53* (49) 6 33 
GA50 11 * (8) 13 4 
DPA 200 48* (54) 46 0 
DPA400 43* (50) 36 0 
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Cholesterol oxidase exhibited lower activity in combi-CLEA than in individual 
cholesterol oxidase CLEA. The reason for the lower activity could be due to mass 
transport limitations as a large amount of catalase surrounded cholesterol oxidase 
in combi-CLEA (cholesterol oxidase: catalase = 100 U (5.92 mg) : 737500 U 
(250 mg». The activity of catalase in combi-CLEA was comparable with the 
activity in the individual catalase CLEA. The activity of both enzymes was lower 
using glutaraldehyde as cross-linker when compared with using dextran 
polyaldehyde as cross-linker at all conditions. This suggests that the cross-linker 
highly influences the enzyme activity in the combi-CLEA. 
Free/released protein fractions of proteins can be determined by SDS-PAGE 
analysis. SDS-PAGE was performed previously for determining the efficiency of 
the CLEAtion in the individual catalase CLEA (Figure 7-10). In the combi-CLEA, 
the effect of cross-linking and the reduction step were examined. The results are 
shown in Figure 7-13. 
Figure 7-13. SDS-PAGE analysis of the protein fractions of catalase. Samples 
are as follows 1: GAI0 - amms, 2: GA10 R - amms, 3: GA50 - amms, 4: GA50 
R - amms, 5: DPA 200 - amms, 6: DPA 200 R - amms, 7: DPA 400 - amms, 
8: DPA 400 R - amms, St: standard. Amms = ammonium sulfate, 
GA = glutaraldehyde, DPA = dextran polyaldehyde, R = reduced. 
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The SDS-PAGE analysis showed that the efficiency of the cross-linking was 
higher using the cross-linker in a higher concentration. Weak bands (when 
present) were found in these samples (3, 4 and 7, 8 in Figure 7-13). The 
cross-linker used in a higher concentration might affect the structure of the 
immobilised biocatalyst by causing mass transport limitations and therefore lower 
activity (Table 7-3), which was observed in most cases. The bands were more 
intense when the reduction step was also included (2, 4, 6, 8 in Figure 7-13). 
Including an additional step in the procedure for preparation of the CLEA can 
increase the loss of protein. 
Further studies were performed on the effect of the precipitation on the activity of 
combi-CLEA. It is possible to prepare individual CLEA and cross-link them to 
produce a combi-CLEA, however, an additional cross-linking step should be 
included in the procedure that is labour intensive and increases the possibility of 
enzyme loss. Also, this combi-CLEA may consist of large branches of individual 
CLEA and not of a homogeneous mixture of the enzymes. Another approach is to 
precipitate the enzymes separately and mix the aggregates before cross-linking. 
Here, the preparation of combi-CLEA was examined using the following methods. 
A. Precipitating the enzymes separately with the same precipitant (ammonium 
sulfate). 
B. Precipitating the enzymes separately with different precipitants 
(ammonium sulfate for cholesterol oxidase and dimethoxyethane for 
catalase). 
The individually precipitated enzymes were mixed before cross-linking. The result 
of the CLEA activity can be seen in Table 7-4. (The major interest of this study 
was how cholesterol oxidase activity was affected by the conditions of the CLEA 
preparation. Therefore the catalase activity is not presented and discussed here.) 
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Table 7-4. The activity of the combi-CLEA of cholesterol oxidase and catalase 
prepared with co- and separate precipitation of the enzymes. Glutaraldehyde 
(GA) (10 mM and 50 mM) was used as cross-linker. Cholesterol oxidase 
activity, conversion of cholesterol (%) is a relative activity compared to 
native. GA = glutaraldehyde. 
Cholesterol Remaining 11202 Combi-CLEA 
oxidase activity (% - fraction of the 
no reduction (%) amount of H202 produced b the native oxidase 
A) GA 10 * 99 26 
A) GA 50 * 90 45 
A)GA 10 ** 99 59 
A) GA 50 ** 75 34 
B) GA 10 * 99 19 
B) GA 50 * 59 1 
B) GA 10 ** 99 14 
B) GA50 ** 66 56 
A) Cholesterol oxidase from Nocardia sp. (19.5 U/mg protein, 6.62 mg, 100 U) 
and catalase from bovine liver (2140 U/mg protein, 62.5 mg, 83750 U) were 
used. The precipitation was performed with saturated aqueous ammonium 
sulfate solution. 
B) Cholesterol oxidase from Nocardia sp. (19.5 U/mg protein, 6.62 mg, 100 U) 
and catalase from bovine liver (2140 U/mg protein, 250 mg, 335000 U) were 
used. The precipitation was performed using saturated aqueous ammonium 
sulfate solution for cholesterol oxidase and dimethoxyethane for catalase. 
Dimethoxyethane was removed from the catalase particles. The cholesterol 
oxidase particles were transferred to the pot containing the catalase 
aggregates. The cross-linking was performed in ammonium sulfate in 
appropriate concentration. 
* Co-precipitation 
** Separate precipitation. The aggregates were mixed before cross-linking. 
The results in Table 7-4 show that the precipitation method did not have a 
significant effect on the cholesterol oxidase activity in the combi-CLEA. It 
suggests that the aggregates of different enzymes can be well mixed even when 
precipitated separately. It can give a great advantage in the making of a 
combi-CLEA where its enzyme are required to be precipitated in different solvent 
in order to retain high activity. 
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The particle size and morphology of the combi-CLEA was determined by SEM. 
Images of several cornbi-CLEA are shown in Figures 7-14 - 7-16. The conditions 
of the preparation are described in the caption below the images. 
Figure 7-14. SEM image of the combi-CLEA. The CLEA was prepared using 
ammonium sulfate as precipitant and glutaraldehyde as cross-linker (A: 10 
mM, B: 50 mM) without a reduction step. Cholesterol oxidase from Nocardia 
sp. (20.1 U/mg protein, 5.92 mg, 100 U) and catalase from bovine liver 
(4540 U/mg protein, 250 mg, 737500 U) were used. 
Figure 7-15. SEM image of the combi-CLEA. The CLEA was prepared using 
ammonium sulfate as precipitant and glutaraldehyde as cross-linker (A: 10 
mM, B: 50 mM) including a reduction step. Cholesterol oxidase from 
Nocardia sp. (20.1 U/mg protein, 5.92 mg, 100 U) and catalase from bovine 
liver (4540 U/mg protein, 250 mg, 737500 U) were used. 
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Figure 7-16. SEM image of the combi-CLEA. The CLEA was prepared using 
ammonium sulfate as precipitant and dextran polyaldehyde as cross-linker 
(A: 200 J..lL DPA solution/mL enzyme solution, B: 400 J..lL DPA solution/mL 
enzyme solution) without a reduction step. Cholesterol oxidase from Nocardia 
sp. (19.5 U/mg protein, 6.62 mg, 100 U) and catalase from bovine liver 
(4540 U/mg protein, 250 mg, 737500 U) were used. 
The SEM images showed very similar structures for all combi-CLEA regardless 
the conditions of preparation. Paste-like structure was observed in all cases which 
suggest that the combi-CLEA contain large aggregates. As similar structures were 
shown for all combi-CLEA, unfortunately, no major conclusion can be drawn 
from the SEM images. 
The CLEA was examined for the oxidation of cholesterol in a continuous flow 
SCC02 system. A CLEA normally contains a small amount of H20 that was 
expected to be sufficient for the enzyme to function in a water-free environment. 
7.3.3. Oxidation of Cholesterol in a Continuous Flow scC02 system 
Enzymatic conversion of steroids may be advantageous in SCFs because steroids 
are nearly insoluble in H20. For example, cholesterol solubility in H20 is 
4.7 J..lM31, while it is significantly more soluble in CO2 184 J..lM (40 °C and 
100 bar)32. Furthermore, SCC02 is miscible with O2 and the single phase can also 
be an advantage for oxidations in SCC02. The oxidation of cholesterol 
(Scheme 7-1) has been investigated here with A of cholesterol oxidase and 
combi-CLEA of cholesterol oxidase and catalase in a continuous flow scC02 
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system. The oxidation of cholesterol with immobilised cholesterol oxidase 
(cholesterol oxidase immobilised on glass beads) has been reported previously to 
b ful . CO 19-21 33 34 H h . b'l' d . h e success In sc 2. " ere, t e enzyme was Immo lIse usmg t e 
CLEA technique which has not yet been investigated. In the continuous oxidation 
in flow SCC02 system, cholesterol was extracted 'in-flow' which required 
optimisation prior to the investigation the oxidation. 
7.3.3.1. 'In-flow' Cholesterol Extraction in a Continuous Flow scC02 system 
In a continuous flow high pressure system, cholesterol can be introduced into the 
system in two ways. 
a) A solution of cholesterol can be pumped into the high pressure system 
using a liquid pump. 
b) Cholesterol can be extracted 'in-flow' by SCe02 (solid cholesterol is 
loaded in a vessel that is attached to the flow system). 
If cholesterol is pumped into the system as a solution, a cosolvent is required to 
bring the cholesterol into solution. A large amount of organic solvent may 
deactivate the enzyme35 and therefore 'in-flow' extraction (b) was used in this 
work. There are several possibilities for sample collection: 
a) The effluent of the reactor can be bubbled through an organic solvent to 
dissolve the oxidation product and the unreacted cholesterol. 
b) A filter attached to the outlet of the BPR (elongated with a short tube) 
allows the collection of the oxidation product and the unreacted cholesterol 
as solid material. 
c) An organic solvent can be pumped into the system after the reactor to 
dissolve the oxidation product and the unreacted cholesterol. 
The sample collection was performed using method 'c' in this work. 
Several different reactors were studied in order to achieve reproducible and 
constant cholesterol concentration in the effluent. The schematic of the reactors is 
shown in Figures 7-17 - 7-20. 
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Figure 7-17. The small scale continuous flow reactor. Setup 1 & Setup 2. 
Parts are labelled as follows. 1: CO2 cylinder, 2: CO2 cooling unit and HPLC 
pump, 3: Parker ball valve, 4: 02 cylinder, 5: Manual pressure regulator, 6: 
Waters switching valve for O2 dosage (two-position six-port switching valve), 
7: Parker ball valve, 8: substrate/solvent reservoir, 9: HPLC pump, 10: 
Parker ball valve, 11: Water bath heater, 12: Cholesterol vessel, 13: Reactor, 
14: GO valve - manual back pressure regulator (BPR), 15: Collection vial. All 
components were connected by 1116" 316 stainless steel tubing. The feed 
streams were mixed in a heated T -piece mixer before being passed through 
the cholesterol vessel and the reactor. Products were collected by continuous 
depressurisation of the system using a manual backpressure regulator, and 
analysed by reverse phase HPLC. 
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Setup 1 and Setup 2 are shown in Figure 7-17. The two reactor setups differentiate 
in the following parameters. 
Setup 1. 
Part 12: Cholesterol vessel (0.7 cm3) 
(Y4" tube, dinner= 3 mm, length 10 cm) 
Part 13: Reactor (0.7 cm3) (Y4" tube, 
dinner= 3 mm, length 10 cm) 
Setup 2. 
Part 12: Cholesterol vessel (14.92 cm3) 
(dinner= 1 cm, length 19 cm) 
Part 13: Reactor (0.7 cm3) (Y4" 
tube, dinner= 3 mm, length 10 cm) 
Cholesterol was loaded into the vessel used in the following ways. 
Setup 1. 
A) Cholesterol (as received). 
8) The vessel was loosely filled with glass wool. Cholesterol was dissolved in 
dichloromethane and pipetted in the vessel and the solvent was evaporated 
by incubation the vessel at 50 DC. In all other cases, solid cholesterol was 
loaded in the reactor. 
C) Ground cholesterol. 
Setup 2. 
A) Alternate layers of cholesterol and glass wool were loaded ill the 
'cholesterol vessel'. 
8) Ground cholesterol was loaded in the vessel. The cholesterol extraction 
was performed in up flow. 
C) Alternate layers of ground cholesterol and glass beads were loaded in the 
vessel. 
D) Ground cholesterol was mixed with glass beads before loading. A thin 
layer of cholesterol was obtained on the surface of the glass beads. 
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Figure 7-18. The small scale continuous flow reactor. Setup 3. Parts are 
labelled as follows. 1: COz cylinder, 2: COz cooling unit and HPLC pump, 3: 
Parker ball valve, 4: Oz cylinder, 5: Manual pressure regulator, 6: Waters 
switching valve for Oz dosage (two-position six-port switching valve), 7: 
Parker ball valve, 8: substrate/solvent reservoir, 9: HPLC pump, 10: Parker 
ball valve, 11: Water bath heater, 12: Cholesterol vessel (dinner=3 mm, length 
100 cm), 13: Reactor (Y.." dinner=3 mm, length 10 cm), 14: GO valve - manual 
back pressure regulator (BPR), 15: Collection vial. All components were 
connected by 1116" 316 stainless steel tubing. The feed streams were mixed in 
a heated T -piece mixer before being passed through the cholesterol vessel 
(7.07 cm3 volume) and the reactor (0.7 cm3 volume). Products were collected 
by continuous depressurisation of the system using a manual backpressure 
regulator, and analysed by reverse phase HPLC. 
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Figure 7-19. The small scale continuous flow reactor. Setup 4. Parts are 
labelled as follows. 1: C02 cylinder, 2: C02 cooling unit and HPLC pump, 3: 
Parker ball valve, 4: 02 cylinder, 5: Manual pressure regulator, 6: Waters 
switching valve for O2 dosage (two-position six-port switching valve), 7: 
Parker ball valve, 8: substrate/solvent reservoir, 9: HPLC pump, 10: Parker 
ball valve, 11: Water bath heater, 12: Vessel for CO2 saturation with H20 
13: Cholesterol vessel (dinner=1 cm, length 19 cm), 14: Reactor 
(Y." dinner=3 mm, length 10 cm), 15: GO valve - manual back pressure 
regulator (BPR), 16: Collection vial. Ground cholesterol was used. Alternate 
layers of cholesterol and glass beads were loaded. All components were 
connected by 1116" 316 stainless steel tubing. The feed streams were mixed in 
a heated T -piece mixer before being passed through the cholesterol vessel 
(14.92 cm3 volume) and the reactor (0.7 cm3 volume). The cholesterol 
extraction was performed in an up flow configuration. Products were 
collected by continuous depressurisation of the system using a manual 
backpressure regulator, and analysed by reverse phase HPLC. 
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Figure 7-20. The small scale continuous flow reactor. Setup 5 & Setup 6. 
Parts are labelled as follows. 1: C02 cylinder, 2: CO2 cooling unit and HPLC 
pump, 3: Parker ball valve, 4: O2 cylinder,S: Manual pressure regulator, 6: 
Waters switching valve for O2 dosage (two-position six-port switching valve), 
7: Parker ball valve, 8: substrate/solvent reservoir, 9: HPLC pump, 10: 
Parker ball valve, 11: Water bath heater, 12: Vessel for C02 saturation with 
H20 13: Cholesterol vessel, 14: Reactor, 15: GO valve - manual back pressure 
regulator (BPR), 16: Collection vial. Ground cholesterol was used. Alternate 
layers of cholesterol and glass beads were loaded. All components were 
connected by 1116" 316 stainless steel tubing. The feed streams were mixed in 
a heated T -piece mixer before being passed through the cholesterol vessel and 
the reactor. The cholesterol extraction was performed in an up flow 
configuration. Products were collected by continuous depressurisation of the 
system using a manual backpressure regulator, and analysed by reverse 
phase HPLC. 
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Setup 5 and Setup 6 are shown in Figure 7-20. The two reactor setups differentiate 
in the following parameters. 
Setup 5. Setup 6. 
Part 13: Cholesterol vessel (14.92 cm3) Part 13: Cholesterol vessel (0.7 cm3) 
(dinner= 1 cm, length 19 cm) (Y4" tube, dinner= 3 mm, length 10 cm) 
P rt 14 R t (0 7 3) (1/" d Part 14: Reactor (0.7 cm3) ( 1 ~ " "a : eac or . cm i'4 inner= i ' ~ ~
3 mm, length 10 cm) tube, dinner= 3 mm, length 10 cm) 
The results of the 'in-flow' cholesterol extraction are shown in Table 7-5. 
Table 7-5. 'In-flow' extraction of cholesterol in continuous flow scC02 
system. The reactor setups can be seen in Figures 7-17 - 7-20. The error in 
the table is the error in cholesterol area of the experiments repeated at 
particular conditions HPLC analysis). 
Reactor T C02 flow P 02 Cholesterol Entry 
setu (mL/min) (bar) concentration (mM) 
1 setup lA 40 2 100 yes 0.08-0.42 
2 setup IB 40 2 100 yes 0.24-0.28 
3 setup IB 50 2 100 yes 0.05 
4 setup lC 40 2 100 no 0.68-0.71 
5 setup lC 40 2 100 yes 0.37-0.5 
6 setup 2A 40 2 100 yes 0.21-0.69 
7 setup 2A 40 2 160 yes 2.31-3.43 
8 setup 2B 40 2 100 yes 0.01-0.02 
9 Setup 2C 40 2 100 yes 0.56-1.57 
10 setup 2C * 40 2 100 yes 0.16-0.71 
11 setup 2D 40 2 100 yes 0.75-1.46 
12 setup 2D * 40 2 100 yes 0.29-0.79 
13 setup 3 40 2 100 yes 0.19-0.57 
14 setup 4 ** 40 2 100 yes 0.16-0.32 
15 setup 4 ** 40 2 160 yes 2.1-2.37 
16 setup 5** 40 2 130 no 2.3-3.48 
17 setup 5 ** 40 2 160 no 3.39-3.49 
18 setup 6 ** 40 1 100 yes 0.07-0.17 
19 setup 6 ** 40 1 160 yes 0.81-1.14 
20 setup 6 ** 40 1 100 no 0.51-1.82 
21 setup 6 ** 40 1 160 no 1.79-2.03 
* Reaction time 120 minutes. 
** Water-saturated CO2 was used. 
Setup 1 and Setup 2: Figure 2-17, Setup 3: Figure 2-18, Setup 4: Figure 2-19, 
Setup 5 and Setup 6: Figure 2-20. 
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As shown in Table 7-5, the concentration of cholesterol in the effluent fluctuated 
significantly using all reactors. The consistency of the cholesterol concentration 
was higher at a higher pressure (160 bar) (Entries 15, 16, 17, 19, 21 except 
Entry 7) than at a lower pressure (100 bar). The changes in mass transfer and also 
in the properties of C02 at the different conditions might influence the extraction. 
The effect of temperature has not yet been investigated extensively (Entries 2, 3). 
It can be seen from the results shown in the Table 7-5 (Entries 4-5, 18-20, 19-21) 
that the presence of O2 had no significant effect on the cholesterol extraction 
(except Entries 4, 5). O2 should not be the major influencing factor on the 
cholesterol extraction as the cholesterol concentration was still highly 
inconsistency even when 02 was not present. 
The particle size of the material to be extracted can influence the performance of 
the extraction. Cholesterol received as pellets was milled in order to obtain small 
particles (Entries 2-3, 4-5, 8-12, 14-15 and 18-21) or was dissolved in 
dichloromethane (and the solvent was evaporated) before loading which produced 
smaller particles (visual observation). Unfortunately, the use of ground cholesterol 
was unsuccessful as inconsistency in the cholesterol concentration was still 
observed. Cholesterol dissolved in dichloromethane (and the solvent evaporated) 
before loading (Entries 2 and 3) resulted in a highly consistent cholesterol 
concentration in the effluent of the system but the reproducibility between two 
runs using the same setup was poor. 
Although the 'in-flow' cholesterol extraction could not be optimised in the 
continuous flow scC02 system, the oxidation of cholesterol was investigated. 
7.3.3.2. Oxidation of Cholesterol in a Continuous Flow seCOl system 
The oxidation was examined using a small scale high pressure equipment shown 
in Figure 7-20 above (Setup 5). A detailed description can be found in Chapter 2. 
The results of the continuous oxidation of cholesterol with CLEA in scC02 are 
shown in Table 7-6. 
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Table 7-6. The results of cholesterol oxidation in a continuous flow SCC02 
system. Cholesterol oxidase from Nocardia sp. (20.1 U/mg protein, 5.92 mg, 
300 U), cholesterol oxidase from Nocardia sp. CLEA (20.1 U/mg protein, 5.92 
mg, 300 U) and combi-cholesterol oxidase-catalase-CLEA (cholesterol 
oxidase: 20.1 U/mg protein, 5.92 mg, 200 U and catalase from bovine liver 
4540 U/mg protein, 500 mg, 1475000 U) were used as catalysts. The CLEA 
were prepared with ammonium sulfate as precipitant and dextran 
polyaldehyde (200 J.1L DPA solution/mL enzyme solution) cross-linker. The 
reactor setup is shown in Figure 7-22. n/a = not available. 
Cholesterol oxidase - yield of 4-cholesten-3-one (%) 
CO2 flow 40°C 130 bar 40 °C 160 bar 50°C 130 bar 50 °C 160 (mVmin) bar 
2 mllmin <0.02 <0.5 0 0 
4 mllmin 0 <0.2 0 0 
6 mllmin <0.2 <0.5 0 0 
8 mllmin 0 <0.2 0 0 
Cholesterol oxidase CLEA - yield of 4-cholesten-3-one (%) 
C02 flow 40°C 130 bar 40 °C 160 bar 50°C 130 bar 50 °C 160 (mVmin) bar 
2 mllmin <0.2 < 1.2 0 <0.1 
4 mllmin 0 0 <0.1 <0.2 
6 mllmin <0.1 < 0.1 <0.1 < 0.1 
8 mllmin 0 0 <0.1 < 0.1 
Combi-CLEA - yield of 4-cholesten-3-one (%) 
C02 flow 40°C 130 bar 40 °C 160 bar 50°C 130 bar 50 °C 160 (mVmin) bar 
2 mllmin 0 0 nla 0.00 
4 mllmin 0 0 nla 0.00 
6 mllmin 0 0 nla < 0.1 
8 mllmin <0.6 0 nla < 0.1 
Reaction conditions: pressure: 100 bar, 02 : substrate ratio = 10 1 
(calculated). 
Unfortunately, the oxidation of cholesterol in a continuous flow scC02 system was 
unsuccessful using all enzymes. The yield of 4-cholesten-3-one was very low and 
therefore the effect of pressure, temperature and flow rate on the reaction could 
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not be detennined. It has been reported previously that an increase in flow rate can 
positively influence the enzyme activit;° but this could not be demonstrated here. 
The activity of cholesterol oxidase may decrease significantly in a water-free 
environment or in an environment containing a small amount of water. 14, 20 
Water-saturated C02 was used here which contained probably an insufficient 
amount of water for the enzyme to function. On the other hand, the reaction rate 
might be very slow and therefore no conversion could be obtained if a short 
residence time was provided. The residence time in the reactor has been calculated 
to be 0.354 min at 2 mLimin CO2 flow rate if the whole volume of the reactor is 
filled with catalyst. Higher conversion may be obtained if a longer reaction time is 
provided, however, low yield of 4-cholesten-3-one was observed at slower CO2 
flow rates 0.5 mL/min and 1 mL/min (the results are not presented here). 
The aggregation of cholesterol under supercritical conditions33 might have 
suppressed the activity of cholesterol oxidase from Nocardia sp. Cholesterol 
oxidase from G. chrysocreas was examined under supercritical conditions and was 
shown to produce benefit from the presence of cholesterol aggregation at a higher 
level.19 The aggregation of cholesterol may be a disadvantage for cholesterol 
oxidase from Nocardia sp. because it can have a different cholesterol uptake 
mechanism than that of cholesterol oxidase from G. chrysocreas. 
Cholesterol oxidase from G. chrysocreas was examined under supercritical 
conditions and no confonnational changes were observed in the protein 
structure.33 These results suggest that confonnational changes of the CLEA of 
cholesterol oxidase Nocardia sp. should not occur under supercritical conditions. 
7.3.3.3. Oxidation of Cholesterol in a Batch scCOz system 
The oxidation of cholesterol was examined in a batch SCC02 system to detennine the 
cause of low activity in the continuous flow SCC02 system. The experimental setup 
and the reactor are described in Chapter 2. The results of the batch oxidation are 
shown in Table 7-7. 
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Table 7-7. The result of cholesterol oxidation in batch SCC02. The CLEA was 
prepared with ammonium sulfate as precipitant and glutaraldehyde (10 mM) 
as cross-linker. Combi-cholesterol oxidase-catalase-CLEA was used as 
catalysts (cholesterol oxidase from Nocardia sp.: 17.3 U/mg protein, 6.85 mg, 
100 U and catalase from bovine liver 4540 U/mg protein, 250 mg, 737500 U). 
A small scale clamp autoclave was used to perform the reactions. A detailed 
description of the autoclave can be found in Chapter 2. The experimental 
setup of the batch oxidation reaction is discussed in detail in Chapter 2. 
Reactor volume was 8 mL. 
Reaction Wet or T Pressure Yield of Entry time (hour) dry? _ e C ~ ~ (bar) cholest-4-en-3-one (%) 
1 5 wet 40 4* 100 
2 5 wet 40 100 8 
3 5 dry 40 100 0 
4 5 dry 40 100 0 
5 20 dry 40 100 0 
Reaction conditions: 
Entry 1: 02: 4 bar, phosphate buffer (20 mM, pH 7.0): 3.8 mL, alcoholic 
solution of cholesterol (IPA, 12 mM): 1 mL, enzyme suspension 
(combi-CLEA): 0.2 mL, 0.67 U. 
* Pressure of 02. 
Entry 2: 02 : 4 bar, CO2: 100 bar, phosphate buffer (20 mM, pH 7.0): 3.8 mL, 
alcoholic solution of cholesterol (IPA, 12 mM): 1 mL, enzyme suspension 
(combi-CLEA): 0.2 mL, 0.67 U. 
Entry 3: 02: 4 bar, C02: 100 bar, alcoholic solution of cholesterol (IPA, 12 
mM): 1 mL, enzyme (combi-CLEA) - dry powder: 0.67 U. 
Entry 4 & 5: O2 : 4 bar, C02: 100 bar, cholesterol: 4.6 mg, enzyme 
(combi-CLEA) - dry powder: 0.67 U. 
As mentioned previously, the continuous flow oxidation was possibly unsuccessful 
due to i) the lack of H20, or ii) aggregation of cholesterol under supercritical 
conditions. The oxidation of cholesterol was investigated in batch with a large 
amount of H20 present without C02 (Entry 1) and with C02 (Entry 2). The enzyme 
produced 8 % yield of 4-cholesten-3-one in a 5-hour reaction (Entry 2), which was 
significantly lower than that observed in the oxidation performed without C02 
(Entry 1). Cholesterol oxidase from G. chrysocreas (Type I cholesterol oxidase) was 
reported to benefit from cholesterol aggregation. 19, 20, 33 In this work, cholesterol 
oxidase from Nocardia sp. (Type II cholesterol oxidase) was used which may work 
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differently: cholesterol aggregation at a higher level under supercritical conditions 
may suppress the catalytic activity of cholesterol oxidase from Nocardia sp. 
No activity was observed in the oxidation of cholesterol without H20 in the batch 
SCC02 system (Table 7-7, Entries 3-5). A CLEA normally contains a small amount of 
H20 which should be sufficient for the enzyme to function, but unfortunately no 
activity was observed here without H20 (Table 7-7, Entries 3-5). The activity of 
cholesterol oxidase was compared using wet cells and freeze-dried cells by Buckland: 
the activity of cholesterol oxidase dropped significantly using freeze-dried enzyme. 14 
The addition of H20 to the reaction medium improved the catalyst performance of the 
freeze-dried enzymes but only 20 % of the activity displayed by wet cells could be 
achieved.14 The CLEA used here were dried by freeze-drying. The freeze-drying 
procedure might remove all H20 from the CLEA and could also change the structure 
of the enzyme and the activity of the enzyme could therefore significantly decrease. 
The activity of cholesterol oxidase in the dry CLEA was examined in aqueous 
medium (CLEA dispersed in phosphate buffer) and the enzyme showed activity for 
the oxidation of cholesterol, but unfortunately no recovery data is available. 
The oxidation was also examined in an IP NscC02 system with dry CLEA (without 
H20) (Entry 3). The lack of water was shown to significantly decrease the activity of 
the enzyme. Furthermore, the presence of IPA in a large quantity may deactivate the 
enzyme l4,35 and therefore the enzyme activity decreases. 
7.4. Conclusions 
CLEA of cholesterol oxidase and combi-CLEA of cholesterol oxidase and catalase 
were successfully prepared with high retained activity. The effect of different 
precipitants, different cross-linkers, and the cross-linker concentration were 
examined. The precipitating agent was demonstrated to be important in order to 
obtain CLEA with high activity and stability. Cholesterol oxidase from Nocardia 
sp. was found to be sensitive to the presence of most precipitants, only ammonium 
sulfate was suitable to precipitate the enzyme without any loss of activity and 
dimethoxyethane produced 10 % activity loss. Catalase from bovine liver could be 
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precipitated without any activity loss with ammonium sulfate, dimethoxyethane 
and acetone. 
Glutaraldehyde and dextran polyaldehyde were examined as cross-linkers. The 
cross-linker had no significant effect on the cholesterol oxidase CLEA. Catalase 
CLEA was generated with higher activities using dextran polyaldehyde as 
cross-linking agent. The concentration of the cross-linker had similar effect in 
most cases: the cross-linker used in a higher concentration resulted in a CLEA 
with lower activity that may be caused by mass transport limitations of the 
substrate to the active site of the enzyme due to a more rigid structure of the 
CLEA. 
The activity of cholesterol oxidase was lower in combi-CLEA than that in 
individual cholesterol oxidase CLEA. In combi-CLEA, the transport of the 
substrate to the active site of the enzyme might be slower than that in the 
individual cholesterol oxidase CLEA because of a large amount of catalase present 
around cholesterol oxidase. The active site of several cholesterol oxidase 
molecules might also have become blocked in the combi-CLEA. 
SEM images were taken to determine the morphology and size of the CLEA. 
Cholesterol oxidase CLEA prepared using glutaraldehyde and dextran 
polyaldehyde as cross-linker in a higher concentration gave CLEA with well 
defined particles of 0.2-1.5 J.lm size in diameter. The structure of all other CLEA 
could not be clearly determined: paste-like structure was observed that can refer to 
the presence of large aggregates. 
Unfortunately, the 'in-flow' extraction of cholesterol m SCC02 could not be 
optimised. A number of different reactors were designed and examined where the 
following parameters were varied. 
• Length of the extraction vessel. 
• Particle size of cholesterol. 
• Flow rate of CO2. 
• Temperature, pressure. 
Unfortunately. the extraction could not be optimised because the concentration of 
cholesterol in the effluent of the reactor was highly inconsistent in all cases. 
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Although, the 'in-flow' cholesterol extraction could not be optimised, the 
oxidation of cholesterol was examined in a continuous flow SCC02 system with 
cholesterol oxidase (as received), cholesterol oxidase CLEA, and combi-CLEA of 
and cholesterol oxidase and catalase. Unfortunately, very low yield was obtained 
in all cases and therefore the effect of pressure, temperature and flow rate on the 
reaction could not be determined. The low activity in the continuous flow system 
could be due to the lack of water that is required by the enzyme to function or the 
presence of C02 that can inhibit the enzyme activity. 
The yield of the oxidation of cholesterol in a batch scC02 system dropped 
significantly when C02 was present even with a large amount of H20. The 
oxidation produced 0 % yield without H20 in scC02. A CLEA normally contains 
a small amount of H20 but it was shown to be insufficient in this case. The drying 
procedure (freeze-drying) of the CLEA could also influence the activity of 
cholesterol oxidase that may be sensitive to freeze-drying. The results suggest that 
cholesterol oxidase form Nocardia sp. may require a small amount of water to 
function and that the drying of enzyme can also be highly influencing. 
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Chapter 8 
Thesis Conclusions and Future Directions 
This Chapter describes the findings of this Thesis. The results of Chapter 3, 4, 
5,6, and 7 are summarised here and future directions are also suggested. 
8.1. Continuous Asymmetric Hydrogenation with Supported 
Homogeneous Chiral Rh Catalysts on Alumina in scC02 
Continuous catalytic asymmetric hydrogenation in supercritical fluids has been 
investigated previously where the chiral modifier was continuously fed. t. 2 The 
work in this Thesis demonstrates one of the first examples of continuous 
enantioselective hydrogenation in scC02 with a supported homogeneous chiral 
catalyst without the need for the addition of the chiral modifier. 
The chiral catalyst [Rh(COD)(ligand)t[BF4]"1PTAlAlumina modified with 
\ different bisphosphine ligands (Josiphos type ligands, Solvias AG, Basel, 
Switzerland) was examined for the continuous enantioselective hydrogenation 
of dimethyl itaconate in SCC02. The asymmetric hydrogenation gave the 
highest enantioselectivity with [Rh(COD)(Josiphos 001)t[BF4rIPTAlAlumina 
ees = 83 % at 55°C and 100 bar. The bisphosphine ligand attached to the Rh 
complex highly influenced the enantioselectivity of the hydrogenation possibly 
due to differences in electron withdrawing/donating properties, size, and steric 
effect of the ligand. 
In addition, the continuous asymmetric hydrogenation of dimethyl itaconate 
was examined in a biphasic system ionic liquid/scC02. The ionic liquids (lLs) 
[BMIM][BF4], [BMIM] [NTf2], and [BMIM][N(CN)2] were investigated to 
immobilise [Rh(COD)(Josiphos 001)t[BF4r. The highest enantioselectivity 
ees = 76 % was observed in [BMIM][NTf2]1scC02 at 70°C and 100 bar. The 
variation in enantioselectivity using different ILs was possibly due to i) 
differences in solubility of H2 in various ILs ii) differences in solubility of C02 
in various ILs and therefore differences in mass transfer, and iii) differences in 
nucleophilicity/coordination strength of the IL anion. 
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This work on asymmetric hydrogenation showed that the nature of the 
bisphosphine ligand attached to the Rh was crucial to achieve high 
enantioselectivity. Modifications on the substituent attached to the ligand 
backbone by altering the electron withdrawing/donating properties to increase 
the chiral performance of the catalyst would be an interesting area to 
investigate in the future. This concept has already been demonstrated to be 
successful: an increase in enantioselectivity was obtained.3 The ligand tuning 
of Walphos type ligands gave enantioselectivity up to 95 % and 97 % in Ru 
and Rh catalysed hydrogenations of alkenes and ketones, respectively. The 
success of this approach demonstrated on Walphos type ligands is promising to 
develop the chiral motif of other bisphosphine ligands of the Josiphos family. 
8.2. Continuous Kinetic Resolution of a-tetralol Catalysed by 
Cal B CLEA in scC02 
Enzymes can also be used as catalysts of selective reactions. The kinetic 
resolution of I-phenylethanol has already been studied in various reaction 
media including scC02 with Novozym4 435 and Cal B CLEA.s Here, the 
continuous kinetic resolution of another secondary alcohol, a-tetralol, 
catalysed by Cal B CLEA was investigated using different acyl donors 
(vinyl acetate, phenyl acetate, p-nitrophenyl acetate) in scC02• By 
investigating the kinetic resolution a-tetralol, the substrate specificity of the 
enzyme could be determined. 
The selective esterification of a-tetralol gave high enantioselectivity eeR up to 
99 % in a continuous flow scC02 system. The acyl donor significantly 
influenced the enantioselectivity of the reaction: the reaction may be driven 
towards the product more depending on the stability of the by-product 
remammg from the acyl donor. Cal B CLEA displayed lower 
enantioselectivity and conversion in the kinetic resolution of a-tetralol than in 
the kinetic resolution of I-pheylethanol. This suggests that the enzyme may be 
more specific for I-phenylethanol than for a-tetralol, which can be due 
differences in size of the two substrates: a-tetralol is larger than 
I-phenylethanol, and therefore the active site of Cal B may accommodate 
a-tetralol poorly, while it accommodates I-phenylethanol well.6 
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The rate limiting step of the kinetic resolution of a-tetralol by Cal B CLEA 
could not be determined due to the limited amount of materials available in the 
lab. It would be interesting to investigate this in the future. It would also be 
interesting to perform molecular modelling for a-tetralol and I-phenylethanol 
to determine whether Cal B distinguishes these molecules due to their size. 
8.3. Catalytic Cascade Reaction in a Continuous Flow scC02 
system: Hydrogenation followed by the Kinetic Resolution of the 
Product 
A two step chemoenzymatic catalytic cascade reaction for the production of 
(R)-I-phenylethyl acetate was investigated in a continuous flow SCC02 system: 
hydrogenation of acetophenone catalysed by Pd Type 31 followed by the 
kinetic resolution of the product catalysed by Cal B CLEA. Two separate 
reactors were used in the continuous flow system which helped to overcome 
the problem of catalyst incompatibility and also allowed separate control of the 
temperature of each step. The cascade reaction gave high enantioselectivity 
and conversion: 
• Step 1 (hydrogenation of acetophenone): conversion up to 91 % 
• Step 2 (kinetic resolution): conversion up to 22 %, enantioselectivity 
eeR>99%. 
A decrease in C02 flow rate increased the performance of both hydrogenation 
and kinetic resolution. The optimisation of the cascade reaction would be 
interesting to perform in the future. 
The continuous supercritical reactor used in this work may be suitable for 
conducting other series/cascade reactions. It provides a great advantage for 
multistep reactions where the catalysts are incompatible as the physical 
separation of the catalysts is easily attainable. 
8.4. Combi-CLEA of Cholesterol Oxidase and Catalase for the 
Continuous Oxidation of Cholesterol in scC02 
The aim of the work was to optimise the process for the preparation of CLEA 
of cholesterol oxidase, and combi-CLEA of cholesterol oxidase and catalase, 
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and to investigate their activity for the continuous oxidation of cholesterol in 
scC02 with 'in-flow' cholesterol extraction. 
The optimisation of the process for the preparation of CLEA was performed by 
examining effect of different precipitating agents, different cross-linkers, and 
the cross-linker concentration, which resulted in CLEA with high retained 
activity: 
• Individual cholesterol oxidase eLBA: activity of cholesterol oxidase up 
to 99 % (relative to native) 
• Combi-CLEA: activity of cholesterol oxidase up to 99 % (relative to 
native), activity of catalase up to 53 % (relative to native). 
The precipitating agent was shown to be important in order to produce CLEA 
with high retained activity and high stability. Cholesterol oxidase was shown 
to be highly sensitive to the presence of a precipitant, while catalase was found 
to be less sensitive. The cross-linker, glutaraldehyde and dextran polyaldehyde, 
and its concentration had a significant effect on the enzyme activity in the 
CLEA. The cross-linker itself had a small effect on cholesterol oxidase CLEA, 
while it had a more significant effect on catalase CLEA that was generated 
with a much higher activity using dextran polyaldehyde as cross-linker. The 
concentration of the cross-linker had a similar effect in most cases: the cross-
linker used in a higher concentration resulted in CLEA with lower activity 
possibly due to mass transport limitations of the substrate to the active site of 
the enzyme in a more rigid structure of the CLEA. In the combi-CLEA, the 
activity of cholesterol oxidase was highly dependent on the amount of catalase 
present: higher cholesterol oxidase activity was observed with less catalase. 
The lower cholesterol oxidase activity might be due to mass transport 
limitations of the substrate to the active site of the cholesterol oxidase which 
was probably due to the large mass of catalase present in the combi-CLEA. 
The CLEA was examined for the continuous oxidation of cholesterol in scC02 
with 'in-flow' extraction of cholesterol. Although, the 'in-flow' extraction of 
cholesterol could not yet be optimised (high inconsistency in the concentration 
of cholesterol in the effluent of the reactor using either reactor setup), the 
continuous oxidation of cholesterol was examined with cholesterol oxidase 
CLEA and combi-CLEA of cholesterol oxidase and catalase in scC02• 
Unfortunately, very low yield was obtained with all catalysts at all conditions 
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in the continuous flow system which could be due to the lack of water. The 
oxidation of cholesterol in a batch scC02 system also showed that the lack of 
water may be the main limiting factor. A CLEA normally contains a small 
amount of H20 but it was shown to be insufficient in this case. The drying 
procedure (freeze-drying) of the CLEA could also influence the activity of 
cholesterol oxidase that may be sensitive to freeze-drying. The results suggest 
that cholesterol oxidase form Nocardia sp. may require a small amount of 
water to function and that the drying can highly influence the enzyme activity. 
The continuous oxidation of cholesterol in SCC02 can have potential in the 
manufacture of the oxidation products of cholesterol and derivatives. The 
findings of this work can aid the development of the process. The catalyst 
performance may increase if H20 is present which would be interesting to 
examine in a continuous flow scC02 system in the future. Cholesterol oxidase 
form Nocardia sp. may be sensitive to freeze-drying, the method used here to 
dry the CLEA, which would be important to investigate in the future. The 
stability of the CLEA and the combi-CLEA against organic solvents and 
temperature would also be important to investigate in the future. Cholesterol 
oxidases from different groups share the same catalytic activity, but they show 
no sequence homology and the FAD cofactor binding is also different. 7, 8 
CLEAtion of cholesterol oxidase from different sources would be interesting to 
investigate to demonstrate whether these differences between cholesterol 
oxidases from different groups influence the immobilisation of the enzyme. 
A number of factors have been investigated to optimise the 'in-flow' 
cholesterol extraction in a continuous flow scC02 system but unfortunately it 
was unsuccessful. Foster and co-workers reported a solubility study on 
cholesterol in a flow SCC02 system.9 The reactor designed by Foster and by us 
differentiated only in the sample collection method that may be key to achieve 
steady state, however, we are convinced that the sample collection method of 
our system was also highly suitable. The optimisation of the 'in-flow' 
extraction in our continuous flow system would be interesting to perform in the 
future. 
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8.5. Thesis Summary 
This Thesis has investigated the use of several immobilised catalysts for 
continuous enantioselective reactions in scC02• The aim of the research was to 
achieve high enantioselectivity using metal complexes and enzymes as 
catalysts. The compatibility of supported homogeneous chiral Rh catalysts and 
Cross-Linked Enzyme Aggregates of different enzymes in continuous flow 
supercritical reactions was demonstrated successfully, which have great 
potential to perfonn exciting and productive research in the future. 
This work also demonstrated examples for individual CLEA and 
combi-CLEA. Although CLEA of several different enzymes have already been 
prepared successfully, CLEAtion still is an intriguing research field and yet to 
be explored in a greater extent. 
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